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 1 
Abstract 
 
Depression is both a risk factor for the development of cardiovascular conditions and a risk 
factor for poorer mortality and morbidity outcomes in those with existing cardiovascular 
disease.  Cardiac rehabilitation programs aim to modify cardiovascular risk factors and 
improve prognosis for cardiac patients, yet little research has investigated the relationship 
between depression, cardiac rehabilitation participation and outcomes.  This study aimed to 
address this need through conduction of a large-scale investigation of depressive symptoms 
in cardiac patients and their relationship with physical health indicators and long-term 
outcomes of morbidity and mortality.   
Method: A total of 1625 consecutively enrolled cardiac rehabilitation cases (24.2 % 
female, mean age = 59.8 yrs) completed the Cardiac Depression Scale (CDS, Hare & 
Davis, 1993) and provided demographic and physical health information.  Follow-up data 
was obtained at discharge (N = 1042), three (N = 742) and twelve (N = 486) month follow-
up.  Data linkage was used to obtain morbidity information through the Victorian Admitted 
Episodes Database and mortality information through the Victorian Death Registry (N 
=1,402) over a mean follow-up period of 3.7 years.   
Results: There was a statistically significant reduction in rates of Moderate/Severe 
depressive symptoms between admission (39.9%) and discharge (19.4%), which was 
maintained at three (20.3%) and twelve month follow-up (21.3%).  Elevated depressive 
symptoms at admission were associated with poorer morbidity and mortality outcomes.  A 
significant interaction effect between depressive symptoms, program completion and 
morbidity was found.  Further findings on the relationships between depressive symptoms, 
patient demographics, program completion, physical outcomes, morbidity and mortality 
are presented. 
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Conclusion: A clinically significant proportion of cardiac rehabilitation patients reported 
moderate/severe levels of depressive symptoms, and these were related to poorer morbidity 
and mortality outcomes.  The potential role of cardiac rehabilitation programs in 
addressing the treatment of depression through provision of structured exercise is 
discussed and recommendations regarding further research made.   
 3 
Introduction 
 
In recent years the relationship between depression and prognosis for cardiac patients 
has received much attention.  Poorer outcomes in terms of morbidity and mortality have 
been reported and large-scale trials of potential treatments have been conducted 
(ENRICHD 2001, 2003; Glassman et al., 2002).  Despite the increasing level of interest in 
this area, relatively little research has explored the role of cardiac rehabilitation programs.  
Cardiac rehabilitation programs may be ideally placed to address this issue given that they 
are designed to implement risk factor modification and improve patients’ prognosis 
(NHFA & ACRA, 2004).  Furthermore, they comprise a structured exercise program, and 
exercise has been found to be an effective treatment for mild/moderate levels of depression 
in the general population (Barbour & Blumenthal, 2005; Dunn, Trivedi, Kampert, Clark, & 
Chambliss, 2005).  It was the aim of this project to conduct a large-scale evaluation of 
depression and outcomes in cardiac rehabilitation patients.   
A total of 1625 consecutively enrolled cardiac rehabilitation patients were enrolled in 
this study. Information on patient demographics, physical health and depressive symptoms 
was obtained at admission, discharge (N = 1042), three (N = 742) and twelve (N = 486) 
month follow-up.  Data linkage was used to obtain morbidity information through the 
Victorian Admitted Episodes Database and mortality information through the Victorian 
Death Registry (N = 1,402) over a mean follow-up period of 3.7 years.  This thesis is a 
detailed report of the research conducted, the findings obtained, and the implications of 
these findings for the detection and treatment of depression in cardiac rehabilitation 
patients.  
Chapter one introduces the biopsychosocial model of health, followed by an 
overview of cardiovascular disease, cardiac rehabilitation, and depression.  A review of the 
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research literature on the relationship between cardiovascular disease and depression is 
then presented, including a discussion of relevant research design factors, such as 
participant characteristics, assessment method, and timing of assessment.  Finally, a review 
of current knowledge about the treatment of depression in cardiac patients, with particular 
reference to the potential of cardiac rehabilitation programs in this area, is presented and 
the research aims of this project specified.  Chapter one is followed by a detailed 
description of the method used in this project, including participants, procedures and 
materials, in chapter two.   
The results of this project are presented in chapters three, four and five.  Chapter 
three explores the prevalence rate of depressive symptoms in the study population, the 
course of depressive symptoms over time and the relationship between depressive 
symptoms and patient demographics.  Chapter four explores the relationship between 
depressive symptoms, cardiac rehabilitation program completion and physical health 
outcomes for participants.  Chapter five explores the relationship between depressive 
symptoms and longer-term outcomes of morbidity and mortality.  Each of the results 
chapters commences with a brief overview of the research literature relating to the research 
aims explored in that chapter.  Additional information about the method pertaining that 
chapter is provided.  The analysis used and the results obtained are then detailed, 
concluding with a summary of findings. 
The final chapter explores each of the six research aims in turn, outlining the results 
obtained in this study and discussing their implications in the context of published 
research.  The limitations of the current study are discussed; conclusions are drawn about 
the relationship between depressive symptoms and outcomes in cardiac rehabilitation 
patients, and recommendations for future research proposed.        
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Chapter 1: 
Cardiovascular Disease and Depression 
 
At the turn of this century cardiovascular disease, cancer and mental disorders were 
identified as the leading causes of disease burden in Australia (Begg et al., 2007). This is a 
marked change from the beginning of the previous century when mortality and morbidity 
were predominantly due to dietary deficiencies and infectious diseases (Caltabiano, Byrne, 
Martin, & Sarafino, 2002). Whilst this change reflects improvements in living conditions 
and progress in disease identification and treatment (Arnetz, 1996; House, 2002), it has 
also heralded a development in our conceptualisation of health and wellness.   
The biomedical model of health drove the development of Western medicine and 
health care in the first two thirds of the twentieth century (Suls & Wallston, 2003).  The 
biomedical model developed from ‘germ theory’, the belief that bacteria, viruses, and other 
pathogens were the principal causes of disease and, as a consequence, medical diagnosis 
and treatment focused on the biological functioning of humans (Suls & Wallston, 2003).  
Whilst a focus on disease-causing organisms has proved extremely effective in 
identification and treatment of infectious diseases, it has been less effective in treating 
more chronic diseases (Brannon & Feist, 2007).  Whereas acute diseases are typically 
identifiable, and treatment returns a patient to full functioning, chronic diseases have 
multiple pathogeneses, less predictable courses, and require ongoing management rather 
than being curable per se (Sperry, 2006).  Whilst the biomedical model has driven 
advances in pharmacological and surgical interventions for chronic diseases, there has 
been a growing recognition that a focus on biological factors alone does not allow 
comprehensive understanding and treatment of such conditions (Main, Richards, & 
Fortune, 2000). 
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Engel (1977) proposed that the biomedical model was inadequate due to its lack of 
recognition of the psychological and social factors that influence illness and health.  He 
proposed adopting a biopsychosocial model of health, that views the patients’ biological 
system as operating within, and being influenced by, both their psychological system of 
beliefs and emotions, and their wider social systems of family, community, and society 
(Caltabiano et al., 2002).  Such an approach allows a more complex understanding of 
chronic diseases, greater flexibility in explaining individual differences in illness 
experiences and the opportunity for a broader range of prevention, management, and 
treatment strategies. 
It has been reported that whilst the biopsychosocial model of health is appealing to 
clinicians and researchers alike, it has been difficult to implement (Weston, 2005; 
Zimmerman & Tansella, 1996).  In medical settings, doctors report difficulty due to a lack 
of training and lack of time to implement such a model (Biderman, Yeheskel, & Herman, 
2005). In medical research, the biomedical definition of health still predominates, with a 
review of published research finding no greater emphasis on psychological and social 
factors in 1996-2000 than in 1978-1982 (Alonso, 2004).  The complexities of 
biopsychosocial models of illness make theoretical development and empirical evaluation 
more difficult (Walker, Jackson, & Littlejohn, 2004).  Despite these difficulties, 
biopsychosocial models and treatments for a variety of conditions such as chronic pain 
(Turk & Monarch, 2006), psoriasis (Main et al., 2000), rheumatoid arthritis (Walker et al., 
2004), and irritable bowel syndrome (Porcelli, 2004) have been developed. 
Cardiovascular Disease (CVD) is one area in which a biopsychosocial approach has 
improved our understanding of its aetiology, treatment, and prognosis.  In addition to 
traditional biological risk factors such as hypertension, smoking, and genetic history (Maas 
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& Boger, 2003), psychosocial risk factors for the development of cardiovascular disease 
have also been identified.   
Stemming from psychosomatic theory of the early twentieth century was the concept 
of specificity, the notion that specific types of psychological distress were linked with 
specific disorders or organ disfunction (Stein, 1986).  In 1974, Friedman and Rosenman 
proposed the ‘Type A behaviour pattern’, characterised by intense ambition, 
competitiveness, aggression, hostility, and impatience (cited in Evans, 1990).  This 
behaviour pattern was reported to be associated with an increased risk of coronary heart 
disease (Kornitzer, Kittel, De Backer, & Dramaix, 1981) and cardiac mortality (Bruhn, 
Paredes, Adsett, & Wolf, 1974).  Whilst subsequent research has indicated Type A 
behaviour pattern is not a reliable predictor of cardiovascular disease development 
(Compare, Manzoni, & Molinari, 2006), significant interest in psychosocial risk factors has 
remained.  The relative contributions of aspects of Type A personality, such as aggression, 
hostility, and stress have been explored (Riska, 2000), as well as other potential 
psychosocial risk factors including anxiety, social support, and depression (Bunker et al., 
2003).  Indeed, a considerable amount of research has examined the link between acute 
emotional stress and sudden cardiac death with recent recommendations about detecting 
vulnerable patients and appropriate treatments for this phenomenon being made 
(Zeigelstein, 2007).   
In addition to the exploration of the role of psychosocial factors as risks for the onset 
of cardiovascular disease, their impact on the prognosis of those with established 
cardiovascular disease has also been investigated.  Psychosocial factors have been found to 
be influential in determining response to cardiac surgery (Doering, Moser, Lemankiewicz, 
Luper, & Khan, 2005; Oxlad, Stubberfield, Stuklis, Edwards, & Wade, 2006), adherence to 
treatment recommendations (Kronish et al., 2006; Lane, Carroll, Ring, Beevers, & Lip, 
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2001b), and long term recovery in terms of subsequent morbidity and mortality (Bush et 
al., 2001; Frasure-Smith, Lesperance, & Talajic, 1995; Jaffe et al., 2006).  In particular, 
depression appears to have a strong and robust relationship with patient outcomes (Bunker, 
Colquhoun et al., 2003; Frasure-Smith & Lesperance, 1999) and there is a growing 
recognition within cardiac care that depression needs to be identified and treated to aid 
cardiac patient recovery (ENRICHD, 2001; NHFA & CSANZ, 2007).   
 
Cardiovascular Disease 
In 2003, cardiovascular disease was estimated to account for 18.0% of Australia’s 
total disease burden, second only to cancer (Begg et al., 2007).  Disease burden is a 
summation of years of healthy living lost due to premature death or disability associated 
with illness or injury (Begg et al., 2007).  Cardiovascular disease remains the leading cause 
of death for males and females despite marked reductions in cardiovascular mortality since 
the 1960’s (Vos & Begg, 2007).  This decline in mortality has been attributed to 
improvements in medical care and intervention, and recognition and modification of 
lifestyle risk factors, in particular smoking, through public health campaigns (AIHW, 
2004c; Begg et al., 2007).   
As survival rates for acute cardiovascular events have improved, there has been an 
associated increase in the number of people living with a chronic cardiovascular condition.  
Over the last decade cardiovascular disease prevalence rates rose by 18.2 % and 
hospitalisation rates rose by 19.8% (AIHW, 2004c).  Furthermore, cardiovascular disease 
accounts for the largest portion of Australian health care expenditure for all groups of 
diseases (AIHW, 2004b).  Thus, whilst significant improvements have been seen in 
cardiovascular disease mortality and risk factor modification, cardiovascular disease 
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remains a significant health issue for Australians.  This is highlighted by its inclusion as 
one of the seven Australian National Health Priority Areas (AIHW, 2004a). 
In order to reduce cardiac mortality and morbidity a combination of primary and 
secondary prevention strategies have been implemented.  Primary prevention aims to 
reduce the incidence of cardiac conditions by identifying risk factors for disease 
development and assisting people to control modifiable risk factors (Jairath, 1999; 
Thompson & Webster, 2004).  For example, primary prevention may target hypertension 
(high blood pressure), smoking or elevated blood lipid levels (cholesterol) (Jairath, 1999).  
Once a coronary condition develops, such as coronary heart disease, secondary prevention 
programs aim to treat the disease and prevent, or slow, subsequent progression of the 
disease (Thompson & Webster, 2004).   
Cardiovascular disease (CVD) refers to all heart and blood vessel diseases, including 
stroke (AIHW, 2004c).  Cardiac conditions are a subset of cardiovascular conditions, and 
are limited to the diseases of the heart.  Following a review of common cardiac conditions 
and their specific treatments, secondary prevention strategies for cardiac conditions will be 
discussed. 
Coronary heart disease, also known as coronary artery disease or ischemic heart 
disease (AIHW, 2004c), is the most common cardiovascular condition in Australia 
(AIHW, 2004a).  It is characterised by insufficient blood supply to the heart muscle 
(myocardium) itself, usually due to atherosclerosis, a build up of fatty deposit (plaque) on 
the inner wall of the coronary artery (Mathur, 2002).   Coronary artery disease has two 
main clinical presentations; angina and heart attack (AIHW, 2004c).  
In angina, atherosclerosis reduces flow of blood to the myocardium impairing its 
ability to pump harder during times of exercise or stress (Mathur, 2002).  This creates a 
temporary feeling of pain or tightness in the chest, but does not lead to permanent damage 
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of the myocardium (Mathur, 2002).  During a heart attack the coronary plaque breaks open 
and a blood clot is created which blocks blood flow in the artery (AIHW, 2004c).  If the 
clot is not treated promptly the myocardium is deprived of oxygen, causing cell and tissue 
death in the heart muscle, a condition called acute myocardial infarction (AMI) (Mathur, 
2002).   
Coronary heart disease is usually treated through a combination of prescribed 
medication and lifestyle modifications such as smoking cessation, reduced alcohol intake, 
exercise, and healthy eating (Gray, Dawkins, Morgan, & Simpson, 2002).  Significant 
progress in pharmacological treatment of cardiac conditions has ensured that there are a 
wide range of effective drug treatments for acute care and secondary prevention of 
coronary conditions (Mathur, 2002).  ACE inhibitors, beta blockers, and other anti-
hypertensives, statins and other lipid lowering drugs, antithrombotics to prevent blood 
clots, and other cardiovascular drugs accounted for 17.4% of all pharmaceutical costs in 
Australia in 2000-01(AIHW, 2005), making them one of the most commonly used and 
prescribed medication types in Australia. 
Patients with persistent narrowing (stenosis) of the coronary arteries may undergo 
surgical revascularisation procedures in order to remove or bypass the blockages (Mathur, 
2002).  Percutaneous transluminal coronary angioplasty (PTCA), involves inserting a 
catheter through the circulatory system to reach the site of blockage and inflating a balloon 
at the catheter tip to flatten the plaque (Bucher & Melander, 1999).  This process enlarges 
the internal diameter of the artery allowing restoration of normal blood flow (Bucher & 
Melander, 1999).  PTCA can be combined with insertion of a stent, a small mesh tube, at 
the affected site to prevent the artery from collapsing or the plaque reforming (Thompson 
& Webster, 2004).  More recently, stents coated with medication (drug eluting stents) have 
been used to reduce likelihood of restenosis (AIHW, 2004c).  
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The second most common revascularisation procedure in Australia is coronary artery 
bypass graft (CABG) surgery (AIHW, 2007).  CABG involves ‘re-routing’ the blood flow, 
by grafting of alternative blood vessels onto the coronary artery to redirect the blood flow 
and by-pass the blocked area (Bucher & Melander, 1999).  Whilst the number of CABG’s 
performed annually in Australia declined by 15% between 1993 and 2002, PTCA 
procedures doubled over this period, with 91% of patients also undergoing a stent insertion 
(AIHW, 2004c).  This trend has continued with most recent figures reporting that 14,222 
CABG’s and 34,705 PTCA’s were performed in Australian hospitals in the year 2005-06 
(AIHW, 2007). 
Heart failure occurs when the heart muscle is too weak to pump blood as effectively 
as usual (AIHW, 2004c).  This may be the result of a previous AMI, sustained high blood 
pressure, a faulty heart valve, or viral infection (NHFA & CSANZ, 2004).  As heart failure 
has multiple causes, treatment varies depending on its pathogenesis (Bucher & Melander, 
1999).  Treatment usually involves medication, promotion of self-care to improve quality 
of life, and less commonly surgical intervention (NHFA & CSANZ, 2004).  Surgical 
treatment may include heart transplant, a relatively rare procedure, with only 72 heart 
transplants performed in Australia in 2000-01(AIHW, 2004c).  
Heart failure is the third leading cause of death among heart, stroke, and vascular 
diseases and is estimated to affect approximately 300,000 Australians (AIHW, 2004c).  
The number of people living with heart failure is expected to increase markedly due to our 
ageing population and decreasing mortality rates for cardiac conditions (NHFA & CSANZ, 
2004). 
Arrhythmia refers to a disturbed rhythm of the heart (Mittal, 2005).  If the heart beats 
too fast, too slowly or in an irregular pattern the optimal flow of blood may be reduced 
(Thompson & Webster, 2004).  In mild cases this may result in fatigue, palpitations or 
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dizziness, in more serious cases little or no effective circulation leads to death (Thompson 
& Webster, 2004).   
Arrhythmia is common following myocardial infarction, and treatment may involve 
medication or electrical intervention (Mittal, 2005).  A patient with a persistent life 
threatening arrhythmia may have a regulating device, such as a pacemaker or an 
implantable cardiac defibrillator (ICD) surgically implanted into their chest cavity (NHFA, 
2004a, 2004b).  A pacemaker is an electrical device attached to the heart to stimulate or 
depress heart rate in response to detection of too slow or too fast a heart beat (NHFA, 
2004a).  An ICD incorporates a pacemaker, but is also able to deliver a shock to the heart 
if a dangerous irregular heart beat is detected (NHFA, 2004b).   
Whilst pharmacotherapy and surgical interventions are effective in treating and 
reducing subsequent progression of cardiac conditions (Braunwald, 1997), it has been 
recognised that the primary prevention strategy of risk reduction is equally important after 
the onset of a cardiac condition (Jairath, 1999).  Thus secondary prevention strategies need 
to involve both appropriate medical interventions and other strategies for risk reduction 
such as education and risk factor modification.   
Cardiac rehabilitation programs are one secondary prevention strategy that has been 
developed to meet this need for risk reduction in those with identified cardiac disease.  The 
aim of cardiac rehabilitation programs is to facilitate recovery from cardiovascular events 
and promote secondary prevention of further cardiovascular morbidity and mortality 
(Goble & Worcester, 1999). These programs are recommended by the World Health 
Organisation for all people with cardiovascular disease (NHFA & ACRA, 2004). 
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Cardiac Rehabilitation 
The National Heart Foundation introduced cardiac rehabilitation programs into 
Australia in 1961 (Bunker & Goble, 2003).  Early cardiac rehabilitation programs focused 
on supervised, high intensity exercise programs (Bunker & Goble, 2003) and targeted low-
risk coronary patients (Ades & Coello, 2000).  These programs aimed to counter the 
physical deconditioning, medical complications, and disability that resulted from extended 
bed rest and limited physical activity (Ades & Coello, 2000).    
In addition to supervised physical activity, modern cardiac rehabilitation programs 
involve education, support, medical evaluation, cardiac risk factor modification, 
behavioural intervention, and counselling (Dafoe & Huston, 1997; NHFA & ACRA, 
2004).  They have also expanded to meet the need of a broader group of cardiac patients.  
Current Australian guidelines recommend that all people who have had myocardial 
infarction, re-vascularisation procedures, stable or unstable angina, controlled heart failure, 
or other vascular or heart disease attend cardiac rehabilitation (NHFA & ACRA, 2004).  
Patients awaiting cardiac investigation or intervention, or those with multiple risk factors 
may also participate in cardiac rehabilitation (NHFA & ACRA, 2004).  
Cardiac rehabilitation occurs across a continuum from hospitalisation through to 
long-term follow-up.  This has traditionally been considered as a phase model with Phase 1 
occurring during the inpatient stay, Phase 2 being discharge up to 6 weeks, Phase 3 being 
6-12 weeks post discharge, and Phase 4 involving long term maintenance (Thompson & 
Webster, 2004).  In current practice outpatient cardiac rehabilitation programs aim to 
provide a continuous model of care covering Phase 2, 3, and, at times, Phase 4 (AACVPR, 
2004).   
The secondary prevention role of cardiac rehabilitation involves modification of 
cardiovascular risk factors (Goble & Worcester, 1999). Traditional cardiovascular risk 
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factors include non-modifiable factors: age, gender, and genetics and modifiable risk 
factors: smoking, hypertension, blood lipid levels, obesity and diabetes (Khot et al., 2003; 
Maas & Boger, 2003; Martinez-Rubio, 1999).  Cardiac rehabilitation programs employ a 
number of strategies to promote risk factor modification. 
A principal means by which cardiac rehabilitation aims to modify patient risk factors 
is through provision of education and information.  Education programs aim to increase 
patients’ knowledge about cardiac risk factors and appropriate management strategies 
(Egan, 1999) in order to increase treatment adherence and lifestyle change (Jairath, 1999).  
A meta-analysis of 28 randomised controlled trials of patient education following CHD 
found significant improvement in exercise and diet for the treatment group, and a 19% 
reduction in mortality (Mullen, Mains, & Velez, 1992).  A more recent meta-analysis of 
psycho-educational programs for CHD reported a 34% reduction in mortality and 29% 
reduction in subsequent AMI (Dusseldorp, van Elderen, Maes, Meulman, & Kraaij, 1999).  
Furthermore, comparison of programs showed that the greater the improvement in risk 
factors, the greater the benefit in long term outcomes of morbidity and mortality 
(Dusseldorp et al., 1999). 
Interestingly a review of patients’ perceptions of the effectiveness of cardiac 
rehabilitation indicated that whilst new information was seen as valuable, other factors 
such as increased confidence were more important in promoting behaviour change (Clark, 
Whelan, Barbour, & MacIntyre, 2005).  This indicates that effective psycho-education 
goes beyond information provision (Sperry, 2006) and requires awareness of the processes 
of behaviour change and meaningful interaction with the cardiac patient (AACVPR, 2004).  
A core component of cardiac rehabilitation programs is the restoration of physical 
functioning through exercise training (AACVPR, 2004). Exercise training has been shown 
to increase exercise tolerance in cardiac patients with stable coronary heart failure 
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(Belardinelli, Georgiou, Cianci, & Purcaro, 1999), following AMI or re-vascularisation 
procedures (Gassner, Dunn, & Piller, 2003; Pasquali, Alexander, Coombs, Lytle, & 
Peterson, 2003; Sundin et al., 2003) and ICD implantation (Fitchet et al., 2003).  Exercise 
training has also effectively increased exercise tolerance in obese cardiac patients (Lavie & 
Milani, 1997) and in elderly patients (Austin, Williams, Ross, Moseley, & Hutchison, 
2005; Lavie & Milani, 1996).   
Improved exercise tolerance is important as it is a significant predictor of long term 
prognosis, with poor exercise capacity increasing risk of cardiac and all cause mortality in 
cardiac patients (Kavanagh et al., 2002).  There are several possible mechanisms for this 
effect.  Exercise training has a positive impact on blood pressure in cardiac patients 
(Gassner et al., 2003; Wallner et al., 1999).   A recent meta-analysis of 48 trials of cardiac 
rehabilitation compared to usual care (N=8940), found significantly greater reductions in 
blood pressure for those in cardiac rehabilitation programs (Taylor et al., 2004). 
Furthermore, the 2001 Cochrane review of exercise-only and comprehensive cardiac 
rehabilitation programs reported that both have significant beneficial effects on blood lipid 
profile (Jolliffe et al., 2001). 
Cardiac rehabilitation also aims to reduce cardiac patient obesity.  Studies report that 
approximately 30% of Australian cardiac patients are obese (Farley, Wade, & Birchmore, 
2003; Vale, Jelinek & Best, 2002; Yap, Mohajeri, & Yii, 2007).  Cardiac rehabilitation has 
been associated with improvements in diet (Koikkalainen, Mykkanen, Julkunen, Saarinen, 
& Lappalainen, 2002; Pasquali et al., 2003) and with weight loss (Lavie & Milani, 1997; 
Wallner et al., 1999; Yates, Braklow-Whitton, & Agrawal, 2003).   However other studies 
have reported cardiac patients experienced no change in body mass index, a measure of 
obesity, as a result of cardiac rehabilitation (Lavie & Milani, 1996; Lindsay, Hanlon, 
Smith, & Belcher, 2003).  It has been suggested that the exercise component of cardiac 
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rehabilitation is often insufficient to provide the caloric expenditure required for weight 
loss (Savage, Brochu, Poehlman, & Ades, 2003) and that exercise alone is a relatively 
ineffective method for weight loss (Bensimhon, Kraus, & Donahue, 2006).  This further 
emphasises the need for comprehensive cardiac rehabilitation programs, which address 
exercise planning and nutrition, as opposed to purely exercise based programs.   
The efficacy of cardiac rehabilitation programs in reducing rates of smoking is less 
clear. Whilst one large meta-analysis reported a significant reduction in self-reported 
smoking rates for those in cardiac rehabilitation (Taylor et al., 2004) the Cochrane review 
reported favourable but non significant trends in smoking reduction (Jolliffe et al., 2001).  
These mixed findings may be influenced by the widespread availability of information and 
support to quit smoking outside of cardiac rehabilitation programs (Jairath, 1999), 
differences in follow-up time given that many cardiac inpatients initially cease smoking 
but resume within 12 months (Willich et al., 2001) and the difficulty of implementing 
intensive smoking reduction support programs within cardiac rehabilitation settings 
(Hajek, Taylor, & Mills, 2002).  
Overall, research indicates that cardiac rehabilitation has demonstrable effects on 
risk factor modification.  This was illustrated in a comparison of 92 sibling pairs who both 
experienced AMI and had similar risk profiles but were discordant on cardiac 
rehabilitation attendance.  Those who attended rehabilitation demonstrated significantly 
better blood pressure, blood lipid profiles, were significantly less likely to be smoking, and 
had fewer modifiable risk factors than their non-attending siblings (Baessler et al., 2001).  
Whilst cardiac rehabilitation is successful in modifying cardiac risk factors, it is also 
important to establish that this translates into long-term benefits of reduced morbidity and 
mortality for participants.  The Lifestyle Heart Trial (Ornish et al., 1990), an evaluation of 
an intensive, comprehensive cardiac rehabilitation program, showed improved morbidity 
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outcomes for its participants.   Progression of coronary atherosclerosis was monitored over 
a five year follow-up period, with those in the intervention group experiencing significant 
improvement in coronary blood flow, and those in the control group showing deterioration 
in coronary blood flow and experiencing twice as many subsequent cardiac events (Ornish 
et al., 1990; Ornish et al., 1998).   
Other evaluations of outpatient programs have shown a reduced risk of re-
hospitalisation for heart failure patients (Belardinelli et al., 1999) and of revascularisation 
for PTCA patients (Wallner et al., 1999), who attend cardiac rehabilitation.  However, 
whilst recurrence of non-fatal AMI was found to be significantly less for cardiac 
rehabilitation patients in earlier studies (Hedback, Perk, & Wodlin, 1993), more recent 
meta-analyses have reported mixed findings.  A meta-analysis of all types of cardiac 
rehabilitation (inpatient, outpatient, community, or home-based) involving an exercise 
component reported no benefit in subsequent rate of non-fatal AMI for participants 
(Jolliffe et al., 2001; Taylor et al., 2004).  However a meta-analysis of solely outpatient 
cardiac rehabilitation programs conducted by health professionals found a significant 
reduction in risk for AMI (Clark, Hartling, Vandermeer, & McAlister, 2005).  This 
indicates that beneficial effects on morbidity are more likely to occur in outpatient cardiac 
rehabilitation programs that provide comprehensive rehabilitation programs delivered by 
appropriately qualified staff.   
Participation in a cardiac rehabilitation program has also been associated with a 
reduced risk of subsequent mortality.  Meta-analyses report a reduced risk of fatal AMI of 
between 17 percent (Clark, Hartling et al., 2005) and 25 percent (O'Connor et al., 1989).  
For mortality due to any cardiovascular cause the reported reduced risk ranges between 22 
percent (O'Connor et al., 1989) and 26 percent (Taylor et al., 2004).  All cause mortality 
was also substantially reduced for those participating in cardiac rehabilitation, ranging 
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from a 15 percent (Clark, Hartling et al., 2005) to a 27 percent (Jolliffe et al., 2001) risk 
reduction.  The benefit also becomes more apparent over longer follow-up periods, 
increasing to 47 percent risk reduction for all cause mortality for those trials with at least 
24 months follow-up (Clark, Hartling et al., 2005).   
This benefit has also been demonstrated in an Australian setting.  A comprehensive 
study assessing outcomes of all AMI or re-vascularisation patients admitted to Victorian 
hospitals in 1988 found a reduced risk for mortality of 35 percent at five-year follow-up for 
those who attended a cardiac rehabilitation program (Sundararajan, Bunker, Begg, 
Marshall, & McBurney, 2004).   
In summary, cardiac rehabilitation is effective in modifying cardiac risk factors and 
confers benefits in terms of reduced risk of subsequent morbidity and mortality.  Cardiac 
rehabilitation has also been shown to have additional benefits including improved quality 
of life (Belardinelli et al., 1999; Beniamini, Rubenstein, Zaichkowsky, & Crim, 1997; 
Gassner et al., 2003; Yu et al., 2004) and return to work rate (Hedback et al., 1993).   
Despite the potential benefits of participation in a cardiac rehabilitation program, 
attendance rates are relatively low in Australia (Bunker & Goble, 2003), and 
internationally (Cooper, Jackson, Weinman, & Horne, 2002; Daly et al., 2002).  In 
Australia, the reported percentage of eligible cardiac patients who attend outpatient cardiac 
rehabilitation ranges from 15-25 percent (Redfern, Ellis, Briffa, & Freedman, 2007; Scott, 
Lindsay, & Harden, 2003; Sundararajan et al., 2004) to 40-50 percent (Farley et al., 2003; 
Worcester, Murphy, Mee, Roberts, & Goble, 2004). These rates are similar to figures 
reported in Canada (Grace et al., 2002), the United States (Ades, 2001; Witt et al., 2004), 
the United Kingdom (Lane, Carroll, Ring, Beevers, & Lip, 2001b), and China (Mak, Chan, 
& Yue, 2005).  Participation rates are higher for males than females (Shanks, Moore, & 
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Zeller, 2007; Sundararajan et al., 2004; Witt et al., 2004) and for younger (less than 70 
years) patients (Cooper et al., 2002; Sundararajan et al., 2004; Worcester et al., 2004). 
 
Cardiac Conditions and Risk Factors 
Whilst cardiac rehabilitation programs have been shown to be effective in targeting 
traditional cardiac risk factors, not all patients with cardiac disease have these risk factors.  
It has been claimed that half of all patients with coronary heart disease do not have any of 
the traditional risk factors (Braunwald, 1997; Futterman & Lemberg, 1998).  Whilst 
subsequent research has indicated that this figure is more likely to lie between 15-25 
percent of coronary heart disease patients (Beaglehole & Magnus, 2002; Khot et al., 2003), 
this claim has driven research to identify additional cardiac risk factors to improve 
prediction of development and progression of cardiac disease (Marmot, 2002; Nieto, 
1999).     
The INTERHEART study examined the effect of modifiable risk factors on AMI in 
11,119 cases and 13,648 controls across 52 countries (Rosengren et al., 2004; Yusuf et al., 
2004).  Over 90 percent of risk for first time AMI was accounted for by nine risk factors: 
traditional risk factors (lipid profile, smoking, hypertension, diabetes, obesity) and four 
newer risk factors; psychosocial factors, fruit and vegetable consumption, alcohol use and 
physical activity (Yusuf et al., 2004).  The strongest risk factors (those with an odds ratio 
greater than 2 for first time AMI) were the five traditional risk factors and psychosocial 
factors (Yusuf et al., 2004).  In this study psychosocial risk factors referred to a combined 
measure of depression, locus of control, perceived stress, and life events (Yusuf et al., 
2004).   
Research into psychosocial risk factors has predominantly focused on internal states 
of anxiety, anger/hostility, and depression and external factors of social support and stress.  
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Reviews of the evidence linking these psychosocial factors with the development and 
progression of coronary heart disease have concluded that there is strong and consistent 
evidence supporting depression as a coronary risk factor, lesser evidence for anxiety and 
lack of social support, and equivocal evidence for stress and hostility (Bunker, Colquhoun 
et al., 2003; Frasure-Smith & Lesperance, 1999; Strike & Steptoe, 2004; Suls & Bunde, 
2005).  Whilst some researchers have attempted to identify an underlying negative 
affective state common to the disparate psychosocial factors such as vital exhaustion 
(Buerki & Adler, 2005), or the distressed (Type D) personality (Pedersen & Denollet, 
2003; Sher, 2005), research has largely focused on exploring the relationship between 
depression and cardiac disease development and prognosis (Purebl, Birkas, Csoboth, 
Szumska, & Kopp, 2006; Rozanski, Blumenthal, Davidson, Saab, & Kubzansky, 2005). 
 
Depression 
Depression is a commonly used term, often used imprecisely to refer to a lowering of 
mood, transient sadness, or loss of energy (Schwartz & Schwartz, 1993).  However 
depression, in a formal sense, is a mental illness, with specific diagnostic criteria.  A 
diagnosis of Major Depressive Disorder requires at least one episode of low mood or loss 
of interest/pleasure lasting two weeks or more, with at least four of the following 
additional symptoms; changes in appetite, sleep disturbance, excessive fatigue, 
psychomotor retardation or agitation, unreasonable feelings of guilt or worthlessness, 
concentration difficulties, or thoughts of death or suicide (APA, 2000).  Additionally the 
episode must cause marked impairment in functioning and should not be due to organic 
causes (e.g. medication, illness or drug use), or be better accounted for by bereavement 
(APA, 2000).  Therefore, it is possible for an individual to experience a number of 
symptoms of depression, without meeting the diagnostic criteria for Major Depression.   
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Two further diagnoses characterised by depressed mood are relevant when 
considering depression in cardiac patients; Dysthymia and Adjustment Disorder with 
Depressed Mood.  Dysthymia is characterised by less severe symptoms than Major 
Depressive Disorder, but a more chronic course, in which the person experiences low 
mood on more days than not for at least a two year period (APA, 2000).  An Adjustment 
Disorder refers to the development of clinically significant emotional or behavioural 
symptoms in response to a stressor in excess of what would be usually expected (APA, 
2000).  In Adjustment Disorder with Depressed Mood, the emotional and behavioural 
symptoms are principally symptoms of depression but are not sufficient to meet the 
diagnostic criteria for Major Depression (APA, 2000).   
Diagnosis of a depressive disorder is usually made through clinical interview, 
traditionally with a psychiatrist or psychologist, however other health professionals, such 
as General Practitioners are now more frequently involved (Arrol, Khin, & Kerse, 2003; 
Ellis & Smith, 2002).  Self-report inventories and checklists may also be used to aid 
diagnosis, and are frequently used to measure depressive symptoms in research settings 
(Davidson et al., 2006; Davidson, Rieckmann, & Rapp, 2005; Maier, Chatkoff, & Burg, 
2006).  Rather than being diagnostic tools, these questionnaires assess the number and 
degree of depressive symptoms reported by a respondent (Davidson et al., 2005).  They 
usually have a pre-determined cut-off score, a score above which indicates a higher 
likelihood of the respondent warranting a diagnosis of a depressive disorder (Davidson et 
al., 2005).  The 1997 Australian Survey of National Mental Health and Wellbeing reported 
twelve month prevalence rates of 5.1% for major depression and 1.1% for dysthymia, with 
women being twice as likely as men to develop depressive disorders (AIHW, 1999).  
Whilst reported prevalence rates vary internationally (Waraich, Goldner, Somers, & Hsu, 
2004), these Australian rates are similar to European 12 month prevalence rates of 6.6% 
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for major depression and 1.0% for dysthymia (Ayuso-Mateos et al., 2001) and US 12 
month prevalence rate of 6.6% for major depression (Kessler et al., 2003).   
 
Depression and Cardiac Conditions 
Depressed mood has long been recognised as a common feature of a patient’s mental 
state following AMI (Bruhn, Chandler, & Wolf, 1969; Kaufmann, Pasacreta, Cheney, & 
Arcuni, 1985).  Traditionally it was viewed as a ‘normal’ transitory response (Lesperance 
& Frasure-Smith, 2000), which would resolve as the patient adjusted to their condition 
(Burg & Abrams, 2001; Ladwig et al., 1992).  However, in addition to depression being an 
independent risk factor for the development of coronary conditions (Bunker, Colquhoun et 
al., 2003; Cohen, Madhavan, & Alderman, 2001; Frasure-Smith & Lesperance, 2003; 
Glassman & Shapiro, 1998; Jiang, Krishnan, & O'Connor, 2002), depression in those with 
established cardiac conditions is also related to poorer prognosis (Blumenthal et al., 2003; 
Bruhn et al., 1974; Bush et al., 2001; Frasure-Smith & Lesperance, 1999; Irvine et al., 
1999; Scheidt, 2000; Thornton, 2001; Ziegelstein, 2001; Ziegelstein, 2003).  This finding 
has instigated considerable research investigating the relationship between depression and 
cardiac conditions.   
Research assessing differences in outcomes between depressed and non-depressed 
cardiac patients has predominantly focused on physical outcomes.  The following is a 
review of the evidence for a link between depression and four principal types of outcome: 
mortality, morbidity, cardiovascular events, and psychosocial outcomes.   
Initial research reported a substantial increased risk of mortality for cardiac patients 
who were depressed following their cardiac event.  Frasure-Smith and colleagues (1995) 
reported that patients who were depressed following AMI had a 3.6 times greater mortality 
rate at 18 month follow-up than non-depressed patients. Recent meta-analyses report a 2 to 
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2.5 fold increased risk of all-cause and cardiac mortality in depressed AMI patients (Van 
Melle et al., 2004), and a 1.8 to 2.4 fold increase in risk for coronary heart disease patients 
(Barth, Schumacher, & Herrmann-Lingen, 2004; Nicholson, Kuper, & Hemingway, 2006).  
Even mild symptoms of depression have been predictive of mortality (Bush et al., 2001), 
though most studies report a dose-response relationship with greater symptom severity 
predicting greater mortality risk (Jiang et al., 2007; Lesperance, Frasure-Smith, & Talajic, 
1996; Murberg & Furze, 2004).   
Not all research has found a significant prognostic relationship (Lane, Carroll, Ring, 
Beevers, & Lip, 2001a; Mayou et al., 2000; Stewart et al., 2003; Strik, Lousberg, Cheriex, 
& Honig, 2004).  It has been suggested that the relationship between depression and 
mortality is an artefact of greater cardiac disease severity in depressed patients (Lane, 
Carroll, Ring, Beevers, & Lip, 2002).  However, studies that have controlled for disease 
severity still report a significant relationship between depression and mortality 
(Blumenthal et al., 2003; Grace, Abbey, Kapral et al., 2005; Jiang et al., 2007), though the 
relative risk is somewhat reduced (Nicholson et al., 2006).   
It has been noted that more recent studies report a lower risk than older studies (Van 
Melle et al., 2004).  It is possible that this change in pattern is due to improvements in 
cardiac care and decreasing mortality rates (Carney & Freedland, 2003), and hence larger 
samples (Lauzon et al., 2003) and longer follow-up periods (Carney & Freedland, 2003) 
are needed to detect significant differences.  Furthermore, it has been suggested that 
survival is more a matter of location at cardiac event (Frasure-Smith et al., 1995), that is 
proximity to hospital or medical care, than any other factor. 
Given declining mortality rates in cardiovascular disease, subsequent cardiac 
morbidity is becoming increasingly important as a cardiac outcome.  Depression following 
AMI has been associated with increases in health care costs through hospital readmissions 
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and increased outpatient contacts (Frasure-Smith et al., 2000; Mayou et al., 2000; Strik, 
Denollet, Lousberg, & Honig, 2003) and more frequent need of surgical intervention 
(Lauzon et al., 2003; Sullivan, LaCroix, Spertus, Hecht, & Russo, 2003).   Depression is 
also associated with poorer physical recovery from coronary heart disease and 
revascularisation procedures (de Jonge, Spijkerman, van den Brink, & Ormel, 2006; 
Doering et al., 2005; Ruo et al., 2003; Sullivan, LaCroix, Baum, Grothaus, & Katon, 
1997). 
Rather than differentiating between mortality and morbidity, some studies have 
looked at a combined outcome of all fatal and non-fatal cardiac events.  Depression has 
been found to predict cardiovascular events in patients with AMI (Jaffe et al., 2006; 
Shiotani et al., 2002), unstable angina (Lesperance, Frasure-Smith, Juneau, & Theroux, 
2000), heart failure (Rutledge, Reis, Linke, Greenberg, & Mills, 2006), coronary artery 
disease (Frasure-Smith & Lesperance, 2008), and in those who have undergone CABG 
(Burg, Benedetto, Rosenberg & Soufer, 2003; Oxlad et al., 2006; Rafanelli, Roncuzzi, & 
Milaneschi, 2006; Tully, Baker, Turnbull, & Winefield, 2008).  Thus it has been 
demonstrated that depression has a negative impact on prognosis in patients with a wide 
range of cardiac conditions.   
In addition to physical outcomes, depression has been associated with poorer 
psychosocial outcomes in cardiac patients. Depressed cardiac patients are typically slower 
to return to work, or less likely to return to work at all, than non-depressed patients 
(Carney, Freedland, Sheline, & Weiss, 1997; Maeland & Havik, 1987; Schleifer et al., 
1989; Soderman, Lisspers, & Sundin, 2003; Stern, Pascale, & Ackerman, 1977; Trelawny-
Ross & Russell, 1987).  Depressed patients also report a greater limitation in social and 
leisure activities, and are less likely to resume previous levels of sexual functioning 
(Mayou et al., 2000; Stern et al., 1977; Taylor, Barber, McIntosh, & Khan, 1998; 
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Trelawny-Ross & Russell, 1987).  Overall, depressed cardiac patients report a poorer 
quality of life than non-depressed patients, and this effect is sustained up to 12 months 
after the cardiac event (Lane, Carroll, Ring, Beevers, & Lip, 2000; Lane et al., 2001a; 
Mayou et al., 2000).  Indeed depressive disorders have been described as the major 
obstacle to resuming a fully functional lifestyle in cardiac patients (Fielding, 1991). 
In summary, depression in those with established cardiovascular disease is associated 
with poorer physical and psychosocial outcomes.  Furthermore, even when disease severity 
is controlled for, depression confers poorer prognosis in terms of mortality and cardiac 
morbidity.  
A number of biological, psychological and social factors have been identified which 
potentially explain why cardiac patients with depression have poorer outcomes.   However, 
as yet there is no comprehensive model synthesising the complex inter-relationships 
between these factors.  The following is an outline of the most commonly proposed 
biological, psychological and social factors contributing to the relationship between 
depression and poor outcomes in cardiac patients. 
Depression has been found to have distinct impacts on physiological functioning 
(Carney, Freedland, Miller, & Jaffe, 2002; Joynt, Whellan, & O'Connor, 2003; 
Musselman, Evans, & Nemeroff, 1998).  Depression has been associated with 
dysregulation of the hypothalamic-adrenocortical-pituitary axis (Lett et al., 2004) as 
evidenced by higher cortisol levels (Otte et al., 2004) and catecholamine levels (Otte, 
Neylan, Pipkin, Browner, & Whooley, 2005) in depressed cardiac patients.  Elevated 
cortisol promotes development of central obesity (Rozanski et al., 2005) and 
atherosclerosis and hypertension (Joynt et al., 2003), factors associated with poorer 
cardiovascular health.  Catecholamines increase resting heart rate, which is associated with 
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increased risk of atherosclerosis, ventricular arrhythmia and AMI (Carney, Freedland, & 
Veith, 2005).   
Depression in cardiac patients has also been associated with decreased heart rate 
variability (Carney et al., 1988) and arrhythmia (Joynt et al., 2003).  Reduced heart rate 
variability indicates poorer cardiac function and is associated with an increased risk of 
sudden cardiac death (Carney, Freedland et al., 2003; Grippo & Johnson, 2002; Stein et al., 
2000).  Frasure-Smith and colleagues (1995) reported that depressed cardiac patients with 
cardiac rhythm disturbances had a 29 times greater risk of death at 18 months follow-up 
than non-depressed patients.   
Depressed cardiac patients have also been observed to exhibit abnormal platelet 
reactivity (Musselman et al., 1996), leading to abnormal levels of platelet aggregation and 
subsequent coronary occlusion (Jiang & Blumenthal, 2003).  This abnormal platelet 
reactivity and aggregation may be related to the finding that depressed patients have a 
higher density of serotonin receptors on platelets, as serotonin excretion following platelet 
activation promotes platelet aggregation (Parissis et al., 2007).  These findings are 
particularly interesting given the role serotonin plays in the pathophysiology of depression 
(Joynt, Whellan, & O'Connor, 2004; Lett et al., 2004).   
Depression is also proposed to lead to poorer outcomes through impact on 
inflammatory responses (Ziegelstein, 2001).  Depression promotes inflammation: sustained 
inflammation facilitates growth of vascular lesions and promotes plaque instability leading 
to rupture and eventual coronary occlusion (Miller, Freedland, Carney, Stetler, & Banks, 
2003).  Whilst this pathway has been supported by a significant interaction effect between 
depression and inflammatory markers in predicting subsequent cardiac events (Frasure-
Smith et al., 2007), not all studies have found a relationship between depression and 
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increased inflammatory markers in cardiac patients (Miller, Freedland, & Carney, 2005; 
Whooley et al., 2007). 
It is likely that a combination of these pathways underlies the relationship between 
depression and poor outcomes for cardiac patients, rather than one single mechanism 
(Glassman, 2005).  However there is also evidence to suggest that mechanisms other than 
pathophysiological pathways are involved.  
In addition to potential biological mechanisms, behavioural patterns associated with 
depression may contribute to the poorer outcomes observed in depressed cardiac patients. 
There is significant evidence that depressed cardiac patients are less likely to adhere to 
their treatment regimes (Januzzi, Stern, Pasternak, & DeSanctis, 2000).  Reduced 
adherence occurs both in terms of medication adherence (Bane, Hughes, & McElnay, 
2006; Gehi, Haas, Pipkin, & Whooley, 2005; Rieckmann et al., 2006) and adoption of 
recommended lifestyle such as changes in diet, exercise, and stress reduction (Ziegelstein 
et al., 2000) and smoking cessation (Kronish et al., 2006).  Indeed, depressed cardiac 
patients are more likely to exhibit other cardiovascular risk factors (Bairey Merz et al., 
2002; Joynt et al., 2003), such as smoking (Freedland, Carney, & Skala, 2005; Taylor et 
al., 1998) and diabetes (Carney et al., 2001). 
A relationship between depression and attendance at cardiac rehabilitation has also 
been identified.  Cardiac patients who report higher levels of depressive symptoms are less 
likely to enrol in cardiac rehabilitation (Kronish et al., 2006; Lane et al., 2001).  Of those 
who initially attend cardiac rehabilitation, depression is associated with poorer attendance 
and higher drop-out (Glazer, Emery, Frid, & Banyasz, 2002; Grace, Abbey, Pinto et al., 
2005; Sanderson, & Bittner, 2005; Turner, Bethell, Evans, Goddard, & Mullee, 2002).  
Thus depressed cardiac patients may have poorer prognoses due to the impact of 
depression on their ability to implement lifestyle changes or treatment recommendations.  
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The biopsychosocial model of health would suggest that both biological and behavioural 
mechanisms are involved. 
Over the last fifteen years a multitude of research reporting prevalence rates for 
depression in cardiac patients has been published.  Reported prevalence rates have varied 
widely, from 10% (Saur et al., 2001; Sorenson, Brandes et al., 2005) to 65% (McCrone, 
Lenz, Tarzian & Perkins, 2001) [see Appendix A for a summary of published prevalence 
rates].  Whilst the variance in reported rates is large, prevalence rates for depression in 
cardiac patients are consistently higher than those reported for the general population 
(Ballenger et al., 2001; Ormel et al., 2007), with a general consensus that the rate lies 
between 20-30% (ENRICHD, 2003; Rutledge et al., 2006; Thombs et al., 2006). 
In a review of studies of both incidence rates and prevalence rates of depression in 
primary care, Waraich and colleagues (2004) attributed variance in rates to differences in 
participant characteristics and the method used to assess depression.  Similar sources of 
variance can also be identified in studies assessing depression prevalence in cardiac 
patients.  The following is a discussion of these factors. 
Patient demographics vary considerably between studies.  Age and sex differences in 
depression rates in the general population have been well documented, with depression 
being more common in females, and rates declining in those over 54 years (Korten & 
Henderson, 2000).  There is evidence that female cardiac patients also experience greater 
levels of depressive symptoms than male cardiac patients (Blumenthal et al., 2003; 
Forrester, Lipsey, Teitelbaum, DePaulo, & Andrezejewski, 1992; Frasure-Smith, 
Lesperance, Juneau, Talajic, & Bourassa, 1999).   Thus, the proportion of females included 
in the study sample may affect the prevalence rate detected.   
The relationship between age and depression in cardiac patients is less clear.  Whilst 
some studies have reported that depression increases with subject age (Timberlake, 
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Klinger, Smith, Venn, & et al., 1997; Valkamo et al., 2001), others have found the reverse 
(Ruo et al., 2003; Sherwood, Hinderliter, Watkins, Waugh, & Blumenthal, 2005; Strik et 
al., 2004; Watkins et al., 2003).  However, most studies report no significant relationship 
between age and depression in cardiac patients (Ladwig et al., 1992; Rieckmann et al., 
2006; Romanelli, Fauerbach, Bush, & Ziegelstein, 2002; Schleifer et al., 1989; Schulz et 
al., 2000; Shiotani et al., 2002; Sorensen et al., 2005; Spijkerman, van den Brink, Jansen, 
Crijns, & Ormel, 2005). 
A further patient characteristic that may impact depression prevalence is the type of 
cardiac condition experienced by the patient.  It is possible that patients may respond 
differently to different cardiac events.  For example a difference may exist between those 
who have a planned hospitalisation for surgery, compared to those who experience an 
unplanned hospitalisation for emergency cardiac events. Whilst prevalence rates have been 
reported for various cardiac conditions, the differences in experimental design and other 
patient characteristics mean that comparisons between these studies are not reliable.  Those 
studies that have had the opportunity to conduct such comparisons, by including subjects 
with different conditions in their participant group (e.g. Cheok, Schrader, Banham, Marker, 
& Hordacre, 2003; Milani, Lavie, & Cassidy, 1996), have not reported comparative 
figures.  Further investigation of the possibility of differences in depression prevalence 
between cardiac conditions is required. 
Studies have also varied considerably in the method they have used to assess 
depression.  Methods used have included structured interview schedules (e.g. Parker et al., 
2006), self-report questionnaires (e.g., Schweitzer, Head, & Dwyer, 2007), combinations 
of both structured interview and self-report questionnaire (e.g., Di Benedetto, Lindner, 
Hare, & Kent, 2006), or questionnaire screening followed by psychiatric assessment by a 
qualified health professional (e.g., Schrader, Cheok, Hordacre, Marker, & Wade, 2005).   
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Structured interview schedules provide the assessor with a set of interview questions 
for assessing presence or absence of key diagnostic criteria for psychiatric disorders 
(Groth-Marnet, 2003).  Depression self-report questionnaires require respondents to 
indicate the number of, and degree to which they experience, symptoms of depression, and 
usually use a cut-off score to determine those at risk of depression (Rodin, Craven, & 
Littlefield, 1991).   Structured interview schedules are closely aligned with diagnostic 
criteria and are less affected by respondents’ perceptions of their difficulties (Groth-
Marnet, 2003). As such their reliability in detecting depression tends to be stronger than 
self-report questionnaires (Groth-Marnet, 2003).  
Comparison of structured interviews and self-report questionnaires indicate that 
prevalence figures tend to be higher when a self-report tool is used to assess depression 
(Bambauer, Locke, Aupont, Mullan, & McLaughlin, 2005; Rutledge et al., 2006).  Studies 
of depression in cardiac patients that report prevalence rates for both a structured interview 
schedule and a self-report questionnaire on the same participant pool support this claim.  
For example, a prevalence of 12% using a diagnostic interview (SCID) compared to 28% 
using a self-report questionnaire (BDI-II)  (Huffman et al., 2006) and 11% using the CIDI 
diagnostic interview compared to 32% using the BDI self-report questionnaire (Di 
Benedetto et al., 2006).  These differences in assessment method not only contribute to 
variance in reported depression prevalence rates but also raise the wider issue of the 
appropriate method for assessing depression in cardiac patients. 
A final factor contributing to variance in the reported depression prevalence rates in 
cardiac patients may be the timing of the assessment.  In studies assessing depression post 
AMI, the initial assessment of depression symptoms has occurred from as early as 24 hours 
post event (Martin & Thompson, 2000), to as late as five months post AMI (Stewart, 
Yusim, & Desan, 2005).  In studies assessing depression in cardiac surgery patients, 
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assessment occurred pre-surgery in some studies (Blumenthal et al., 2003; Ho et al., 2005; 
Saur et al., 2001) and post-surgery in others (Con, Linden, Thompson, & Ignaszewski, 
1999; Connerney, Shapiro, McLaughlin, Bagiella, & Sloan, 2001).   
It has been suggested that depression rates may be higher in the hospitalization 
period, reflecting a sharp increase in depressive symptoms that resolves for many patients 
upon discharge (Poston, Haddock, Conard, Jones, & Spertus, 2003).  However, studies that 
have attempted to identify a course of depression in cardiac patients by assessing 
depressive symptoms at multiple time points have reported no consistent pattern (Junior, 
Ramadan, Pereira, & Wajngarten, 2000; Luutonen, Holm, Salminen, Risla, & Salokangas, 
2002; Martin, Lewin, & Thompson, 2003; McKhann, Borowicz, Goldsborough, Enger, & 
Selnes, 1997; Mitchell et al., 2005; Pirraglia, Peterson, Williams-Russo, Gorkin, & 
Charlson, 1999; Schleifer et al., 1989; Trelawny-Ross & Russell, 1987).   
This lack of consistency in the course of depression indicates there is unlikely to be a 
single course of depression following a cardiac event.  Further evaluation of the 
differences in depression course between cardiac patients is required, and guidelines as to 
the most appropriate time to conduct assessment of depression should be established.   
In summary, considerable variance exists in the prevalence rates reported for 
depression in cardiac patients.  Research evaluating depression in cardiac patients needs to 
consider possible sources of variance including patient characteristics, assessment method 
and timing of assessment in both research design and when reporting findings.  These latter 
two issues will be explored in further detail in the following sections.  Nonetheless, despite 
the variance in reported figures, it is important to note that prevalence rates for depression 
in cardiac patients are consistently higher than those found in the general population.  This 
indicates that not only is depression a serious issue given it’s an important risk factor for 
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poorer outcomes in cardiac patients, it is a significant problem given it effects a sizeable 
proportion of cardiac patients.   
 
Assessing Depression in Cardiac Patients: Assessment Tools 
Since depression has been acknowledged as a risk factor for both cardiovascular 
disease and poorer prognosis, the need for a reliable, effective, and appropriate assessment 
method for depression in cardiac patients has arisen.   
Whilst structured interview schedules are more reliable than self-report 
questionnaires in identifying cases of clinical depression (Myers & Weissman, 1980; 
Whooley, Avins, Miranda & Browner, 1997), this does not necessarily make them more 
appropriate than self-report questionnaires. Research has indicated that even mild levels of 
depressive symptoms, that may not meet criteria for diagnosis of major depressive 
disorder, are associated with poorer outcomes for cardiac patients (Bush et al., 2001; 
Rafanelli et al., 2003; Sullivan et al., 1999). Thus, assessment methods that are limited to 
identifying those with major depressive disorders, and exclude other conditions such as 
adjustment disorder with depressed mood, may underestimate the number of cardiac 
patients at increased risk of poorer health outcomes and impaired functioning.  
Furthermore, two meta-analyses of depression as a risk factor for mortality in patients with 
CHD concluded that there was no prognostic difference between studies that defined 
depression through structured clinical interviews compared to self-report (Barth et al., 
2004; Van Melle et al., 2004). 
Self-report questionnaires are more easily utilised in cardiac settings than structured 
interview schedules (Shen, Wachowiak & Brooks, 2005).  Self-report questionnaires do 
not require specialist training to administer and are time-efficient to complete and score 
(Dobbels et al., 2002; Van Melle et al., 2004).  Thus, whilst structured interview schedules 
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and self-report questionnaires have equal prognostic validity for cardiac patients, self-
report questionnaires may be more appropriate given their ease of use. 
A variety of self-report questionnaires have been used to assess depression in cardiac 
patients (Martin & Thompson, 2006; McGee, Hevey, & Horgan, 1999; Rutledge et al., 
2006).  Whilst further research has been recommended to establish which tool, or tools, are 
the most appropriate (Ballenger et al., 2001; Davidson et al., 2006) some comparison of 
measures has taken place. The self-report questionnaires can be broadly grouped according 
to the basis of their development and intended use: assessment of depression in the general 
population, assessment in medically ill patients, and, most specifically, assessment in 
cardiac patients.   
Measurement tools that were developed or validated for use in a general population 
but have been used in cardiac patients include the CES-D (e.g., Brummett et al., 1998), the 
Zung SDS (e.g., Salminen, Isoaho, Vahlberg, Ojanlatva, & Kivela, 2005) and the BDI, 
both version I (e.g., Frasure-Smith, Lesperance et al., 1999) and II (e.g., Sanderson & 
Bittner, 2005). The CES-D was developed in the US as a tool for assessing the current 
level of depressive symptoms in a general adult population, and tends to be used as a 
research tool, particularly for epidemiological studies, rather than a clinical tool (Radloff, 
1977).  The Zung SDS was also targeted towards assessing depressive symptoms in adults 
(Nezu, Ronan, Meadows, & McClure, 2000).  The BDI was originally developed for use in 
a clinical psychiatric population, but is commonly used in the general population (Nezu et 
al., 2000).  Both the CES-D and the BDI have shown good predictive validity for further 
cardiac events (Davidson et al., 2005).  However, the BDI’s psychometric properties 
indicate a substantial positive skew, which makes identification of mild depression 
difficult (Di Benedetto et al., 2006; Shen et al., 2005).  Given the prognostic importance of 
mild depression, a tool that can adequately differentiate between levels of depressive 
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symptoms at the lower end of the spectrum is of vital importance.  Alternatively, it has 
been suggested that adjusted cut-off scores for the BDI should be used in cardiac patients 
to improve case detection (Strik, Honig, Lousberg, & Denollet, 2001), however this 
decreases specificity, increasing incorrect diagnoses and possible unnecessary treatment 
(Guck, Kavan, Elsasser, & Barone, 2001). 
The principle drawback of using self-report measures developed in the general 
population to assess depression in the cardiac population is the overlap between diagnostic 
criteria for depression and normal physical responses to a cardiac event or to 
hospitalisation (Bambauer et al., 2005; Carney et al., 1997; Guck et al., 2001).  Symptoms 
of depression which also occur as normal responses to cardiac conditions or hospitalisation 
include fatigue, altered sleep and eating habits, psychomotor agitation, and loss of pleasure 
(Clarke, McKenzie, Marshall, & Smith, 1994; Strik et al., 2001).   Thus patients’ scores 
may be artificially inflated due to endorsement of these symptoms, leading to false 
positives (Dobbels et al., 2002). In order to lessen the potential bias caused by somatic 
symptoms, there is a preference for use of measures that more heavily weight the 
cognitive-affective symptoms rather than the physical symptoms of depression (Bambauer 
et al., 2005; Cheok et al., 2003).  In recognition of this, a number of depression assessment 
tools have been developed for use in medically ill patients.  
Self-report questionnaires that have been developed for use in medical populations 
and have been used in cardiac patients include the General Health Questionnaire (GHQ-
12) (e.g., Stewart et al., 2003), the Symptom Check List (SCL-90) (e.g., Strik et al., 2003) 
and the Hospital Anxiety and Depression Scale (HADS) (e.g., Turner et al., 2002).  The 
GHQ-12 is a non-specific indicator of psychological distress, and whilst it is equally valid 
as the SCL-90 for identifying non-psychotic mental disorders in patients (Schmitz, Kruse, 
Heckrath, Alberti, & Tress, 1999), its lack of specificity for identification of depressive 
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symptoms is problematic.  Whilst the SCL-90 has a depression subscale, its psychometric 
properties are poor when used in isolation (Nezu et al., 2000).   
The HADS is a fourteen-item scale that has commonly been used in cardiac 
populations (Bambauer et al., 2005; Harrison, 2005). It comprises two subscales assessing 
anxiety and depression, however recent analysis has shown that the underlying two-factor 
structure has not been replicated when used in a cardiac population (Martin et al., 2003).  
This indicates that whilst the overall score is a sound indicator of psychological distress, 
the differentiation of two scales purporting to assess anxiety and depression is not valid for 
cardiac patients (Martin & Thompson, 2006)  Furthermore a comparison of HADS to a 
structured diagnostic interview (PRIME-MD) recommended a lowered cut-off score of 7 
be used on the depression subscale, resulting in an acceptable sensitivity of 81% but a 
relatively low specificity of 54% (Bambauer et al., 2005).  Thus the validity of SCL-90, 
GHQ and HADS as measures of depression in cardiac patients has not been established.  
This emphasises the importance of appropriately validating depression self-report 
measures in cardiac patients, rather than assuming their validity in other populations will 
be replicated in cardiac patients (Martin & Thompson, 2006). 
Whilst other scales show some promise for use in detecting depression in cardiac 
patients, such as the Depression in the Medically Ill (DMI) scale (Hilton et al., 2006; 
Parker, Hilton, Hadzi-Pavlovic, & Bains, 2001) and the Major Depression Inventory 
(MDI) (Martin & Thompson, 2006), further validation is required before they could be 
recommended.  
In order to counter concerns about the validity of using generic measures of 
depression in cardiac patients, the Cardiac Depression Scale (CDS) (Hare & Davis, 1996) 
was developed. The CDS is a 26 item self administered questionnaire comprising both 
negative and positive items (Hare & Davis, 1996).  Though longer than many other 
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depression questionnaires, it appears to be acceptable to patients (Birks, Roebuck, & 
Thompson, 2004).  It has good psychometric properties, with high internal consistency 
(Birks et al., 2004; Di Benedetto et al., 2006; Hare & Davis, 1996; Hevey, McGee, & 
Horgan, 2004; Wise, Harris, & Carter, 2006) and good concurrent validity with other self 
report measures of depression including the BDI (Birks et al., 2004; Hare & Davis, 1996), 
the BDI-II (Di Benedetto et al., 2006), the depression subscale of the HADS (Birks et al., 
2004), and the Geriatric Depression Scale - Short Form (Wise et al., 2006).  Furthermore, 
it correlates moderately well with clinical assessment of adjustment disorder with 
depressed mood (Hare & Davis, 1996). 
The scale was particularly designed to be sensitive in detecting degrees of depression 
rather than distinguishing between cases and non-cases of major depression (Hare & 
Davis, 1996). This is achieved through its normal distribution, which enables greater 
differentiation between degrees of depressive symptoms, particularly in the mild to 
moderate range of symtpoms, than more skewed measures such as the BDI (Di Benedetto 
et al., 2006; Hare & Davis, 1996).  Furthermore it is responsive to variation in depressive 
symptoms, making it a sensitive tool for assessing change over time or following 
intervention (McGee et al., 1999).   
Whilst self-report measures are not diagnostic tools, cut-off scores are necessary for 
screening purposes.  One limitation of the CDS is that it was not originally published with 
cut-off scores (Martin & Thompson, 2006).  However the authors recommend a 
statistically driven cut-off score of 100 (approximately 1 SD above the mean) for detection 
of severe depressive symptoms (Martin & Thompson, 2006; Wise et al., 2006).  Using 
ROC analysis against the Geriatric Depression Scale, a score of 100 yielded a sensitivity of 
88% and specificity of 84%, and a cut-off score of 90 was recommended for 
mild/moderate depression (Wise et al., 2006).  This yielded a prevalence rate of 21.6% for 
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severe depression, and a further 16.7% had mild/moderate depressive symptoms when 
used in a cohort of cardiac rehabilitation patients (Wise et al., 2006).   
Another validation study reported that a cut-off of 80 on the CDS is equivalent to the 
BDI cut-off of 10 for mild depression, yielding a prevalence rate of 43.2% (Di Benedetto 
et al., 2006).  Furthermore, a cut-off of 80 identified 89% of the patients diagnosed with a 
major depressive episode by a structured diagnostic interview, no specificity data was 
reported (Di Benedetto et al., 2006). A need for further analysis to determine ideal cut-off 
scores has been identified (Martin & Thompson, 2006).  Furthermore it would be 
important to establish whether the greater ability of the CDS to differentiate patients in the 
milder range of depressive symptoms is useful in predicting outcomes for cardiac patients.  
Overall the CDS is a valuable tool for the assessment of depression in cardiac 
patients.  It has strong psychometric properties and avoids the limitations identified for 
other medical or generic depression self-report questionnaires.  
 
Assessing Depression in Cardiac Patients: Timing of Assessment 
It is as important to determine when the assessment of depression should be 
conducted, as it is to use the correct method for assessment.  As indicated earlier, 
published research has varied widely in the timing of depression assessment. Previously, 
depression was seen as a ‘normal’ reaction to a cardiac event that would resolve naturally 
(Burg & Abrams, 2001; Ladwig et al., 1992; Lesperance & Frasure-Smith, 2000). Whilst a 
subset of patients that demonstrate significant depressive symptoms in hospital improve 
without intervention (Kaptein, De Jonge, Van Den Brink, & Korf, 2006), not all patients 
experience the expected resolution of depressive symptoms (Kronish et al., 2006).    
Some studies have attempted to identify a course of depression in cardiac patients by 
assessing depressive symptoms at multiple time points.  Those comparing depressive 
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symptomatology pre and post surgery for CABG have found no consistent pattern, with 
some reporting a decline in symptoms (Mitchell et al., 2005; Pirraglia et al., 1999) and 
others reporting minimal change (Junior et al., 2000; McKhann et al., 1997).  Two studies 
that assessed the course of symptoms over four time points both reported an initial sharp 
increase in symptoms in the few days following surgery followed by a decline in the weeks 
and months after surgery, to a level similar or less than the pre-surgery rate (McCrone et 
al., 2001; Timberlake et al., 1997).   
Similar research investigating the course of depressive symptoms following AMI has 
not replicated this pattern.  One study found little change in depressive symptom levels 
from hospitalisation up to six months (Trelawny-Ross & Russell, 1987).  Two further 
studies reported a decrease in symptoms post-hospitalisation, but not the marked decline 
noted with CABG patients (Martin et al., 2003; Schleifer et al., 1989), whilst one study 
reported a steady increase in symptoms over eighteen month follow-up (Luutonen et al., 
2002).   
This lack of consistency in the course of depression indicates there may be several 
possible courses of depression following a cardiac event.  The above studies used 
aggregate rates for depression, rather than tracking individuals over time in order to 
identify multiple patterns.  A study comparing depression during cardiac hospitalization to 
depression at 3 months reported similar prevalence rates for no, mild and severe depression 
at both time points but noted that 35.8% of patients had moved from one category to 
another (Schrader, Cheok, Hordacre, & Guiver, 2004).  At twelve month follow-up, 
approximately half of those depressed (both mild and severe) during hospitalization 
remained depressed, whereas those who were mildly depressed during hospitalisation were 
as likely to have no depression at 12 months as they were to increase to severe depression 
(Schrader, Cheok, Hordacre, & Marker, 2006).  Similar patterns have been reported for 
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patients undergoing elective diagnostic cardiac surgery (Hance, Carney, Freedland, & 
Skala, 1996).   
Kaptein and colleagues (2006) investigated the relationship between depression 
course (assessed at hospitalisation, 3, 6 and 12 month follow-up) and cardiac prognosis in 
475 AMI patients.  They reported five different depression courses: sustained absence of 
depressive symptoms (56.4%), sustained level of mild depressive symptoms (25.7%), 
initially moderate and increasing depressive symptoms (9.3%), initially significant but 
decreasing depressive symptoms (4.6%) and initially significant and increasing depressive 
symptoms (4.0%) (Kaptein et al., 2006).  Those in the latter class had a significantly 
greater risk of cardiac event in the 12 month follow-up period (Kaptein et al., 2006).  
Replication of this study in this and other cardiac diagnostic groups is warranted.  
However, these initial results suggest that ongoing monitoring of depressive symptom 
course may be more effective in identifying those at risk of poorer outcomes than cross-
sectional assessment.  Furthermore, research that identifies the predictors of sustained or 
increasing depressive symptoms would be beneficial in order to aid early detection of those 
at risk of persistent depressive symptoms.  
 
Treatment of Depression in Cardiac Patients 
Despite recognition of the increased prevalence of depression in cardiac patients 
compared to the general population, and the relationship with poorer prognosis, many 
cardiac patients with clinically significant depressive symptoms do not receive treatment 
for their depression (Huffman et al., 2006; Jiang & Blumenthal, 2003).  Treatment rates of 
only 10 to 20% of cardiac patients with a major depressive disorder have been reported 
(Hance et al., 1996; Huffman et al., 2006; Jiang et al., 2001; Schleifer et al., 1989).  One 
study found that none of the patients with moderate to severe depression at 6 and 18 
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months post AMI were prescribed anti-depressant medication, though some were 
prescribed benzodiazepines, treatment primarily for anxiety disorders (Luutonen et al., 
2002).   
Low treatment rates may be driven by issues discussed earlier; the perception that 
depression is a normal reaction to cardiac event that will resolve naturally, and difficulty 
with assessing and diagnosing depression in this population (Guck et al., 2001; Luutonen 
et al., 2002).  However, there are additional issues regarding the safety and effectiveness of 
depression treatments in cardiac patients that may increase reluctance of primary care 
providers to prescribe or refer patients for treatment (Guck et al., 2001; Jiang & 
Blumenthal, 2003).   
A number of pharmacotherapeutic options for the treatment of depression in the 
general population exist (Davies, Jackson, Potokar, & Nutt, 2004), however they are not all 
safe or effective when used in cardiac patients.  The cardiovascular side-effects of tricyclic 
antidepressants (TCA’s) and monoamine oxidase inhibitors (MAOI’s) in the general 
population are well established (Carney, Freedland, Veith, & Jaffe, 1999; Davidson et al., 
2006; Jiang & Davidson, 2005).  Thus they are often contraindicated for cardiac patients 
(Carney & Jaffe, 2002; Sheline, Freedland, & Carney, 1997).  Evaluation studies of TCA’s 
and MAOI’s in cardiac patients are rare: a comparison study of nortriptyline (a TCA) to 
paroxetine (an SSRI) found that though they were equally effective in treating depression, 
the TCA was associated with a greater number of adverse cardiac events (Roose et al., 
1998).  This increased risk has also been documented for other TCA’s (Roose & Miyazaki, 
2005).   
Research has predominantly focused on the newer anti-depressants, selective 
serotonin uptake inhibitors (SSRI’s), as they are relatively free of cardiotoxic side-effects 
when used in healthy depressed patients (Carney & Jaffe, 2002).  Trials of sertraline 
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(Glassman et al., 2002; Shapiro et al., 1999), paroxetine (Roose et al., 1998), citalopram 
(Lesperance et al., 2007), and fluoxetine (Roose & Miyazaki, 2005; Strik et al., 2000) 
indicate they are safe for use in cardiac patients.  However, whilst these studies all 
demonstrated significant improvement in depressive symptoms for the intervention groups, 
this improvement was not always superior to placebo (Glassman et al., 2002; Strik et al., 
2000).  The relatively small effect sizes for SSRI treatment compared to placebo control is 
probably due to the relatively high levels of spontaneous remission which occur in 
untreated cardiac patients (ENRICHD, 2003).  Furthermore, whilst SSRI’s appear to have 
no substantive effect on incidence of cardiac events, there is concern that they may impact 
on the metabolism of other drugs, thus affecting blood levels of other prescribed 
medications (Sheline et al., 1997).  Investigation of the safety of other anti-depressants in 
cardiac patients is limited (Dobbels et al., 2002; Jiang & Davidson, 2005). 
Whilst improvement in depressive symptoms is a desirable outcome in itself (Carney 
et al., 1999), it is also important to establish whether treatment of depression confers 
improvement in morbidity and mortality outcomes.   Unfortunately there is little evidence 
that pharmacological treatment of depression reduces risk of cardiac mortality in depressed 
cardiac patients (Glassman, 2005).  Two large scale studies have produced findings which 
suggest sertraline (an SSRI) may lead to improvements in cardiac mortality, however the 
lack of statistical power in one (SADHART trial: Glassman et al., 2002) and the lack of 
randomisation for SSRI treatment in the other (ENRICHD, 2003) preclude definitive 
conclusions being drawn (Glassman, 2005, 2007; Jiang & Krishnan, 2004).  Further large 
scale, randomised controlled trials of anti-depressant medication in cardiac patients 
assessing long term morbidity and mortality outcomes are required (Davidson et al., 2006; 
Glassman, 2005).    
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Until recently, evaluation of psychological interventions provided to cardiac patients 
focused predominantly on the provision of supportive counselling, relaxation training and 
education in individual or group settings (Burg & Abrams, 2001).  Whilst such programs 
have often been associated with improvements in quality of life, adjustment to illness and 
patient satisfaction (e.g. Johnston, Foulkes, Johnston, Pollard, & Gudmundsdottir, 1999; 
McLaughlin et al., 2005), the non-standardised nature of the interventions makes 
replication difficult (Linden, Stossel, & Maurice, 1996) and the quality of the research 
makes conclusions about their effectiveness ambiguous (Lett, Davidson, & Blumenthal, 
2005; Rees, Bennet, West, Davey Smith, & Ebrahim, 2004).   
Two large-scale randomised controlled trials of established psychotherapies for 
depression have attempted to redress the issue of poor research evidence for psychotherapy 
in treating depression in cardiac patients.  Cognitive Behaviour Therapy (CBT) and 
Interpersonal Therapy (IPT) have been shown to be effective in treating depression in the 
general population (Dobbels et al., 2002).  CBT aims to assist a patient through 
identification and modification of unhelpful beliefs and behaviours which contribute to 
their identified problem (Schwartz & Schwartz, 1993).  IPT focuses on an individual’s 
interpersonal relationships with the aim of improving these relationships or altering the 
individual’s expectations about them (Stuart & Robertson, 2003). 
The ENRICHD study assessed the effectiveness of CBT conducted by qualified, 
trained therapists in improving depression, social support and morbidity and mortality 
outcomes in 2481 AMI patients (ENRICHD, 2001).  Whilst intervention significantly 
improved depression symptoms, it was not associated with improvement in cardiac events, 
recurrent AMI or cardiac death, when compared to usual care (ENRICHD, 2003).  
However, post hoc analysis indicated that depressed patients who did not respond to 
treatment had significantly greater mortality rates than those who did (Carney et al., 2004).  
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It should be noted that patients in the ENRICHD study who had severe levels of depressive 
symptoms at intake were also prescribed anti-depressant medication, making conclusions 
about the effectiveness of CBT as a stand alone treatment in cardiac patients not viable 
(ENRICHD, 2001).   
Whilst CBT did not significantly improve prognosis for cardiac events in the 
ENRICHD trial, two pilot trials have suggested mechanisms by which CBT may have an 
effect on physical functioning.  CBT was found to be associated with an improvement in 
heart rate and heart rate variability in severely depressed cardiac patients (Carney et al., 
2000).  CBT was also associated with improvement in inflammatory markers and 
indicators of infection in women following CABG (Doering, Cross, Vredevoe, Martinez-
Maza, & Cowan, 2007).   
The CREATE study assessed the effectiveness of 12 weekly IPT sessions with or 
without adjunctive pharmacotherapy (citalopram) compared to usual care for 284 patients 
with CAD (Frasure-Smith et al., 2006).  Although IPT, without adjunctive anti-depressant, 
improved depressive symptoms, this improvement was not statistically greater than the 
improvement observed for the control group (Lesperance et al., 2007).  It was concluded 
that there was no significant benefit to IPT in addition to usual clinical management 
(Lesperance et al., 2007).  
Exercise has been identified as an effective treatment for depression in the general 
population, particularly in those with mild to moderate levels of symptoms (Barbour & 
Blumenthal, 2005; Dunn, Trivedi, Kampert, Clark, & Chambliss, 2005).  In CAD patients, 
participation in an exercise program has been associated with a decrease in depressive 
symptoms (Blumenthal et al., 2005; Milani & Lavie, 1998).  Post hoc analyses of the 
ENRICHD trial data identified that exercise was associated with lower baseline depression 
scores, greater reduction in depression symptoms and fewer cardiac events during follow-
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up, although interaction effects between exercise and depression on prognosis were not 
identified (Blumenthal et al., 2004).  In the Heart and Soul study lower exercise capacity 
was associated with higher levels of depressive symptoms even when measures of heart 
function were controlled for, however given this was not a prospective study causality 
could not be determined (Ruo, Rumsfeld, Pipkin, & Whooley, 2004). 
No randomised controlled trials assessing the treatment effect of exercise on 
depression and prognosis in cardiac patients have been conducted (Blumenthal et al., 
2007).  The UPBEAT study, currently in progress, aims to address this research gap, and 
compare the efficacy of exercise to pharmacological intervention (sertraline) in CAD 
patients (Blumenthal et al., 2007).   
 
Treatment of Depression in Cardiac Patients: The role of cardiac rehabilitation 
Cardiac rehabilitation programs have the potential to have a positive impact on 
depression symptoms in cardiac patients as they involve structured exercise training, 
provide the opportunity for increased social support and have the capacity to provide 
additional group or individual psychotherapy (Dobbels et al., 2002).  Participation in 
traditional cardiac rehabilitation programs, those that focus on exercise, dietary changes 
and modification of other risk factors, has been associated with a reduction in symptoms of 
depression (Barr Taylor, Houston Miller, Ahn, Haskell, & DeBusk, 1986; Denollet & 
Brutsaert, 1995; Lavie & Milani, 2004; Milani et al., 1996; Oldridge, Streiner, Hoffmann, 
& Guyatt, 1995).  This effect is also reported in female attendees (Lavie, Milani, Cassidy, 
& Gilliland, 1999) and patients over 75 years (Lavie & Milani, 1996). 
Cardiac rehabilitation programs that have developed specific treatments or 
components to target depression have had varied success.  Behavioural therapy has been 
shown to improve quality of life (Mayou et al., 2002) and decrease depression, but not 
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reduce re-hospitalisation rates (Black, Allison, Williams, Rummans, & Gau, 1998).  A 
meta-analysis of 37 studies of psycho-educational programs, including health education 
and stress management, indicated no overall effect on reducing depression, however 
health, morbidity and mortality did show improvement (Dusseldorp et al., 1999).  
Counselling of cardiac inpatients has been associated with lower levels of depression 
(Johnston et al., 1999) however a combination of counselling, psycho-education, and 
follow up telephone counselling was found to have no effect on depression in post AMI 
patients (van Elderen-van Kemenade, Maes, & van den Broek, 1994).  
In a study assessing the impact of self-management training with regard to physical 
activity in cardiac patients, the intervention was associated with increased physical activity 
and reduced depressive symptoms, however the perception of achieving exercise goals was 
found to be predictive of depression symptoms, not level of physical activity (Scholz, 
Knoll, Sniehotta, & Schwarzer, 2006).  Thus, cardiac rehabilitation programs that assist 
patients to obtain their goals may have additional positive impacts on depression above the 
impact of pure physical training.   
Randomised controlled trials provide conflicting evidence as to the beneficial impact 
of cardiac rehabilitation on depression in cardiac patients.  Two studies reported similar 
reductions in depressive symptoms for cardiac patients participating in cardiac 
rehabilitation compared to usual care (Engblom, Korpilahti, Hamalainen, Ronnemaa, & 
Puukka, 1997; Oldridge et al., 1995).  A further study reported significantly lower 
depressive symptom levels in cardiac rehabilitation attendees at 12 month follow-up 
(Bettencourt et al., 2005).  None of these studies controlled for other depression treatment 
or levels of physical activity in either the control or treatment groups. Furthermore, these 
studies appear to be impacted by lack of statistical power due to small sample sizes and the 
high rate of depression remission in the placebo group encountered in evaluation of 
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depression specific treatments.  Whilst a large scale randomised controlled trial would be 
ideal, the ethical concerns about withholding cardiac rehabilitation, an established 
efficacious intervention for cardiovascular disease, would preclude such a research design. 
Only one study has assessed the impact of cardiac rehabilitation on depression and 
long-term mortality outcomes.  Patients who completed cardiac rehabilitation were 
compared to a non-randomised sample of cardiac patients who attended less than five 
sessions of cardiac rehabilitation (Milani & Lavie, 2007).  A significant decrease occurred 
in depressive symptoms following rehabilitation, however comparison data for the control 
group was not available to determine if this reduction was greater than that experienced by 
those who did not complete the cardiac rehabilitation program (Milani & Lavie, 2007).  In 
both treatment and control groups, depression at admission to the cardiac rehabilitation 
program was associated with increased mortality during follow-up, however depressed 
patients who completed cardiac rehabilitation had a significantly lower (73%) mortality 
rate than depressed patients who dropped out of rehabilitation (Milani & Lavie, 2007).  
Whilst these results indicate cardiac rehabilitation may have a protective or treatment 
effect for depressed patients, the lack of randomisation means there may have been another 
factor (e.g., poorer baseline health, exercise tolerance, or more persistent depression) 
which caused both drop-out from the program and increased mortality.  Nonetheless, these 
results indicate cardiac rehabilitation has potential to be an effective treatment for 
depression in cardiac patients.   
A possible barrier to cardiac rehabilitation as a treatment for depression in cardiac 
patients lies in the potential interaction between depression and attendance.  Non attenders 
of cardiac rehabilitation have been found to have higher levels of depressive 
symptomatology (Lane et al., 2001b; Turner et al., 2002), though depressive state has not 
always been a reliable predictor of attendance (Grace et al., 2002).  Thus, those who 
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perhaps are at greatest risk, and most in need of effective treatment, may be less likely to 
participate in cardiac rehabilitation.  If cardiac rehabilitation is found to be particularly 
effective for cardiac patients with depression, strategies for identifying and retaining 
depressed cardiac patients in cardiac rehabilitation programs need to be developed (Turner 
et al., 2002).     
 
Conclusion and Study Aims 
A significant proportion of people with a cardiac condition also experience 
significant depressive symptoms.  Research has shown that depression is a risk factor for 
onset of cardiovascular disease, and in those with established cardiovascular disease, 
depression predicts poorer outcomes in terms of quality of life, health care costs, physical 
recovery, morbidity, and mortality.  The precise mechanisms by which depression leads to 
poorer outcomes in cardiac patients have not yet been identified, though a combination of 
biological, psychological, and social factors is likely. Although research has investigated 
the potential of pharmacotherapy and psychotherapy as treatments for depression in 
cardiac patients, the results have been inconsistent.  Where treatment has led to significant 
improvement in depression symptoms compared to placebo or usual care, the effect size 
has been small.  Furthermore, randomised control trials have failed to show evidence that 
treatment of depression leads to improved morbidity and mortality outcomes.   
Cardiac rehabilitation, a secondary prevention strategy aimed at assisting risk factor 
modification and improving prognosis, is recommended for all cardiac patients.   Cardiac 
rehabilitation may also be a suitable treatment for depression in cardiac patients, as it 
combines exercise training, social support, and the opportunity for provision of individual 
and/or group psychotherapy.   Participation in cardiac rehabilitation has been associated 
with improvements in depressive symptoms and in subsequent mortality rates.  However, 
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existing research is predominantly limited by poor methodological design.  Consideration 
needs to be given to participant characteristics as well as the method and timing of 
depression assessment when conducting research in this area.  A comprehensive, large-
scale study of depression in cardiac rehabilitation patients is required.   
 
The aims of this investigation are  
1. To investigate the prevalence of elevated depressive symptoms in patients attending a 
cardiac rehabilitation program. 
2. To investigate whether the level of depressive symptoms in cardiac rehabilitation 
patients varies according to age, gender, or cardiac condition. 
3. To investigate the course of depressive symptoms in cardiac rehabilitation patients over 
time. 
4. To investigate whether level of depressive symptoms predicts completion of a cardiac 
rehabilitation program. 
5. To investigate the relationship between level of depressive symptoms and physical 
outcomes following participation in a cardiac rehabilitation program.  
6. To investigate the impact of depressive symptoms and cardiac program completion on 
morbidity and mortality. 
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Chapter 2 
Method 
Participants 
A cohort of 1,625 consecutively enrolled attendees of the Caulfield General Medical 
Centre Cardiac Rehabilitation Unit (CGMC CRU) between 1st of July, 1997 and 30th 
June, 2004 were included in this study.   Of the 1,625 cases, 24.2% (n = 393) were female 
and 75.8% (n = 1232) male.  Their age ranged between 20 and 88 years (M = 59.8 years, 
SD = 12.82).   Figure 2.1 displays the number of participants by age. 
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Figure 2.1 Number of participants in each age group 
 
Figure 2.1 indicates that there was a slight negative skew (skew = -.19), with fewer 
participants in the lower age ranges than in the upper age ranges.   
Country of birth was not reported for almost a third of participants (n = 522, 32%).  
Table 2.1 (overleaf) lists the origin of birth for the remaining 1,103 cases.  Australian 
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Bureau of Statistics estimates of Australian population by region of birth for 2003 are 
included for comparison (ABS, 2005). 
 
Table 2.1. 
Number of Participants by Origin of Birth. 
Region Number of Participants 
(N = 1,103) 
% N Australian 
Population % 
Australia 659 59.7 76.6 
Western / Northern Europe 161 14.6 7.4 
Southern / Eastern Europe 151 13.7 4.3 
Central Asia (e.g. India) 42 3.8 1.2 
Africa 30 2.7 0.9 
Oceania (inc New Zealand) 25 2.3 2.7 
Asia 14 1.3 4.7 
Americas 11 1.0 0.9 
Middle East 10 0.9 1.3 
 
The figures in Table 2.1 indicate that the most common place of birth was Australia 
(n = 659, 59.7%), however over 40% of participants were born overseas with the most 
common region being Western and Northern Europe (n = 161, 14.6%).  Compared to 
Australian population figures, a greater percentage of participants were born overseas 
(40.3%) than the national average (23.4%).  This is consistent with a greater concentration 
of migrant settlement in Melbourne compared to other regions of Australia (ABS, 2007).   
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Eligibility criteria for participation in the CGMC CRU program were presence of a 
cardiac condition or the need for coronary risk factor modification.  The participants’ 
presenting cardiac conditions are listed in Table 2.2. 
 
Table 2.2. 
Number of participants by cardiovascular condition. 
Diagnosis N % 
AMI/Stent 391 24.1 
Heart Failure 247 15.2 
CABG 239 14.7 
Stent 236 14.5 
AMI 182 11.2 
Multiple e.g. CABG / valve 87 5.3 
Risk Factors 76 4.7 
Angina 53 3.3 
Valve Repair / Replacement 44 2.7 
PTCA 15 0.9% 
Other e.g. arrhythmia, heart transplant 55 3.4% 
Note: AMI = Acute Myocardial Infarction, CABG = Coronary Artery Bypass Graft, PTCA 
= Percutaneous Transluminal Coronary Angioplasty. 
 
Inspection of Table 2.2 indicates that the most common cardiac condition was 
combined AMI and stent procedure, followed by heart failure, CABG procedure, stent 
procedure and AMI.  Other conditions such as angina, risk factors, arrhythmia, and other 
procedures such as valve repair or PTCA were less common.  
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Over the seven year data collection period some patients were admitted to the 
CGMC CRU for more than one course of cardiac rehabilitation.  Table 2.3 lists the number 
of patients by their number of admissions. 
 
Table 2.3 
Number of Participants by number of admissions 
Number of Admissions Number of Patients (N = 1493) 
1 1372 (91.9%) 
2 112 (7.5%) 
3 7 (0.5%) 
4 2 (0.1%) 
 
Inspection of Table 2.3 indicates that during the data collection period 1493 
individuals enrolled in the CGMC CRU.  The majority of patients attended for one course 
of cardiac rehabilitation (n = 1372), a smaller number attended the program twice (n = 
112), with a few attending the program on three or four occasions (n = 9).  Given that 
records were not available to identify whether patients had attended the program prior to 
July 1st 1997 or whether they had previously attended another cardiac rehabilitation 
program, it was not possible to determine with certainty that all participants who attended 
once were first time attendees of cardiac rehabilitation.  
Comparisons between the 1,625 cases and the 1493 individuals were conducted to 
investigate whether retention of all 1,625 cases for data analysis would skew the 
demographic variables of participants.  A two-way contingency table analysis was 
conducted to assess whether the male: female ratio was significantly different between the 
two samples.  Results indicated no statistically significant difference, Pearson χ2 (2, N = 
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3118) = .000, p = 0.99.  An independent samples t-test was conducted to assess for 
significant difference in age between the two sample groups.  This was also not significant, 
t (3114) = .40, p = 0.69.   This indicates that retention of all cases does not significantly 
skew the age and gender of the cardiac patient population.   
 
Materials 
The Cardiac Depression Scale - CDS (Hare & Davis, 1996) was used to assess 
depressive symptomatology.  The CDS is a 26 item, self administered, disease-specific 
depression scale for use in patients with coronary heart disease (CHD).  It was developed 
in Australia and shows good psychometric properties; reliable internal consistency with a 
chronbach’s alpha score of  0.9, correlation with Beck Depression Inventory 0.73.  Items 
are scored on a 7-point likert scale, a higher score indicating more severe levels of 
depressive symptomatology.   
Statistical analyses were performed using SPSS version 11.0.2 for Mac OS 10.  
 
Procedure 
The CGMC CRU provides a program of education and /or supervised exercise for 
patients with coronary artery disease, heart failure, other cardiac conditions or those who 
require risk factor modification. There are no geographical boundaries for patients, 
however a written referral from a health professional is required.  All patients are assessed 
at a pre-admission clinic prior to commencing the program.  Young or employed patients 
are given priority for an assessment appointment and are usually assessed between seven 
and ten days post hospital discharge.  Other patients are assessed approximately three 
weeks post hospital discharge.  Interpreters are provided for assessment interviews where 
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required.  The data included in this study is routinely collected during patient assessment 
interviews.   
 
At the pre-admission clinic patients:- 
1. Provide personal / demographic information; name, age, date of birth, address, 
medicare number, country of birth 
2. Provide medical information; G.P., cardiologist, cardiac diagnosis, cardiac 
hospitalisation details, other medical illness, medication, cardiac risk factors 
3. Complete the Cardiac Depression Scale.  Those with a score over 90 are offered 
referral to the Clinical Psychology service within the Caulfield General Medical 
Centre. 
4. Calculate the time they spend exercising per week 
5. Complete a physical assessment; height, weight, waist circumference, blood 
pressure, and a submaximal bike assessment.   
On the basis of this information, patients are recommended to attend one of four 
program types.   
Program 1 – Typically targeted for patients with CAD, who aim to return to work, are 
fitter, younger or have multiple risk factors.  The program entails a combination of 
exercise and education three times a week for 6 weeks, with a total of 18 sessions. 
Program 2 – Typically targeted for patients with CAD, who have co-morbid health issues, 
limited exercise capacity or are older. The program entails a combination of exercise and 
education twice weekly for 6 weeks, with a total of 12 sessions.  
Program 3 – Typically targeted for patients with limited English, previous attendance at 
cardiac rehabilitation, those not interested in the education component or for whom the 
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education program is not relevant. The program comprises exercise only, two or three 
times a week for 6 weeks, with a minimum of 12 sessions. 
Program 4 – Typically targeted towards patients with heart failure. The program entails a 
combination of exercise, education and a peer support group, two or three times a week for 
12 weeks, with a minimum of 22 sessions. 
Program structure and length may be tailored to suit individual needs. 
Records are kept of the number of physical training sessions and educational lectures 
attended by patients.  Patients are invited to attend a review at discharge if they have 
attended 85% or more of their program.  Sections three, four and five of the assessment are 
repeated during this review.  Those who attend the discharge assessment are invited to 
attend for a repeat assessment three months after discharge.  Those who attend the three 
month review are again invited to attend for a final repeat assessment at twelve months 
after discharge.  Figure 2.2  (overleaf) displays a flow chart for the participation rates at 
each stage of assessment. 
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    Participants     Participants 
    Retained  Withdrawn 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.2 Number of participants assessed at admission, discharge, 3 and 12 month 
follow-up. 
 
As Figure 2.2 indicates 64% (n = 1042) of participants completed the discharge 
assessment.  Of the original 1625 participants, 46% completed the three month follow-up 
assessment, and 30% completed the twelve month follow-up assessment. 
All assessment information is routinely entered into an Excel database managed 
within the CGMC CRU.  A copy of the database for all patients attending the CGMC 
cardiac rehabilitation program between July 1, 1997 and June 30, 2004 was provided to 
Victoria’s Department of Human Services (DHS) Metropolitan Health and Aged Services 
N= 1625 
N= 1042 
N= 742 
N= 486 
ADMISSION 
DISCHARGE 
3 MONTHS 
12 MONTHS 
n= 583 
n= 300 
n= 256 
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Branch.  A unique linkage key was developed by combining the patient’s name, date of 
birth, and Medicare number.  This linkage key was used to retrieve records pertaining to 
each patient held in the Victorian Admitted Episodes Database (VAED) and the Victorian 
Death Registry following their admission to the CGMC cardiac rehabilitation program.  
The VAED is a minimum data set maintained by DHS Victoria, which contains 
information on every Victorian hospital admission, including diagnosis, procedures 
performed, length of stay and type of separation (discharge home / death).  The Victorian 
Death Registry provides information about all deaths in Victoria, including cause of death.  
Of the 1,493 individual patients, 1,402 patients (93.9%) were identified in the DHS 
databases using the unique linkage key.  Records were retrieved for each of these patients 
from their date of admission to the CGMC CRU until June 30, 2005.  These records were 
used to create a second database containing information about the number of subsequent 
cardiac related hospital admissions, the length of stay, and date of death (if applicable) for 
each patient.  Each patient was assigned a unique identifying number, to allow linkage 
between the databases, and identifying information was removed from both databases.   
These two de-identified databases were provided to the principal researcher for analysis.   
The CGMC CRU is a service of Bayside Health.  Ethics approval was obtained from 
the Bayside Health Ethics Committee, RMIT University Human Research Ethics 
Committee and DHS Victoria Human Research Ethics Committee. Patient consent was not 
obtained for inclusion in this specific study however all participants in the Caulfield 
General Medical Centre Cardiac Rehabilitation program are informed at intake that there 
information may be used in evaluation of the program.  The ethical implications of using 
the data without obtaining informed consent for this specific study was one of the key 
issues evaluated by the respective Ethics Committee involved.  The standard procedure of 
informing patients about use of patient information, the provision of de-identified data to 
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the principal researcher and the potential value of the study for the public interest, was 
judged to be adequate to compensate for the potential ethical considerations. 
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Chapter 3 
Prevalence and Course of Depressive Symptoms in Cardiac Rehabilitation Patients 
 
 Whilst depression has been recognized as a significant issue for cardiac patients 
(Frasure-Smith & Lesperance, 2005), there is little consensus on the extent of the problem.  
Studies investigating the prevalence of depression in cardiac patients have reported results 
of varying magnitude. A review of the literature indicates prevalence rates for depression 
from as low as 10% of cardiac patients (Parker et al., 2006; Saur et al., 2001; Sorensen et 
al., 2005) up to 65% (McCrone, Lenz, Tarzian, & Perkins, 2001) [See Appendix A for a 
summary table of published prevalence rates].  These studies primarily report prevalence 
rates for cardiac inpatients, with relatively few studies assessing depressive symptoms in 
cardiac rehabilitation patients (Milani, Lavie, & Cassidy, 1996; Rafanelli et al., 2003; 
Rafanelli et al., 2006; Sanderson & Bittner, 2005; Turner et al., 2002).  
 Published prevalence rates for depression in cardiac rehabilitation patients ranges 
from 11.4% (Rafanelli et al., 2003) to 31% (Sanderson & Bittner, 2005).  Whilst this range 
is not as large as that reported for cardiac patients across all settings, there are several 
factors to be considered when interpreting this variance in rates. Assessment of cardiac 
rehabilitation patients occurred at entry to a rehabilitation program, typically within one 
month of hospitalisation (Rafanelli et al., 2003; Rafanelli et al., 2006). This timing of 
assessment means that those patients who experience an increase of depressive symptoms 
during their hospitalisation, followed by resolution on discharge (Poston et al., 2003), will 
not be assessed as depressed in these studies.  
 Furthermore, as discussed in chapter one, differences in patient characteristics; age, 
sex, and cardiac condition, and in the method of assessment may contribute to the variance 
in prevalence rates.  For example, the study reporting the largest prevalence rate of 31%, 
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assessed only female patients with CAD and used a self-report measure (Sanderson & 
Bittner, 2005).  Females tend to report higher rates of depressive symptoms than males, 
both in the general population (Korten & Henderson, 2000) and in cardiac patients 
(Blumenthal et al., 2003).  In addition, prevalence rates tend to be higher when using a 
self-report measure compared to a structured interview (Bambauer et al., 2005).  This 
highlights the importance of considering these factors when interpreting depression 
prevalence rates in cardiac patients. 
 Investigations of course of depression in groups of cardiac patients have failed to 
identify a consistent pattern, with some reporting a decline in prevalence rates (Grace, 
Abbey, Pinto et al., 2005; McCrone et al., 2001; Timberlake et al., 1997), others reporting 
a sustained rate (Schrader et al., 2004; Trelawny-Ross & Russell, 1987) and one reporting 
an increase in depression rate over time (Luutonen et al., 2002).  It has been suggested that 
there are multiple courses of depression, and that some courses (e.g., high initial depressive 
symptoms maintained or increasing over time) are more strongly associated with poorer 
outcomes (Kaptein et al., 2006).  Several studies have reported a decline in depressive 
symptom rates for patients between admission and discharge from cardiac rehabilitation 
programs (Barr Taylor et al., 1986; Denollet & Brutsaert, 1995; Lavie & Milani, 2004; 
Milani et al., 1996; Milani & Lavie, 2007; Oldridge et al., 1995), however few have 
assessed depression prevalence over a post-rehabilitation follow-up period  (Scholz et al., 
2006).      
To the author’s knowledge, no Australian studies of prevalence rates for depression 
in cardiac rehabilitation patients have been published.  Therefore, it is the aim of this study 
to investigate the prevalence of elevated depressive symptoms in patients attending an 
Australian cardiac rehabilitation program, and to assess whether this rate varies according 
to age, sex or cardiac condition.  Furthermore, an investigation of the prevalence rate over 
 61 
time will also be conducted, through comparison of prevalence rates at admission, 
discharge, three-month, and twelve-month follow-up.  It is expected that the prevalence 
rate obtained will be similar to that reported for other cardiac rehabilitation populations 
(between 10 – 30 %).  It is also expected that females will report higher levels of 
depressive symptoms than males.  Given the inconsistent findings regarding relationship 
between patient age and depressive symptoms in cardiac patients (e.g., Sherwood et al., 
2005; Spijkerman et al., 2005; Valkamo et al., 2001) and lack of research comparing 
prevalence rates between cardiac conditions, no specific hypotheses about these variables 
were made.  Whilst it is expected that prevalence rates of depression will decline between 
admission and discharge, predictions about the course over twelve month follow-up cannot 
be made given the lack of consistency in previous reported results in the general cardiac 
population and a scarcity of research in cardiac rehabilitation patients.     
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Method 
Participants 
Of the 1,625 patients enrolled in the CGMC CRP during the study period, data for 
CDS score at admission into the program was available for 100% of participants (N = 
1,625).  Participant pool comprised 393 females (24.2%) and 1232 males (75.8%), with an 
age range between 20 and 88 years, (M = 59.8 years, SD = 12.82).  Sex and cardiac 
diagnosis was available for all participants; age was available for 1,624 (99.9%) of the 
participants.  CDS was completed by 1042 participants at discharge, 765 participants at 3 
month follow-up and 507 participants at 12 month follow-up.  CDS was available at all 
four time points for 486 participants.   
 
Materials and Procedure 
The materials and procedure described in chapter two were used. 
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Results 
3.1   Prevalence of elevated depressive symptoms. 
Exploration of patients’ CDS scores at admission into the CR program indicated a 
range of scores from 26 to 165, with a mean of 82.4 (SD = 24.9).  The minimum score 
possible on the CDS is 26, and the maximum score is 182.  Figure 3.1 displays the 
distribution of scores. 
CDS at Admiss ion
165
155
145
135
125
115
105
9585756555453525
N
u
m
b
e
r 
o
f 
P
a
rt
i c
i p
a
n
t s
140
120
100
80
60
40
20
0
 
Figure 3.1.  Distribution of CDS scores at admission. 
 
As inspection of Figure 3.1 indicates, the CDS scores at admission were normally 
distributed.  Whilst there are some outliers at the upper range of scores, these do not create 
a significantly skewed distribution, skewness = .21, p > .05. 
Whilst the CDS was not originally published with defined cut-off scores, subsequent 
validation studies have identified potential scores for use.  Di Benedetto and colleagues 
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(2006) reported that a score of 80 was equivalent to the cut off score for mild depression 
on the BDI-II.  Furthermore, Wise and colleagues (2006) used 90 as a cut off for 
Mild/Moderate depression and 100 for Severe depression.  These cut-off scores were used 
for this analysis.  The proportion of participants obtaining scores greater than 80, 90, and 
100 were calculated, these are displayed in Table 3.1.   
 
Table 3.1.  
Number of Participants Exceeding Proposed CDS Cut-Off Scores 
CDS Score Proportional N (%) Cumulative N (%) 
80-89 221 (13.6%) 869 (53.5%) 
90-99 240 (14.8%) 648 (39.9%) 
100 or above 408 (25.1%) 408 (25.1%) 
 
As can be seen in Table 3.1, over half of all participants (53.5%) obtained a CDS 
score at admission equal to or greater than 80.  Two hundred and twenty-one participants 
scored between 80 and 89, two hundred and forty scored between 90 and 99, and over a 
quarter (N = 408) scored greater than 100 on the CDS at admission.  For the purposes of 
further discussion those scoring 100 or greater will be categorised as ‘Severe’ depressive 
symptoms, those scoring between 90 and 99 (inclusive) designated ‘Moderate’ depressive 
symptoms, those between 80 and 89 (inclusive) labelled ‘Mild’ depressive symptoms, and 
those scoring 79 or below termed ‘Minimal’ depressive symptoms. 
 
3.2   Depressive symptoms and sex.  
In order to assess sex differences in depressive symptoms, an independent samples t-
test was conducted with sex as the grouping variable and CDS score at admission as the 
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dependent variable.  Assumptions of independence of samples and equal variances 
between samples were met.  Assumption of normal distribution was met for the female 
sample but not the male sample due to eight outlier scores in the upper range, however 
given the large sample size this violation does not preclude the test being conducted.  The 
test indicated a significant difference, t (1623) = -2.136, p = .033, d = .12, 95% CI d (.01, 
.24).  Mean CDS score was significantly higher for female participants (84.72, SD = 23.74) 
than male participants (81.64, SD = 25.23), however the effect size indicates this 
difference is of little clinical significance.  The test was re-run excluding the eight male 
outliers, however the effect size remained small t (1615) = -2.539, p = .011, d = .15, 95% 
CI d (.03, .26).  Figure 3.2 displays a comparison of CDS score at admission for all male 
and female participants using a box-plot format.  
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Figure 3.2. Box plot comparison of CDS at admission for male and female participants. 
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As can be seen in Figure 3.2, the mean CDS at admission was marginally higher for 
female participants than male participants, however there was considerable overlap 
between the two distributions.  The proportion of males and females scoring 90 or above 
on the CDS was calculated (Males = 38.7%, Females = 43.5%).  The odds ratio of females 
to males scoring in the Moderate or Severe depressive symptom categories was 
determined, OR = 1.22 (CI 95% = 0.97, 1.53).  Whilst the OR indicates females have a 
slightly higher risk of having elevated levels of depressive symptoms, the lower bound 
confidence interval falls below one indicating that this risk is not statistically significant.   
 
3.3   Depressive symptoms and age. 
In order to assess for a relationship between age and CDS at admission, a Pearson 
product-moment correlation analysis was conducted.  This was not significant, r (1624) = -
0.047, p = .061.   Participants were grouped according to age as done previously by Lavie 
and Milani (1996); adults less than 60 years, 60 to 74 yrs, and 75 years and over.  Given 
the presence in this cohort of a considerable number of younger adults a further category of 
under 45 years was also created.  Table 3.2 (overleaf) displays the number of participants 
in each age category. 
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Table 3.2. 
Number of Participants by Age Group 
Age Group Number of Participants (%) 
> 45 years 205 (12.6%) 
45-59 yrs 604 (37.2%) 
60-74 yrs 588 (36.2%) 
> 75 yrs 227 (14.0%) 
 
As can be seen in Table 3.2, the majority of participants fell in the 45-59 year age 
group (37.2%), followed closely by the 60-74 year age group (36.2%). 
A boxplot of CDS at admission by age group was configured, this identified six 
outliers that were excluded from further analysis.  The boxplot was repeated identifying an 
additional outlier which was also excluded.  Outliers were excluded to ensure the 
assumption of a normally distributed population was met for each factor in the subsequent 
analysis.  All outliers had relatively high CDS scores at admission, with four falling in the 
45-59 year old age group and three falling in the 60-74 year old age group.  
A one-way analysis of variance (ANOVA) was conducted to evaluate the 
relationship between age and CDS score at admission.  The independent variable, age 
group, had four levels and the dependent variable was CDS score at admission.  A 
significant Levene statistic indicated the assumption of homogeneity of variances was 
violated, thus the more conservative Welch F statistic was calculated. This indicated there 
was no significant difference between age groups for CDS score, Welch F (3, 592.2) = 
2.42, p = .065. Figure 3.3 (overleaf) displays a comparison of CDS at admission, excluding 
the seven outliers, for the four age groups using a box plot format.   
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 Figure 3.3.  Box plot spread of CDS at admission by age group. 
 
Figure 3.3 highlights that there is little variation in CDS at admission by age group 
and that these minor differences would not be clinically meaningful.    
Previous research has tended to investigate whether age differences exist between 
depressed and non-depressed patients, treating age as a dependent variable and depression 
as a categorical independent variable.  To allow comparison with previous research this 
approach was taken.  Two depression categories were created, those scoring below 80 on 
the CDS at admission (Minimal) and those scoring 90 or over on the CDS at admission 
(Moderate and Severe symptoms grouped together).  Those identified as “Mild”, scoring 
between 80 and 89 inclusive at admission were excluded to allow greater differentiation 
between the depressed and non-depressed groups.  A box-plot spread indicated three 
outliers (age 20, 21, and 22) who were also excluded from further analysis in order to meet 
the assumption of normality for each factor required for the subsequent analysis. An 
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independent samples t-test was not significant, t (1398) = 1.36, p =.17, indicating no 
statistically significant difference between the mean age of those with Minimal symptoms 
of depression (N = 753, M = 60.22 yrs) and those with Moderate or Severe symptoms of 
depression (N = 647, M = 59.30 yrs).   
 
3.4   Depressive symptoms and cardiac condition. 
For the purpose of investigating the relationship between depressive symptoms and 
cardiac condition, patients were grouped according to their primary referral reason.  The 
cardiac conditions with at least fifty participants in each group were retained for further 
analysis.  A total of 1,424 cases were included across seven diagnostic categories; Acute 
Myocardial Infarction (AMI), AMI/Stent, Angina, Coronary Artery Bypass Graft (CABG), 
Heart Failure, Risk Factors, and Stent.  Table 3.3 lists the number of patients in each 
cardiac condition category.   
 
Table 3.3. 
Number of Participants by Cardiac Condition Category 
Cardiac Condition Number of Participants (%) 
AMI / Stent  391 (12.8%) 
Heart Failure 247 (17.3%) 
CABG 239 (16.8%) 
Stent  236 (16.6%) 
AMI 182 (12.8%) 
Risk Factors 76 (5.3%) 
Angina 53 (3.7%) 
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As can be seen in Table 3.3, combined AMI/Stent procedure was the most common 
referral reason for participants in the cardiac rehabilitation program.  A between subjects 
one-way ANOVA was conducted to determine whether patients with different diagnoses 
reported different levels of depressive symptoms at admission to the cardiac rehabilitation 
program.  Assumptions of independence of samples and homogeneity of variance were 
met.  A significant difference was found, F (6, 1417) = 11.93, p < 0.001, with a moderate 
effect size, η2 = .05.  Figure 3.4 displays a comparison of mean CDS for each cardiac 
condition grouping. 
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Figure 3.4.  Mean CDS score at admission for each cardiac condition. 
 
Figure 3.4 indicates that patients with angina reported the highest mean CDS score at 
admission (M = 92.51) and those with combined AMI/Stent reported the lowest (M = 
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77.80).  Post hoc analyses indicated two homogenous subsets; patients with Heart Failure, 
Angina and Risk Factors reported higher CDS scores than those with AMI, AMI/Stent, 
CABG, or Stent. These two groups were noted to vary in terms of the acuity of the cardiac 
condition and were labeled chronic and acute respectively.  An independent t-test 
comparing mean CDS score at admission between these two groups was significant, t 
(1422) = 8.11, p < 0.001, with a medium effect size, d = .49, 95% CI d (.37, .61).  This 
indicates that those with chronic conditions tend to report significantly higher levels of 
depressive symptoms at admission to cardiac rehabilitation than those with acute cardiac 
conditions.  The proportion of acute and chronic patients scoring greater than 90 on the 
CDS was calculated (acute = 35.8%, chronic = 53.7%), and the odds ratio for chronic: 
acute patients to score in the Moderate or Severe category of depressive symptoms 
determined, OR = 2.08 (CI 95% = 1.64, 2.65).  This indicated that patients with chronic 
conditions had a significantly greater risk of elevated depressive symptoms than patients 
with acute conditions.  
 
3.5   Interaction effects between sex & cardiac condition on depressive symptoms. 
In order to ensure that the significant relationship between cardiac condition and 
CDS score at admission was not an artifact of unequal representation of males and females 
in cardiac condition groups a two-way contingency table analysis was conducted.  The two 
variables were sex with two levels, male and female, and cardiac condition, with seven 
levels: AMI, AMI/Stent, Angina, CABG, Heart Failure, Risk Factors, and Stent.  The 
assumption of independent observations was met, and no cell had an expected frequency 
less than five. Sex and cardiac diagnosis were found to be significantly related, Pearson χ2 
(6, N = 1424) = 14.86, p = .02, Cramer’s V = .10.  Follow-up pairwise comparisons were 
conducted to evaluate the difference among these proportions.  The Holm’s sequential 
 72 
Bonferroni method was used to control for Type I error across the 21 comparisons.  
Results for the pairwise comparisons are displayed in Table 3.4. 
 
Table 3.4. 
Results for the Pairwise Comparisons Using the Holm’s Sequential Bonferroni Method 
Comparison Pearson chi 
square 
p value (alpha) Cramer’s V 
AMI/Stent vs Risk Factors 9.96 .002 (.002) .15 
CABG’s vs Risk Factors 8.58 .003 (.003) .17 
AMI/Stent vs Angina 4.72 .030 (.003) .10 
Angina vs CABG’s 4.22 .040 (.003) .12 
Risk Factors vs Stent 4.10 .043 (.003) .12 
Heart Failure vs Risk Factors 4.03 .045 (.003) .11 
AMI vs Risk Factors 3.11 .078 (.003) .11 
AMI vs. AMI/stent 2.31 .129 (.004) .06 
AMI/Stent vs Heart Failure 2.02 .155 (.004) .06 
AMI/Stent vs Stent 1.84 .175 (.004) .05 
AMI vs CABG’s 1.83 .176 (.005) .07 
Angina vs Stent 1.60 .206 (.005) .07 
CABG’s vs Heart Failure 1.54 .214 (.006) .06 
Angina vs Heart Failure 1.55 .214 (.006) .07 
CABG’s vs Stent 1.42 .234 (.007) .06 
AMI vs Angina 1.14 .285 (.008) .07 
Table 3.4. Cont’d overleaf 
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Table 3.4. cont’d 
 
Comparison Pearson chi 
square 
p value (alpha) Cramer’s V 
Angina vs Risk Factors .17 .684 (.010) .04 
AMI vs Stent .06 .813 (.013) .01 
AMI vs Heart Failure .04 .841 (.017) .01 
Heart Failure vs Stent .00 .968 (.025) .00 
AMI/Stent vs CABG’s .00 .984 (.050) .00 
 
Inspection of Table 3.4 indicates that none of the pairwise comparisons were 
statistically significant, when using the Holm’s sequential Bonferroni adjustment for Type 
1 error.  However both the comparisons between AMI/Stent and Risk Factors groups, 
Pearson χ2 (1, N = 467) = 9.96, p = .002, Cramer’s V = .15, adjusted α = .002, and between 
CABG’s and Risk Factor groups, Pearson χ2 (1, N = 315) = 8.58, p = .003, Cramer’s V = 
.17, adjusted α = .003, approached significance.  In both cases the trend was toward a 
greater proportion of females than expected in the risk factor groups, and a greater 
proportion of males in the acute condition groups of AMI/Stent and CABG’s. 
A second two-way contingency table analysis was conducted to evaluate whether 
male: female ratio differed between the two groups of cardiac condition acuity.  The two 
variables were sex with two levels, male and female, and cardiac condition acuity, with 
two levels: acute and chronic.  Sex and cardiac condition acuity were found to be 
significantly related, Pearson χ2 (1, N = 1424) = 6.06, p = .014, Cramer’s V = .07, with 
females more likely to experience chronic conditions and males more likely to experience 
acute conditions.   
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This indicated that the finding that those with chronic cardiac conditions report 
higher levels of depressive symptoms at admission to cardiac rehabilitation may be due to 
the higher proportion of females in this group, as females tend to report higher levels of 
depressive symptoms than males.  In order to assess this possibility, a 2 x 7 ANOVA was 
conducted to assess the effects of sex and cardiac condition on CDS score at admission.  
The means and standard deviations for CDS score at admission for the two factors are 
displayed in Table 3.5. 
 
Table 3.5. 
Means and Standard Deviations for CDS at Admission by Sex and Cardiac Condition 
Female Male Cardiac Condition 
Mean SD Mean SD 
AMI 84.87 27.18 81.97 24.78 
AMI/Stent 84.12 24.36 76.30 23.02 
Angina 88.18 24.66 94.56 26.87 
CABG 83.28 22.79 80.29 24.66 
Heart Failure 90.14 22.12 91.55 25.83 
Risk Factors 90.04 19.61 93.51 26.20 
Stent 79.48 23.62 79.42 24.76 
  
As can be seen in Table 3.5, the mean CDS score at admission varied between 
cardiac condition categories for both males and females.  For females, the lowest mean 
CDS at admission was for those who had undergone a stent procedure (M = 79.48), and the 
highest for those with heart failure (M = 90.14).  For males the lowest mean CDS at 
admission was for those in the AMI/Stent group (M = 76.30), and the highest was for those 
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with Angina (M = 94.56).  The ANOVA indicated no significant interaction effect between 
sex and cardiac condition, F (6, 1424) = 1.16, p = .38, partial η2 =  .005, and no main 
effect for sex, F (1, 1424) = 0.04, p = .84, partial η2 <  .001.  However there was a main 
effect for cardiac condition, F (6, 1424) = 6.42, p < .001, with a small to medium effect 
size, partial η2 =  .03.  This suggests that there is a significant relationship between cardiac 
condition and CDS score at admission independent of sex, despite the uneven male/female 
ratio across the cardiac conditions.  
A 2 x 2 ANOVA was conducted to confirm that this was also the case for 
comparison of chronic and acute conditions.  Table 3.6 displays the means and standard 
deviations for CDS score at admission for sex and cardiac condition acuity. 
 
Table 3.6. 
CDS at Admission Means and Standard Deviations by Sex and Cardiac Condition Acuity 
Female Male Condition Acuity 
Mean SD Mean SD 
Acute 82.93 24.39 78.85 24.14 
Chronic 89.79 21.73 92.30 25.96 
 
As can be seen in Table 3.6, those with chronic conditions had higher mean CDS 
scores than those with acute cardiac conditions, though the sex difference varied between 
the cardiac condition acuity groups with females having a higher CDS score if they had an 
acute condition but not if they had a chronic condition.  However, the ANOVA indicated 
no significant interaction effect between sex and cardiac condition acuity, F (1, 1424) = 
3.82, p = .051, partial η2 =  .003, and no main effect for sex, F (1, 1424) = 0.22, p = .64, 
partial η2 <  .001.  There was a main effect for cardiac condition acuity, F (1, 1424) = 
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36.34, p < .001, with a small to medium effect size, partial η2 =  .03.  Figure 3.5 displays 
the mean CDS score at admission for the two factors, sex and cardiac condition acuity. 
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Figure 3.5.  Mean CDS at admission for males and females by cardiac condition acuity. 
 
Figure 3.5 highlights that for both males and females, CDS score at admission is 
higher for those with chronic conditions than those with acute conditions.  Although the 
interaction effect was non-significant (p = .051), there is an interesting trend towards 
differential responding in terms of depressive symptom level between males and females 
for chronic and acute conditions.  The graph suggests a trend for females with acute 
conditions to report higher levels of depressive symptoms than males, in contrast to a trend 
for males to report higher levels of depressive symptoms than females for those with 
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chronic cardiac conditions.  Figure 3.6 shows the means CDS score at admission for males 
and females for all seven cardiac conditions investigated. 
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Figure 3.6.  Mean CDS at admission by sex and cardiac condition. 
 
Figure 3.6 indicates that this trend is true for all conditions except Stent, in which 
both males and females reported equivalent levels of depressive symptoms (Males M = 
79.42, Females M = 79.48). The odds ratio of females to males scoring in the Moderate or 
Severe depressive symptom categories was determined separately for those with acute 
conditions, OR = 1.30 (CI 95% = 0.35, 1.99), and those with chronic conditions, OR = 
0.88 (CI 95% = 0.52, 1.50).  Neither of the results was statistically significant.   
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3.6  Course of depressive symptoms. 
In order to assess changes in prevalence of elevated depressive symptoms over time, 
the proportion of participants falling in the Minimal (CDS >80), Mild (CDS 80-89), 
Moderate (CDS 90-99) and Severe (CDS >100) depressive symptom categories were 
calculated for each of the time points; admission, discharge, 3 month follow-up, and 12 
month follow-up.  These are displayed in Table 3.7. 
 
Table 3.7. 
Proportion of Participants in each Depressive Category over Time 
Depression 
Category 
Admission 
N = 1625 
Discharge 
N = 1042 
3 months 
N = 765 
12 months 
N = 507 
 % 
(n) 
% 
(n) 
% 
(n) 
% 
(n) 
Minimal 46.5 % 
(756) 
67.2 % 
(700) 
66.0 % 
(505) 
66.9 % 
(339) 
Mild 13.6 % 
(221) 
13.3 % 
(139) 
13.7 % 
(105) 
11.8 % 
(60) 
Moderate 14.8 % 
(240) 
8.7 % 
(91) 
9.8 % 
(75) 
10.1 % 
(51) 
Severe 25.1 % 
(408) 
10.7 % 
(112) 
10.5 % 
(80) 
11.2 % 
(57) 
 
It can be seen in Table 3.7 that both the proportion of participants in the Moderate 
and Severely depressed categories decreased between admission and discharge from the 
cardiac rehabilitation program, and that these reductions were maintained at three and 
twelve month follow-up.  The proportion of participants in the Mild group remained 
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relatively stable at all four time points, and the proportion in the Minimal group increased 
between admission and discharge, and maintained this increase at three and twelve month 
follow-up.  This is illustrated in Figure 3.7. 
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Figure 3.7.  Proportion of participants in each depression category over time 
 
Figure 3.7 suggests that the greatest changes in proportion of participants in each 
depression category occurred between admission and discharge.  Furthermore, at all four 
times the largest group of participants fell in the Minimal depression category.   
In order to assess whether these changes were statistically significant a one-way 
repeated measures ANOVA was conducted with time as the factor (admission, discharge, 3 
month, and 12 month follow-up) and CDS score as the dependent variable.  For this 
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analysis, only participants for whom a CDS score was available at all four time points were 
retained (N = 486).  To establish this subset was representative of all cases independent 
sample t-tests comparing CDS score at all four time points for those retained with those 
excluded were conducted.  Table 3.8 displays the CDS means and standard deviations for 
the retained participants and the results of the t-tests. To control for Type I error the alpha 
level was adjusted using the Bonferroni method, α = .0125.  
 
Table 3.8. 
Means, standard deviations and t-test results for CDS score across time 
All Participants N = 486 Time 
Mean SD Mean SD 
t p 
Admission 82.38 24.90 80.28 24.23 2.23 .03  
Discharge 69.97 22.80 68.95 22.09 1.35 .18 
3 months 70.47 23.10 70.03 22.78 .69 .49 
12 months  71.33 22.45 71.45 22.69 -.61 .54 
 
Table 3.8 indicates that the CDS means for the retained participants were not 
significantly different from those who were excluded at any time point.  The results for the 
ANOVA indicated a significant time effect, Wilks’s Λ = .76, F (3, 483) = 50.39, p < .001, 
with a large effect size, partial η2 = .24.  Follow-up paired samples t-tests were conducted 
to assess at which time point significant differences existed.  Table 3.9 (overleaf) displays 
the results of these t-tests. To control for Type I error the alpha level was adjusted using 
the Bonferroni method, α = .01. 
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Table 3.9. 
T-test results comparing CDS score between time points 
Comparison t p d (95%CI) 
Admission - Discharge 12.01 .000 * .54 (.45, .64) 
Discharge – 3 months  -1.52 .130 - 
3 months  – 12 months -2.03 .043 - 
Admission – 3 months 10.53 .000 * .48 (.38, .57) 
Admission – 12 months 8.73 .000 * .40 (.30, .49) 
 
Table 3.9 confirms the trends indicated by comparison of mean CDS scores in Table 
3.6.  There was a significant reduction in depressive symptoms reported between 
admission and discharge, t (485) = 12.01, p < .001, with a medium effect size, d = .54, 
95%CI (.45, .64).  The non-significant results when comparing mean CDS at discharge to 
3 month follow-up and 3 month to 12 month follow-up indicate that this reduction in 
symptoms was maintained through out the follow-up period.   This was confirmed by 
checking that the mean CDS score at 3 months, t (485) = 10.53, p < .001, d = .48, 95%CI 
(.38, .57), and 12 months, t (485) = 8.73, p < .001, d = .40, 95%CI (.30, .49), was 
significantly lower than that at admission.  Figure 3.8 (overleaf) displays a comparison of 
mean CDS score at all four time points. 
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Figure 3.8.  Mean CDS score over time.  
 
A two-way contingency table was created order to assess patterns of movement 
between categories of depressive symptom severity.  Table 3.10 (overleaf) displays the 
number and percentage of participants in each depression category; Minimal, Mild, 
Moderate, and Severe depressive symptoms at admission and discharge.   
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Table 3.10. 
Two-Way Contingency Table Reporting CDS at Admission and Discharge 
CDS Category at Admission CDS Category at 
Discharge Minimal Mild Moderate Severe 
Minimal 447 
(42.9%) 
85 
(8.2%) 
77 
(7.4%) 
91 
(8.7%) 
Mild 37 
(3.6%) 
26 
(2.5%) 
33 
(3.2%) 
43 
(4.1%) 
Moderate 16 
(1.5%) 
17 
(1.6%) 
22 
(2.1%) 
36 
(3.5%) 
Severe 11 
(1.1%) 
9 
(0.9%) 
15 
(1.4%) 
77 
(7.4%) 
 
Whilst the mean CDS score decreased between admission and discharge, Table 3.10 
indicates that for some participants their CDS score remained stable or increased over this 
period.  The majority of participants (54.9%) remained in the same depression category, as 
indicated by the light grey shading, with the bulk of this group being those who reported 
low levels of depressive symptoms at both admission and discharge (42.9%).  Over a third 
of participants (35.1%) moved to a lower depressive category, as indicated by no shading.  
This included 16.1% of participants who moved from the Moderate or Severe levels of 
depressive symptoms at admission to Minimal at discharge.  Of concern are the 10.1% of 
participants whose level of depressive symptoms increased, putting them in a higher 
category of depressive symptoms at discharge than admission.  This is indicated by the 
dark grey shading in Table 3.10.     
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A two-way contingency table comparing CDS category between discharge and three-
month follow-up (N = 742) indicates that 68% of participants remain in the same category 
(58% of them remaining in the Minimal category), 14.8% move to a lower category and 
17.2% move to a higher category.  A comparison of three-month follow-up to twelve 
month follow-up data (N = 500) indicates a similar pattern with 72% remaining in the same 
category (57.8% in the Minimal category), 12.4% moving to a lower category and 15.6% 
moving to a higher category.    
 
3.7   Depression course and sex. 
A 2 x 4 mixed factorial ANOVA was conducted to assess for a possible interaction 
effect between sex and time for CDS score.  The factor sex, was a between subjects factor 
with two levels, male and female, and the factor, time, was a repeated measures factor with 
four levels, admission, discharge, three month follow-up, and twelve month follow-up.  
The dependent variable was CDS score.  The interaction effect was not significant, Wilks’s 
Λ = .99, F (3, 482) = 1.40, p = .24, indicating that course of depressive symptoms over the 
four time points did not differ significantly between males and females.  Figure 3.9 
(overleaf) displays a graph of Mean CDS over time for male and female participants. 
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Figure 3.9. Mean CDS over Time by Sex 
 
Figure 3.9 highlights that both females and males had a marked decline in mean CDS 
between admission and discharge.  Furthermore it suggests that female participants 
maintained this reduction, whilst male participants demonstrated an increase in symptoms 
over follow-up such that they had a higher mean CDS at 12-month follow-up than females.  
However, the lack of a significant interaction effect indicates that this trend is non-
significant.  
 
3.8   Depression course and cardiac condition 
A 2 x 4 mixed factorial ANOVA was conducted to assess for a possible interaction 
effect between cardiac condition acuity and time for CDS score.  The factor acuity, was a 
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between subjects factor with two levels, acute and chronic, and the factor, time, was a 
repeated measures factor with four levels, admission, discharge, three month follow-up and 
twelve month follow-up.  The dependent variable was CDS score.  The interaction effect 
was not significant, Wilks’s Λ = .99, F (3, 407) = 1.79, p = .15, indicating that course of 
depressive symptoms over the four time points did not differ significantly between 
participants with an acute or a chronic condition.  Figure 3.10 displays a graph of Mean 
CDS over time for participants with acute and chronic conditions. 
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Figure 3.10. Mean CDS over time by cardiac condition acuity. 
 
As can be seen in Figure 3.10, the same pattern of symptom reduction between 
admission and discharge, followed by maintenance of this reduction at three and twelve 
month follow-up was displayed by participants with both acute and chronic conditions.  
However, the relative magnitude of depressive symptoms remains higher for those with 
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chronic conditions across all four time points than for those with acute conditions.  This 
difference was confirmed as statistically significant by a main effect for condition acuity, F 
(1, 409) = 17.64, p < .001, with a small to medium effect size, partial η2 = .04.  
 
3.9   Cluster analysis: Depression course over time. 
In order to assess whether course of depression, rather than initial depression score, 
was a better indicator of outcome a cluster analysis was conducted to identify distinct 
groups of depression courses.  K-Means Clustering was used.  An a priori decision was 
made to identify 5 clusters given this was the solution determined by Kaptien and 
colleagues (2006).  Given this procedures sensitivity to outliers box-plot graphs were 
produced for CDS at all four time points to identify outliers.  Eleven cases were identified 
as outliers, these were excluded from further analysis and the box plot procedure repeated, 
this identified one further outlier that was excluded.  A third iteration identified no further 
outliers.  A total of 12 cases were excluded leaving a total sample for further analysis of N 
= 474.   
The K-means clustering procedure was conducted three times with different 
orderings of the included cases.  Each solution yielded the same pattern of groupings, the 
solution with the smallest number of iterations (14) was selected as the final categorisation.  
This solution had 88% and 99% agreement with the other two solutions.  Table 3.11 
(overleaf) shows the mean and standard deviation for CDS at each time point for each of 
the five groups. 
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Table 3.11. 
Means and Standard Deviations for CDS across time by Depression Course Cluster 
Cluster Admission 
M (SD) 
Discharge 
M (SD) 
3 Months 
M (SD) 
12 Months 
M (SD) 
1 Very Low (n=97) 53.7 (13.8) 42.6 (8.9) 43.0 (10.0) 45.4 (11.1) 
2  Low (n=122) 64.7 (10.7) 63.7 (10.6) 64.7 (12.2) 65.8 (11.4) 
3  Medium (n=111) 85.3 (11.2) 80.2 (11.8) 81.5 (9.1) 83.5 (11.6) 
4  Decreasing (n= 68) 99.8 (13.4) 61.4 (11.9) 59.3 (13.2) 60.9 (13.1) 
5  High (n=76) 107.4 (13.2) 93.7 (12.7) 98.0 (11.2) 98.0 (13.8) 
 
As can be seen in Table 3.11 groups 1, 2, 3, and 5 had relatively stable mean CDS 
scores across time, whereas group 4 showed a high mean CDS at admission (M = 99.8) 
followed by lower mean CDS scores at discharge, 3 month and 12 month follow-up (M = 
61.4, 59.3 and 60.9 respectively).  Cluster 1 was labelled “Very Low” as the mean CDS 
score across time fell well below the Mild depressive symptoms cut-off score of 80.  
Cluster 2 was labelled “Low” as it’s mean also fell below the Mild depressive symptoms 
cut-off score.  Cluster 3 was labelled “Medium” as the mean fell within the Mild 
depressive symptom range (CDS 80-89).  Cluster 5 was labelled “High” as it’s mean fell 
within the Moderate or Severe depressive symptom range at all four time points.  Finally, 
cluster 4 was labelled “Decreasing” as it had a mean CDS within the Moderate depressive 
symptom range at admission, but subsequent means fell below the Mild depressive 
symptoms cut-off score.  Figure 3.11 (overleaf) shows a plot of the mean CDS over time 
for each cluster. 
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Figure 3.11. Mean CDS over time for each depression course cluster. 
 
Figure 3.11 displays the mean CDS score over time for each of the five depression 
course clusters.  This figure further illustrates that four of the clusters maintain similar 
mean CDS scores over all four time points, whereas the Decreasing cluster shows a mean 
CDS score at admission on the cut-off between Moderate and Severe levels of depressive 
symptomatology (M = 99.8, cut-off = 100), but mean CDS score at subsequent time points 
within the Minimal range (M = 61.4, 59.3, 60.9, cut off < 80).  It is possible that the 
outcomes for this group who experienced initially high but decreasing symptoms of 
depression may differ significantly to the group with similarly high initial symptoms that 
maintained clinically significant levels of depressive symptoms over time. 
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Summary of Findings 
These findings indicate that a sizeable proportion of cardiac rehabilitation patients 
report experiencing clinically significant levels of depressive symptoms. Using previously 
proposed cut-off scores (Martin & Thompson, 2006; Wise et al., 2006), one quarter 
(25.1%) of the participants reported Severe levels of depressive symptoms, and a further 
14.8 percent reported Moderate levels of depressive symptoms, indicating almost forty 
percent (39.9%) of participants reported elevated levels of depressive symptomatology.  
Di Benedetto and colleagues (2005) found that a score greater than 80 on the CDS 
was equivalent to a score above 10 on the Beck Depression Inventory, the cut-off used to 
indicate Moderate depression.  In this cohort 53.5 percent of patients scored greater than 
80 on the CDS.  If this cut-off is adopted for the current study, this indicates that over half 
of the cardiac rehabilitation patients reported clinically significant levels of depressive 
symptomatology, placing it as the second highest prevalence rate in the group of reviewed 
studies.  
Evaluation of the relationship between depressive symptoms and patient 
characteristics indicated that, in the current study, female patients were more likely to 
report higher CDS scores than male patients.  However, the effect size was small, and the 
odds ratio indicated that sex was not a significant risk factor for having a CDS score in the 
Moderate or Severe depressive symptom category.  No significant relationship between 
age and CDS score was found in this study.  
The inclusion of cardiac patients with a variety of cardiac conditions allowed 
comparisons to be made between diagnostic groups.  In the current study cardiac condition 
was found to relate to CDS score at admission.  Further analysis indicated that those with 
chronic cardiac conditions; risk factors, angina and heart failure reported significantly 
higher levels of depressive symptoms than those with acute conditions; AMI, AMI/Stent, 
 91 
Stent and CABGs.  Both these findings were maintained when sex was controlled for.  The 
odds of experiencing elevated levels of depressive symptoms, in either the Moderate or 
Severe depressive symptom categories, was twice that for those with chronic conditions 
compared to those with acute conditions.   
The current research also allowed investigation of changes in depressive symptoms 
over time.  This showed a significant reduction in depressive symptoms between admission 
and discharge, and that this reduction was maintained at three and twelve month follow-up.  
This same pattern was displayed when participants were grouped according to sex and 
cardiac condition acuity.  Unfortunately follow-up CDS scores were not available for those 
participants who dropped out of the cardiac rehabilitation to confirm whether this 
reduction in symptoms was a naturally occurring reduction over time, or could be a 
potential beneficial result of participation in the program.    
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Chapter 4 
Depressive Symptoms, Program Completion and Physical Health Outcomes in Cardiac 
Rehabilitation Patients 
 
Cardiac rehabilitation programs aim to facilitate recovery from cardiovascular 
disease and promote secondary prevention of further cardiovascular events (Goble & 
Worcester, 1999).  Participation in these programs has been shown to significantly reduce 
subsequent cardiac morbidity and mortality (Belardinelli et al., 1999; Hedback et al., 1993; 
Joliffe et al., 2001; McAlister, Lawson, Teo, & Armstrong, 2001; O’Connor et al., 1989; 
Sundararajan et al., 2004; Taylor et al., 2004; Wallner et al., 1999).  
In Australia, cardiac rehabilitation programs are recommended for all people with 
identified cardiac conditions or significant cardiac risk factors (NHFA & ACRA, 2004).  
Despite the potential benefits of participation in a cardiac rehabilitation program, 
attendance rates are relatively low.  An evaluation of attendance at Victorian cardiac 
rehabilitation programs found that of all eligible patients discharged from hospital 
following AMI, PTCA, or CABG in one year, only 23% attended cardiac rehabilitation 
(Sundararajan et al., 2004).  Low figures for attendance at cardiac rehabilitation have also 
been reported in New Zealand, the UK, France, and the USA (Beswick et al., 2005).   
Furthermore, those who attend cardiac rehabilitation do not necessarily complete the entire 
program.  A review of six studies reporting drop-out rates from cardiac rehabilitation 
indicated a further 10% to 40% of cardiac patients who initially attend cardiac 
rehabilitation do not complete the program (Turner et al., 2002).  Thus a significant 
proportion of cardiovascular patients are not accessing cardiac rehabilitation programs and 
are therefore foregoing the potential beneficial effects such programs have on recovery and 
subsequent morbidity and mortality.   
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Research examining the reasons cardiac patients do not participate in cardiac 
rehabilitation programs has highlighted a number of potential barriers and patient 
characteristics associated with attendance and adherence.  Comparison of research in this 
area is complicated by a lack of specificity about the term ‘attendance’, being used 
interchangeably with the terms ‘compliance’ or ‘adherence’ (Bock 2002) and variously 
being used to refer to program enrolment, program completion, or completing a pre-set 
percentage of program sessions (Cooper et al., 2002).  For the purposes of this review 
‘attendance’ will refer to patients enrolling in cardiac rehabilitation, and ‘adherence’ will 
refer to completing the program. 
Research examining cardiac rehabilitation program attendance and adherence has 
identified a number of barriers related to the accessibility of programs for cardiac patients.  
Whilst referral to cardiac rehabilitation programs may be recommended for all cardiac 
patients, not all patients are informed about cardiac rehabilitation or referred to a program 
(Grace et al., 2002).  Furthermore, not all patients have a program in their local area 
(Bunker & Goble, 2003); particularly those in remote or rural regions (Dollard, Smith, 
Thompson & Stewart, 2004) or they may lack appropriate transport to gain access (Farley 
et al., 2003; Cooper, Jackson, Weinman & Horne, 2005).  For other cardiac patients, the 
timing of the program may be inconvenient (Grace et al., 2002), or they may be 
unavailable due to work commitments or being the main carer for another (Cooper et al., 
2005; King, Humen, Smith, Phan, & Teo, 2001; Lane et al., 2001b).  Thus, program 
accessibility is one reason behind low cardiac rehabilitation program attendance and 
adherence. 
Comparisons of cardiac patients who attend cardiac rehabilitation programs to non-
attenders have indicated differences in demographic characteristics.  It has commonly been 
reported that patients attending cardiac rehabilitation programs are typically male, middle 
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aged and have uncomplicated myocardial infarction (Beswick et al., 2005; Lane et al., 
2001b).  In a review of 15 studies assessing cardiac rehabilitation attendance, older age 
was associated with non-attendance (Cooper et al., 2002).  However the relationship 
between sex and attendance was less robust.  In half of the studies, being female was 
associated with poorer attendance, however the other half reported no significant 
relationship between sex and attendance (Cooper et al., 2002).   
It has been suggested that the relationship between sex and cardiac rehabilitation 
program attendance may be an artefact of the age effect, given that female cardiac patients 
tend to be significantly older than male cardiac patients (Daly et al., 2002).  However, in 
two of the studies reviewed by Cooper and colleagues the sex effect remained when the 
influence of age was controlled (Evenson, Rosamond & Luepker, 1998; Mc Gee & 
Horgan, 1992 both cited in Cooper et al., 2002).  Therefore, whilst the relationship 
between sex and attendance may not be strong, it appears to be independent of the effect of 
age.   
Physical health indicators have also been associated with cardiac rehabilitation 
attendance and adherence.  Whilst cardiac diagnosis or cardiac disease severity do not 
appear to relate significantly to attendance (Farley et al., 2003; Cooper et al., 2002), 
general physical health may be important.  A Japanese study evaluating barriers to cardiac 
rehabilitation reported that the most common reason for non-attendance was reduced 
physical fitness (49% of participants), such as requiring a walking aid or having a co-
morbid health issue (Mak et al., 2005).  Other physical factors predictive of non-attendance 
or poor adherence include obesity (Farley et al., 2003; Sanderson & Bittner, 2005) and 
lower levels of exercise prior to cardiac event (Farley et al., 2003; Lane et al., 2001b). 
Thus, in addition to program accessibility, the age, sex, and physical health of 
cardiac patients may be significantly related to cardiac rehabilitation program attendance 
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and adherence.  In addition to these physical and demographic characteristics, research has 
proposed that psychosocial characteristics may also be strongly linked to program 
attendance. 
Patients with lower levels of social support have been reported to participate less in 
cardiac rehabilitation (Daly et al., 2002).  However this finding was only partially 
replicated by Farley and colleagues who found having a partner increased women’s 
likelihood of attending cardiac rehabilitation but not men’s (Farley et al., 2003), and was 
not replicated at all by King and colleagues (2001). 
Patient’s beliefs about themselves, their illness, and cardiac rehabilitation have also 
been linked to cardiac rehabilitation attendance and adherence.  A meta-analysis of 
research investigating illness perceptions reported that cardiac patients with beliefs that 
cardiac illness was controllable, symptomatic and had severe consequences were more 
likely to attend a cardiac rehabilitation program (French, Cooper, & Weinman, 2006).  
However not all research has found significant relationships between illness perceptions 
and attendance at cardiac rehabilitation (French, Lewin, Watson, & Thompson, 2005).   
An investigation of beliefs about cardiac rehabilitation reported non-adherent 
patients perceived the exercise program as unhelpful to them and viewed the other 
participants as old, needy and illness-focussed, whereas those who adhered to the program 
saw the other participants as similar to themselves in terms of age and circumstances 
(Clark, Barbour, White, & MacIntyre, 2004).  Farley et al. (2003) reported the most 
common reason patients cited for not attending cardiac rehabilitation was a belief that “[I] 
can deal with [it] by myself”. 
Depression has also been associated with program participation, with research 
finding that increased depressive symptoms are associated with non-attendance (Lane et 
al., 2001b; Kronish et al., 2006), and with non-adherence (Glazer et al., 2002; Grace, 
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Abbey, Pinto et al., 2005; Turner et al., 2002).  Reduced energy, fatigue, a sense of 
hopelessness and helplessness are characteristic of depression (APA, 2000) and could act 
as potential barriers to engagement in cardiac rehabilitation.   
It is possible that the relationship between depression and participation is partially an 
artefact of the relationship between sex and attendance, given that women tend to have 
higher levels of depressive symptoms (Blumenthal et al., 2003; Forrester et al., 1992; 
Frasure-Smith, Lesperance et al., 1999) and may tend to drop out more often.  However, an 
evaluation of attendance within a population of female cardiac patients found depressive 
symptoms predicted drop-out (Sanderson et al., 2005).  Given the potential confounding 
relationships between age, sex, and depressive symptoms, all three variables should be 
considered together when evaluating cardiac rehabilitation attendance or adherence. 
Not all research has found a relationship between higher levels of depressive 
symptoms and non-attendance or drop-out (Cooper et al., 2002).  Whilst some have found 
no difference in depressive symptomatology between attenders and non-attenders of 
cardiac rehabilitation (Farley et al., 2003; Grace, Abbey, Pinto et al., 2002b), one study 
found adherent participants had significantly higher depressive symptomatology than non-
adherent participants (Whitmarsh, Koutantji, & Sidell, 2003).   
The relationship between depression and cardiac rehabilitation attendance is 
important given the possible explanation it provides for the relationship between 
depression and poorer outcomes for cardiac patients.  It is possible that depression 
decreases adherence to treatment recommendations, and that these poor health behaviour 
choices then result in poorer health outcomes for cardiac patients with depression (Carney, 
Freedland, Miller, & Jaffe, 2002; Grace, Abbey, Kapral et al., 2002; Ziegelstein et al., 
2000).   
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This theory is supported by research indicating that elevated depressive symptoms 
are associated with other treatment non-adherence in cardiac patients.  Persistent 
depression has been associated with lower rates of quitting smoking, taking prescribed 
medications, and exercising (Kronish et al., 2006).   Others have found depression post 
AMI predicted non-adherence to dietary, exercise and stress management 
recommendations (Ziegelstein, Bush, & Faurbach, 1998), and depression has frequently 
been linked to poorer adherence with prescribed medications (Bane et al., 2006; Carney, 
Freedland, Eisen, Rich, & Jaffe, 1995; Gehi et al., 2005; Morgan et al., 2006) though not in 
all studies (Schweitzer et al., 2007).  Thus, if depression decreases a cardiac patient’s 
likelihood of attending cardiac rehabilitation, patients with depression are 
disproportionately missing out on the potential beneficial effects of cardiac rehabilitation 
on recovery, morbidity and mortality. 
It is also possible that depression may differentially affect cardiac patient’s response 
to cardiac rehabilitation.  Whilst a depressed cardiac patient may attend the same number 
of cardiac rehabilitation sessions as a non-depressed peer, their depression may affect the 
extent to which they implement the lifestyle changes advocated by cardiac rehabilitation 
programs.  It is important to assess whether depression in cardiac rehabilitation patients is 
related to changes in measures of physical health typically modified by cardiac 
rehabilitation programs, such as weight, blood pressure, and physical activity capacity. To 
the author’s knowledge this relationship has not previously been investigated. 
The relationship between depression, cardiac rehabilitation program adherence, and 
long term health outcomes may be further influenced by the relationship between exercise 
and depression treatment. Exercise has been identified as an effective treatment for 
depression in the general population, particularly in those with mild to moderate levels of 
symptoms (Barbour & Blumenthal, 2005; Dunn et al., 2005).  Furthermore, participation in 
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traditional cardiac rehabilitation programs with a significant focus on regular group 
exercise has been associated with a reduction in symptoms of depression (Barr Taylor et 
al., 1986; Denollet & Brutsaert, 1995; Lavie & Milani, 2004; Milani et al., 1996; Oldridge 
et al., 1995).   Thus, not only do those patients with depression who attend cardiac 
rehabilitation programs receive the generalised benefits of program participation, they may 
receive the additional benefit of exercise treating their depressive symptoms, and 
potentially reducing the risk of poorer long-term outcomes.   
Given the recognised health benefits of participation in a cardiac rehabilitation 
program, and the potential supplementary benefits for depressed cardiac patients due to the 
emphasis on regular exercise, it was proposed to conduct a large-scale evaluation of the 
relationship between level of depressive symptoms and adherence to a cardiac 
rehabilitation program.  It was hypothesised that those who do not complete the cardiac 
rehabilitation program would have higher levels of depressive symptoms at admission than 
those that completed the cardiac rehabilitation program. Furthermore, it was proposed that 
the potential impact of patient characteristics; age, sex, and cardiac condition, on this 
relationship should be assessed.  Given that no study has looked at all of these 
characteristics concurrently, no hypotheses regarding their impact on the relationship 
between depression and adherence were made.  
In addition to the relationship between level of depressive symptoms and adherence 
it was additionally proposed that the relationship between level of depressive symptom and 
physical health outcomes be investigated.  It was proposed that the relationship between 
depression and physical activity, BMI, and blood pressure be assessed given that cardiac 
rehabilitation programs aim to modify these physical health measures.  Given the 
relationship between depression and treatment non-adherence, it was hypothesised that 
cardiac patients with higher levels of depressive symptoms would be less likely to improve 
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on physical health measures between admission and discharge than those patients with 
lower levels of depressive symptoms.   
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Method 
Participants. 
The 1,625 patients enrolled in the CGMC CRP during the study period were divided 
into two groups based on attendance figures.  Those who attended more than 85% of their 
scheduled sessions at the cardiac rehabilitation program were invited to attend for a 
discharge assessment.  Those who participated in this discharge assessment were 
categorised as completing the program, ‘completer’.  The remainder, both those who 
completed less than 85 % of the program and those who did not participate in the discharge 
assessment were classed as ‘non-completers’.  Using this criteria, 64.1% (N = 1042) 
completed the cardiac rehabilitation program.  Of the 1042 participants identified as 
completers, 249 were female (23.9%) and 793 were male (76.1%), with an age range 
between 22 and 88 years, (M = 61.1 years, SD = 12.08).  Table 4.1 (overleaf) displays the 
number of patients for which data was available for each of the variables assessed in 
Chapter 4. 
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Table 4.1. 
Number of Participants by Variable 
Variable Admission N=1625 
n (%) 
Discharge N=1042 
n (%) 
Age 1624 (99.9%) 1042 (100%) 
Sex 1625 (100%) 1042 (100%) 
Cardiac Condition 1625 (100%) 1042 (100%) 
Body Mass Index (BMI) 1621 (99.8%) 1002 (98.1%) 
Blood Pressure 1615 (99.4%) 1017 (97.6%) 
Exercise – minutes per week 1491 (91.8%) 955 (91.7%) 
Bike Level 1173 (70.3%) 926 (88.9%) 
Walk Time 770 (47.4%) 639 (61.3%) 
Walk – Number of Laps 758 (46.6%) 631 (60.6%) 
 
Materials and Procedure 
The materials and procedure described in Chapter 2 were used. 
Body Mass Index (BMI) was calculated for each participant using the standard 
computation weight divided by height squared (WHO, 2006). 
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Results 
4.1   Cardiac rehabilitation program completion. 
4.1.1.   CDS at admission and program completion. 
In order to assess whether completers and non-completers differed significantly in 
their level of depressive symptoms at admission, an independent sample t-test was 
conducted with CDS score as the dependent variable and completion as the grouping 
variable.  The result was significant, t (1623) = 2.06, p = .04, d = 0.11, 95% CI d (.01, .21), 
with non-completers having a higher mean CDS (M = 84.1) than completers (M = 81.4).  
Figure 4.1 shows the percentage of completers / non-completers by depression category. 
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Figure 4.1. Percentage of completers and non-completers by depression category 
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As can be seen in Figure 4.1, only in the Minimal depressive symptom category was 
the proportion of completers greater than the proportion of non-completers.  In the Mild, 
Moderate and Severe depressive symptom categories participants were proportionally 
more likely to drop-out than complete the program, with the greatest difference occurring 
in the Severe category (28% non-completers vs 24 % completers).   
In order to assess whether CDS score at admission differed significantly between 
those who completed the program compared to those who did not complete the cardiac 
rehabilitation program a discriminant function analysis was performed.  CDS at admission 
was entered as the predictor variable and program completion as the dependent variable.  
The overall Wilk’s lambda was significant, Λ = .99, χ2 (1, N =1625) = 4.22, p < .05, 
indicating that CDS score at admission differentiated between program completers and 
non-completers.  However CDS at admission was a poor predictor (percentage classified 
correctly = 52.7%), thus whilst it was statistically significant it accounts for only a small 
amount of variance in program completion (η2 = .03). 
 
4.1.2.   Program completion and patient characteristics. 
To determine whether the patient characteristics age and body mass index (BMI) 
were related to program completion, independent samples t-tests were conducted for age 
and BMI at admission with program completion as the grouping factor.  Age was 
significantly related to completion, t (1622)= -5.37, p < .001, with older participants being 
more likely to complete the program (non-completers M =57.6 yrs, completers M =61.1 
yrs).  BMI at admission was not significantly related to completion, t (1619) = 0.79, p = 
.43). 
A two-way contingency table analysis was conducted to evaluate whether sex or 
baseline weekly exercise was related to program completion.  Neither sex, Pearson χ2 (1, N 
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= 1625) = 0.13, p = .72, nor baseline exercise, Pearson χ2 (1, N = 1491) = 3.81, p =.051, 
were significantly related to completion.   
The relationship between cardiac diagnosis and program completion was also 
investigated.  The seven cardiac diagnostic groups identified in Chapter 3 were used for 
this analysis; AMI, AMI/Stent. Angina, CABG’s, Heart Failure, Risk Factors, Stent (N = 
1424).  A two-way contingency table analysis indicated that cardiac diagnosis was 
significantly related to program completion, Pearson χ2 (6, N =1424) = 44.23, p < .001, 
Cramers V = .18.   The proportions of each cardiac condition group; AMI, AMI/Stent. 
Angina, CABG’s, Heart Failure, Risk Factors, Stent who completed the cardiac 
rehabilitation program were .56, .69, .68, .73, .49, .70, and .59 respectively.   
Post-hoc pairwise comparisons were conducted to evaluate the difference among 
these proportions.  The Holm’s sequential Bonferroni method was used to control for Type 
I error across the 21 comparisons.  Results for the pairwise comparisons are displayed in 
Table 4.2 (overleaf). 
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Table 4.2. 
Pairwise Comparisons of Program Completion between Cardiac Conditions  
Comparison Pearson χ2 p (alpha) Cramer’s V 
CABG’s vs Heart Failure 29.96 .000 (.002)* .25 
AMI/Stent vs Heart Failure 25.69 .000 (.003)* .20 
AMI vs CABG’s 12.74 .000 (.003)* .17 
CABG’s vs Stent 10.27 .001 (.003)* .15 
Heart Failure vs Risk Factors 10.07 .002 (.003)* .18 
AMI vs. AMI/stent 8.49 .004 (.003) .12 
Angina vs Heart Failure 6.27 .012 (.003) .15 
AMI/Stent vs Stent 6.16 .013 (.004) .10 
Heart Failure vs Stent 5.19 .023 (.004) .10 
AMI vs Risk Factors 3.87 .049 (.004) .12 
Risk Factors vs Stent 2.64 .104 (.005) .09 
AMI vs Heart Failure 2.43 .119 (.005) .08 
AMI vs Angina 2.18 .140 (.006) .10 
Angina vs Stent 1.35 .246 (.006) .07 
AMI/Stent vs CABG’s 1.24 .265 (.007) .04 
Angina vs CABG’s 0.61 .436 (.008) .05 
CABG’s vs Risk Factors 0.35 .554 (.010) .03 
AMI vs Stent 0.31 .575 (.013) .03 
Angina vs Risk Factors 0.05 .827 (.017) .02 
AMI/Stent vs Angina 0.03 .868 (.025) .01 
AMI/Stent vs Risk Factors 0.01 .906 (.050) .01 
* p value ≤ alpha 
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As illustrated in Table 4.2, five of the pairwise comparisons were significant.  These 
significant differences were due to relatively high levels of program completion in the 
CABG cardiac condition group and relatively low levels of program completion in the 
Heart Failure cardiac condition group.  Figure 4.2 displays a comparison of completers and 
non-completers by cardiac condition group. 
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Figure 4.2. Number of completers and non-completers by cardiac condition 
 
As can be seen in Figure 4.2, only those in the heart failure condition group were 
more likely to drop-out of the program (N = 126, 51.0%) than complete it (N = 121, 
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49.0%), though the ratio of completers to non-completers varied between the other six 
cardiac condition groups.   
A two-way contingency table analysis was conducted to assess the relationship 
between program completion and cardiac condition acuity using the groups from chapter 3; 
acute (AMI, AMI/Stent, CABG, Stent) and chronic (Angina, Heart Failure, Risk Factors).  
There was a significant relationship with program completion, Pearson χ2 (1, N = 1424) = 
11.40, p = .001, with a medium effect size, Cramers V = .09.  Participants were less likely 
to complete the cardiac rehabilitation program if they had a chronic condition (55.8% 
completed) than if they had an acute condition (65.6% completed).   
 
4.2.   Predictive model for program completion. 
A step-wise logistic regression was conducted to assess whether the five predictors; 
age, sex, obesity, baseline weekly exercise and CDS score at admission, could predict 
program completion. Given potential confounding of depression by age and sex, a step 
wise approach was used.  Age, sex, obesity, and baseline weekly exercise were entered at 
the first step, and CDS score added at the second step to assess whether it contributed any 
additional predictive power to the model.  
Whilst the model was statistically significant at the first step, χ2 (4, N = 1472) = 
33.49, p < .001, and the Hosmer and Lemeshow goodness of fit test indicated it had better 
predictive power than the null hypothesis, χ2 (8, N = 1472) = 11.50, p = .18, it was poor at 
correctly predicting completion or non-completion, percentage classified correctly = 
67.8%.   Adding CDS score at admission at the second step did not improve the model, χ2 
(1, N = 1472) = 1.49, p = .22, indicating that CDS at admission was not a statistically 
significant predictor of program completion once age, sex, BMI, and exercise at baseline 
were accounted for.   
 108 
When cardiac condition was added to the other baseline variables at the first step the 
model remained significant, χ2 (10, N = 1298) = 67.89, p < .001, but the predictive power 
of the model did not improve, percentage classified correctly = 67.8%, indicating that 
including cardiac condition provided no further predictive power to the model.  
Furthermore, the predictive significance of CDS at admission when added at the second 
step remained non-significant, χ2 (1, N = 1298) = .04, p = .84. 
 
4.3.   CDS and measures of physical health. 
4.3.1.   Body mass index (BMI). 
Descriptive statistics for BMI at admission, discharge, 3 month, and 12 month 
follow-up were calculated.  These are displayed in Table 4.3. 
 
Table 4.3. 
Means and Standard Deviations of BMI Across Time 
 N Mean SD 
Admission 1621 28.09 4.78 
Discharge 1115 27.98 4.41 
3 months 790 27.82 4.40 
12 months 529 27.95 4.28 
 
As Table 4.3 shows, the mean BMI for participants remained around 28 at all four 
time points.  Complete BMI data for all four time points was available for 521 participants.  
The World Health Organisation (WHO, 2006) classification system was used to categorise 
participants into weight classes.  The proportion of participants falling in each class at each 
time point is displayed in Table 4.4 (overleaf). 
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Table 4.4. 
Proportion of Participants in each BMI Classification over Time 
 Admission 
N = 1621 
Discharge 
N = 1115 
3 months 
N = 790 
12 months 
N = 529 
 n (%) n (%) n (%) n (%) 
Underweight 
   BMI < 18.5 
9 (0.6) 4 (0.4) 3 (0.4) 2 (0.4) 
Normal 
   BMI 18.5-24.99 
404 (25.0) 264 (23.7) 198 (25.1) 123 (23.3) 
Overweight 
   BMI 25-29.99 
727 (45.0) 546 (49.1) 385 (48.8) 264 (50.1) 
Obese – class I 
   BMI 30-34.99 
350 (21.7) 222 (19.9) 150 (19.0) 105 (19.9) 
Obese – class II 
   BMI 35-39.99 
87 (5.4) 55 (4.9) 41 (5.2) 26 (4.9) 
Obese – class III 
   BMI ≥ 40 
39 (2.4) 22 (2.0) 12 (1.5) 7 (1.3) 
 
As can be seen in Table 4.4, approximately one quarter of participants fell in the 
normal (healthy) weight range at admission into the cardiac rehabilitation program.  The 
majority of participants fell in the overweight category at all four time points; 45% at 
admission, 49.1% at discharge, 48.8% at 3 month follow-up, and 50.1% at 12 month 
follow-up.  Furthermore, over a quarter of all participants were classed as obese (class I-
III) at admission, discharge, and 3 and 12 month follow-up.    
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In order to assess the relationship between depressive symptoms and BMI Pearson 
product-moment correlation coefficients were calculated between CDS score at admission 
and BMI at all four time points.  Using the Bonferroni approach for Type I error across the 
four correlations a p value of less than .0125 (.05/4 = .0125) was required for significance.  
The results of the correlational analyses are displayed in Table 4.5. 
 
Table 4.5. 
Correlations between CDS at Admission and BMI across Time 
  CDS at Admission  
 N R p 
BMI at Admission 1621 .02 .38 
BMI at Discharge 1115 .04 .14 
BMI at 3 months 790 .02 .66 
BMI at 12 months 529 .03 .56 
 
As can be seen in Table 4.5, CDS at admission was not significantly correlated with 
BMI at admission, discharge, 3 or 12 month follow-up.   
In order to assess the relationship between CDS score at admission and change in 
BMI over time, Pearson product-moment correlation coefficients were calculated for those 
participants with a BMI of 25 or greater between CDS score at admission and BMI at 
discharge, 3 month, and 12 month follow-up. Only those participants identified as being 
overweight or obese at admission were retained (N = 1204), given it is only this group that 
is targeted by cardiac rehabilitation with the aim of reducing BMI to the healthy/normal 
range.  Then partial correlation coefficients were conducted for the same variable pairs, 
controlling for the effect of BMI at admission.  The Bonferroni method was used to control 
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for Type I error yielding a p value of less than .0125 for significance for the bivariate 
correlations and a p value of less than .017 for significance for the partial correlations. 
Table 4.6 shows the results of these comparisons. 
 
Table 4.6. 
Correlations between CDS at Admission and BMI at Admission and Discharge 
 CDS at Admission 
 Bivariate Correlations 
 N r p a 
BMI at admission 1204 .08 .009* 
BMI at discharge 838 .08 .018 
BMI at 3 months 584 .07 .081 
BMI at 12 months 392 .09 .069 
 Partial correlations controlling for BMI at admission 
 df r p b 
BMI at discharge 382 .02 .640 
BMI at 3 months 382 .05 .300 
BMI at 12 months 382 .02 .665 
a  p < .0125 
b p < .017 
 
As can be seen in Table 4.6, when only those participants with a BMI of 25 or 
greater are retained, CDS score at admission is significantly correlated with BMI r = .08, p 
= .009.  The positive correlation indicates that those with higher BMIs report higher levels 
of depressive symptoms, however the effect size is very small, r2 = .006 indicating the 
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relationship has limited clinical significance.  Some writers have argued for the use of r as 
a more suitable effect size meaure (Rosenthal, 1994), however in either case the effect size 
indicates no meaningful clinical significance.  There was no significant relationship 
between CDS at admission and BMI at discharge, 3 month, or 12 month follow-up.  In 
order to assess whether CDS at admission was related to change in BMI, the effect of BMI 
at admission on subsequent measures of BMI was partialled out.  These partial correlations 
indicate that there was no significant relationship between CDS at admission and BMI 
change at discharge, 3 or 12 month follow-up.      
 
4.3.2.   Depression course cluster and BMI. 
In order to assess whether course of depressive symptoms over time was related to 
change in BMI over time, a 4 x 5 mixed factorial ANOVA was conducted with BMI as the 
dependent variable. The within subject factor, time, had four levels, admission, discharge, 
3 month follow-up, and 12 month follow-up, and the between subject factor, course, had 
five categories; Very Low, Low, Medium, High and Decreasing. Only those participants 
with a BMI of 25 or greater and for whom BMI was available at all four time points were 
included (N = 331). The time main effect and the interaction effect between time and 
course were tested using the multivariate criterion of Wilks’s lambda (Λ).  The time main 
effect was significant, Λ = .88, F (3, 324) = 15.30, p < .001, with a large effect size, partial 
η2 = .13.  However, the time by course interaction effect was not significant, Λ = .99, F 
(12, 857) = .25, p = .996.  The univariate test associated with the course main effect was 
also nonsignificant, F (4, 326) = .75, p = .56.  The mean BMI at each time point for each 
depressive symptom course is displayed in Figure 4.3 (overleaf). 
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Figure 4.3. Mean BMI over time for each depression course cluster 
 
As Figure 4.3 shows, all participant course clusters experienced a decrease in mean 
BMI between admission and discharge that was either maintained or further reduced by 3 
months, but that all clusters increased mean BMI between 3 month and 12 month follow-
up.  Whilst this graph indicates a trend for those in the High and Medium group to have 
higher mean BMI over time than those in the Very Low, Low, and Decreasing groups this 
trend was non-significant, as indicated by the lack of a significant main effect for course.  
Six paired samples t-tests were conducted to follow up the significant main effect for time.  
The familywise error rate was controlled for by using Holm’s sequential Bonferroni 
approach.  Table 4.7 (overleaf) displays the results of these tests. 
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Table 4.7. 
Paired Samples t-test results for BMI over Time 
 t p (alpha) d 
3 Months vs 12 Months -5.19 .000 * (.01) .29 
Admission vs Discharge 4.64 .000 * (.008) .25 
Admission vs 3 Months 4.10 .000 * (.013) .23 
Discharge vs 12 Months -2.97 .003 * (.017) .16 
Discharge vs 3 Months 1.85 .07 (.025) - 
Admission vs 12 Months -.16 .87 (.05) - 
* statistically significant 
 
Table 4.7 indicates that overall all participants with a BMI of 25 or greater 
experienced a statistically significant reduction in BMI between admission and discharge, t 
(331) = 4.64, p < .001, d = .25, that this reduction was maintained at 3 month follow-up, t 
(331) = 4.10, p < .001, d = .23, but there was no further reduction between discharge and 3 
month follow-up, t (331) = 1.85, p = .07.  However, by 12 month follow-up there is a 
statistically significant increase in BMI compared to both discharge, t (331) = -2.97, p = 
003, d = .16, and 3 month follow-up levels, t (331) = -5.19, p < .001, d = .29), such that by 
12 month post discharge from the program there is no significant difference between 
admission BMI and 12 month follow-up BMI, t (331) = -.16, p = .87.  This indicated that 
the BMI reduction achieved during the program is not maintained at long term (12 month) 
follow-up.  Furthermore this pattern of BMI change occurs regardless of course of 
depressive symptoms.  
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       4.3.3.   Physical activity: Admission. 
Measures of physical activity used by the cardiac rehabilitation program include 
participant’s capacity on a bike fitness task (bike level), number of laps able to be walked 
of a circuit (walk laps), and the total time able to be walked (walk time).  Furthermore, 
participants indicate whether they are achieving a benchmark target of 150 minutes 
exercise per week or not.   
Paired samples t-tests were conducted on the three activity measures bike level, walk 
laps and walk time with performance at admission compared to performance at discharge.  
There was a significant improvement on all three measures for participants; bike level t 
(1110) = -42.2, p < .001, d = 1.27, walk laps t (734) = -45.8, p < .001, d = 1.69, walk time t 
(752) = -19.8, p < .001, d = 0.72.  A two-way contingency table analysis was conducted 
comparing weekly exercise at admission to weekly exercise at discharge  (< or >150 
minutes per week).  There was a significant difference, Pearson χ2 (1, N = 1032) = 49.44, p 
< .001, with a large effect size, Cramers V = .22, with 42.4% of participants meeting the 
exercise benchmark at admission increasing to 85.5% at discharge. 
Pearson product moment correlations were calculated to assess the relationship 
between CDS at admission and participants’ exercise capacity on the walk and bike tasks.  
The Bonferroni approach was used to control for Type 1 error across the three correlations, 
such that a p value of less than .017 (.05/3 = .017) was required for significance.  The 
results of the correlation analyses are displayed in Table 4.8  (overleaf). 
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Table 4.8. 
Correlations between CDS at Admission and Physical Activity at Admission 
 CDS at Admission 
 N r p r2 
Admission Bike Level 1173 -.14  .000* .02 
Admission Walk Laps 758 -.14  .000* .02 
Admission Walk Time 770 -.09 .018 - 
* p < .017 
 
As can be seen in Table 4.8, CDS at admission was significantly correlated with both 
bike level and number of laps walked at admission, but not with time spent walking.  The 
negative direction of the correlation indicates that those with higher levels of depressive 
symptomatology performed more poorly on these measures of physical activity, however 
the effect size for both correlations was small (r2 = .02).    
An independent samples t-test was conducted with exercise minutes per week at 
admission (<150 minutes vs >150 minutes) as the grouping variable and CDS at admission 
as the dependent variable.  The test was significant, t (1489) = 5.35, p < .001, d = .28, with 
those with higher levels of depressive symptoms being less likely to meet the physical 
activity target of 150 minutes exercise per week at admission.    
 
4.3.4   Physical activity: Discharge. 
In order to assess whether CDS at admission was related to participants’ change in 
physical activity between admission and discharge correlation coefficients were computed 
for CDS at admission with bike capacity, walk number of laps and walk time.  These are 
displayed in the upper half of Table 4.9 (overleaf).  Partial correlation coefficients were 
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then calculated for the same variable pairs, controlling for the physical activity level on 
that task at admission.  These results are displayed in the lower half of Table 4.9.  The 
Bonferroni approach was used to control for Type 1 error across each set of three 
correlations, such that a p value of less than .017 (.05/3 = .017) was required for 
significance. 
 
Table 4.9 
Correlations between CDS at Admission and Physical Activity measures at 
Discharge 
 CDS at Admission 
 N r p r2 
 Bivariate correlations 
Discharge Bike Level 1115 -.14  .000* .02 
Discharge Walk Laps 752 -.12  .001* .02 
Discharge Walk Time 764 -.09 .012 * .01 
 Partial correlations controlling for admission 
activity level 
Discharge Bike Level 1108 -.06 .03 - 
Discharge Walk Laps 732 -.06 .10 - 
Discharge Walk Time 750 -.07 .06 - 
*p < .017  
 
As can be seen in the upper half of Table 4.9, CDS at admission was significantly 
correlated with all three measures of physical activity level at discharge.  The direction of 
the relationship indicates that higher levels of depressive symptoms at admission were 
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related to lower levels of physical activity at discharge, though the effect size for all three 
correlations was small (r2 = .02, .02, and .01 respectively).   However, when the effect of 
physical activity on each task at admission was partialled out, as displayed in the lower 
half of Table 4.9, CDS at admission was not significantly related to any of the three 
physical activity measures at discharge.  This indicates that level of depressive symptoms 
at admission did not differentially effect participants’ change on the bike or walking tasks 
between admission and discharge.   
An independent samples t-test was conducted with exercise minutes per week at 
discharge (<150 minutes vs >150 minutes) as the grouping variable and CDS at admission 
as the dependent variable.  The test was significant, t (1041) = 3.91, p < .001, d = .34, with 
those with higher levels of depressive symptoms being less likely to meet the physical 
activity target of 150 minutes exercise per week at discharge.    
In order to assess whether CDS score at admission was related to participants’ 
change in exercise per week between admission and discharge, participants were grouped 
into four categories; ‘low exercisers’ for those who exercised less than 150 minutes per 
week at admission and discharge, ‘high exercisers’ for those who exercised greater than 
150 minutes per week at both time points, ‘increasing exercisers’ for those who were 
exercising less than 150 minutes at admission but greater than 150 minutes per week at 
discharge, and ‘decreasing exercisers’ for those who exercised more than 150 minutes per 
week at admission and less than 150 minutes at discharge.  Table 4.10 (overleaf) displays 
the number of participants in each exercise category. 
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Table 4.10 
Number of Participants by Weekly Exercise Group 
 Admission 
Discharge < 150 minutes per week > 150 minutes per week 
< 150 minutes per week Low Exercisers 
N=125  (12.1%) 
Decreasing Exercisers 
N= 24  (2.3%) 
> 150 minutes per week Increasing Exercisers 
N= 469  (45.4%) 
High Exercisers 
N= 414  (40.1%) 
 
As can be seen in Table 4.10, the proportion of participants achieving the benchmark 
of 150 minutes of exercise per week or more increased from approximately forty per cent 
(N = 438) at admission to over eighty-five per cent at discharge. A two-way contingency 
table analysis indicated that this change was statistically significant, Pearson χ2 (1, N = 
444) = 47.41, p < .001, with a large effect size, Cramers V = .33.   
An independent sample t-test was conducted between the low exercisers group and 
the increasing exercisers group to assess whether CDS score at admission was related to 
change in weekly exercise between admission and discharge.  The test was significant, t 
(592) = 2.61, p = .009, however the effect size was small d = .10.  Those who improved 
their weekly exercise (increasing exercisers) had a lower mean CDS at admission (M = 
82.9) than those who continued to exercise below the recognised benchmark at discharge 
(low exercisers, M = 89.1).   
 
4.4   Depression course cluster and exercise outcomes. 
In order to assess whether course of depression was related to exercise capacity and 
outcomes, statistical analysis was conducted using the five clusters identified previously; 
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Very Low, Low, Medium, Decreasing, and High.  A one way multivariate analysis of 
variance (MANOVA) was conducted with depression course cluster as the grouping 
variable and the three exercise measures; bike level, walk number of laps, and walk time, 
at admission as the dependent variables. Significant differences were found between the 
depression course groups on the dependent measures, Wilks’s Λ = .92, F (3,42) = 2.05, p = 
.02.  The multivariate η2 based on Wilks’s Λ was small, .03, indicating a minimal effect 
size.  Table 4.11 displays the means and standard deviations on the dependent variables for 
the five courses. 
 
Table 4.11. 
Means and Standard Deviations for Physical Activity Measures at Admission for 
Depression Courses 
Bike Level Walk – Time Walk – Laps Depression Course 
M SD M SD M SD 
Very Low 347 141 13.50 4.7 7.98 3.4 
Low 306 132 12.00 4.7 6.53 3.1 
Medium 276 129 12.38 5.0 6.48 3.1 
Decreasing 307 143 12.89 5.4 7.32 3.6 
High 255 138 11.66 5.4 5.66 3.2 
 
As can be seen in Table 4.11, generally the mean level of physical activity decreases 
as the mean level of depressive symptoms increases, the exception to this rule being the 
Decreasing course cluster.  Analyses of variance (ANOVA) on each dependent variable 
were conducted as follow- up tests to the MANOVA.  Using the Bonferroni method each 
ANOVA was tested at the .017 level to control for Type I error.  The ANOVA on the bike 
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level was significant, F (4,284) = 3.44, p = .009, with a medium effect size η2 = .05, as 
was the ANOVA for number of laps walked at admission, F (4,284) = 3.69, p = .006, η2 = 
.05.  The ANOVA for walk time was not significant, F (4,284) = 1.08, p = .37.   
Post hoc analyses to the univariate ANOVA for bike level at admission and number 
of walk laps at admission consisted of pairwise comparisions between depression course 
groups.  The assumption of equality of variances was met for both bike level, Levene’s F 
(4,284) = .28, p = .89, and walk number of laps, Levene’s F (4,284) = .78, p = .54. 
Therefore, pairwise comparions were conducted using Tukeys HSD method.  For bike 
level, two comparisons were statistically significant, with the Very Low group having a 
significantly higher bike level at admission than both the Medium (p = .036), and High 
courses, (p = .008).  It is interesting to note that the Decreasing group, those with similar 
mean CDS at admission to the High group but declining CDS over time were not 
significantly different to the Very Low group on bike level at admission.  Figure 4.4   
(overleaf) displays a comparison of mean bike level at admission between the five risk 
groups. 
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Figure 4.4. Mean bike level at admission for each depression course cluster. 
 
For number of laps walked at admission, one comparison was statistically 
significant, with the Very Low group walking a significantly higher number of laps at 
admission than the High group (p = .004). Figure 4.5 (overleaf) displays a comparison of 
mean number of laps walked at admission between the five risk groups. 
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Figure 4.5. Mean number of laps walked at admission by depression course cluster. 
 
A one way multivariate analysis of covariance (MANCOVA) was conducted with 
depression course as the grouping variable, the three exercise measures; bike level, walk 
number of laps, and walk time at admission as the covariates and at discharge as the 
dependent variables. No significant differences were found between the depression course 
groups on the dependent measures when admission measures were entered as covariates, 
Wilks’s Λ = .98, F (12,711) = 1.08, p = .38.   
In order to assess whether course of depressive symptoms was related to weekly 
exercise at admission, a 2 x 5 contingency table analysis was conducted, with the variable 
weekly exercise having two categories; <150 minutes per week and >150 minutes per 
week, and the variable depressive symptom course having five categories; Very Low, Low, 
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Medium, Decreasing, and High.  Weekly exercise at admission and depressive symptom 
course were found to be significantly related, Pearson χ2 (4, N = 468) = 14.17, p = .007, 
with a large effect size, Cramér’s V = .17.  Figure 4.6 displays the number of participants 
in each depression course by weekly exercise at admission.  
 
Depression Cours e
HighDecreasingMediumLowVery  Low
N
u
m
b
e
r 
o
f 
P
a
rt
i c
ip
a
n
ts
70
60
50
40
30
20
10
Exercise
<150
>150
 
Figure 4.6 Weekly exercise at admission by depression course cluster. 
 
As can be seen in Figure 4.6, the ratio of participants meeting the weekly exercise 
target varies between depression course groups.  The proportions of Very Low, Low, 
Medium, Decreasing, and High course patients who met the weekly exercise target at 
admission were .55, .53, .42, .34, and .35 respectively. Follow-up pairwise comparisons 
were conducted to evaluate the difference among these proportions.  The Holm’s 
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sequential Bonferroni method was used to control for Type I error at the .05 level across all 
ten comparisons.  The results are displayed in Table 4.12. 
 
Table 4.12. 
Pairwise Comparisons of Weekly Exercise at Admission between Depression 
Course Groups  
Comparison Pearson χ2 p (alpha) Cramer’s V 
Very Low vs Decreasing 7.32 .007 (.005) .21 
Very Low vs High 6.77 .009 (.006) .20 
Low vs Decreasing 6.65 .01 (.006)  .19 
Low vs High 6.10 .014 (.007) .18 
Very Low vs Medium 3.68 .06 (.008) .13 
Low vs Medium 3.05 .08 (.01) .16 
Medium vs Decreasing 1.13 .29 (.013) .08 
Medium vs High .83 .36 (.017) .07 
Very Low vs Low .08 .78 (.025) .02 
Decreasing vs High .03 .87 (.05) .01 
* p value ≤ alpha 
 
As can be seen in Table 4.12, none of the pairwise comparisons attained statistical 
significance, however the trend was towards those in the Very Low group being more 
likely to achieve the weekly exercise target at admission than those in either the 
Decreasing or High group.   
The relationship between change in weekly exercise levels at discharge and 
depression course was also assessed.  Only those patients that did not meet the weekly 
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exercise target at admission were included. A 2 x 5 contingency table analysis was 
conducted, with the variable weekly exercise at discharge having two categories; <150 
minutes and >150 minutes, and the variable depressive symptom course having five 
categories; Very Low, Low, Medium, Decreasing, and High.  Weekly exercise at discharge 
and depressive symptom course were not significantly related, Pearson χ2 (4, N = 242) = 
9.01, p = .06. 
 
4.5   CDS and blood pressure. 
Participants were categorised as having low or high blood pressure at admission.  
High blood pressure is considered blood pressure equal to or greater than 139/80 prior to 
January 2000, or greater than 130/80 post this date.  This change was due to an alteration 
in the recommended benchmark for healthy blood pressure at this time.  At admission, 
blood pressure was recorded for 1625 patients.  Of these, over 70 per cent had low blood 
pressure (N = 1166).  A two-way contingency table analysis comparing blood pressure at 
admission to blood pressure at discharge found a significant difference, Pearson χ2 (1, N = 
1109) = 159.94, p < .001, Cramers V = .38, with 72.0% of participants meeting the blood 
pressure benchmark at admission increasing to 74.8% at discharge. 
An independent sample t-test was conducted with high/low blood pressure as the 
grouping variable and CDS at admission as the dependent variable.  The result was 
significant, t (1613) = 2.44, p = .015, however the effect size was very small, d = .14.  
Those with high blood pressure had a lower mean CDS at admission (M = 79.8) than those 
with a lower blood pressure (M = 83.2).   
In order to assess for the possible effect of cardiac condition acuity a 2 x 2 ANOVA 
was conducted with CDS score at admission as the dependent variable and blood pressure 
at admission (low or high) and cardiac condition acuity (acute or chronic) as the 
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independent variables. The ANOVA indicated no significant interaction between blood 
pressure at admission and cardiac condition acuity, F (1,1412) = 0.04, p = .85, partial η2 = 
.000.  The main effect for blood pressure at admission was non-significant, F (1,1412) = 
3.24, p = .07, partial η2 = .002, however the main effect for cardiac condition acuity was 
significant, F (1,1412) = 50.04, p < .001, partial η2 = .03. 
Blood pressure was recorded for 1109 patients at discharge, with almost three 
quarters of participants recording a reading in the low range (N = 830). In order to assess 
whether blood pressure at discharge was related to level of depressive symptoms an 
independent sample t-test was conducted with high/low blood pressure at discharge as the 
grouping variable and CDS at admission as the dependent variable.  The result was not 
significant, t (1107) = .50, p = .615.  When this test was repeated with only those who had 
high blood pressure at admission the result remained non-significant, t (308) = .23, p = 
.820.  
Participants were categorised into four groups based on blood pressure at admission 
and discharge, those who maintained low blood pressure at both time points, Low (N = 
680), those who maintained high blood pressure, High (N = 160), those whose blood 
pressure dropped from high at admission to low at discharge, Improving (N = 150), and 
those whose blood pressure increased between admission and discharge, Worsening (N = 
119).  A one-way analysis of variance (ANOVA) was conducted to assess whether CDS at 
admission differed significantly between these four groups.  The ANOVA was not 
significant, F (3, 1105) = 1.03, p = .38.    
 
4.6   Depression course cluster and blood pressure. 
In order to assess whether course of depressive symptoms was related to blood 
pressure at admission, a 2 x 5 contingency table analysis was conducted, with the variable 
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blood pressure having two categories; low and high, and the variable depressive symptom 
course having five categories; Very Low, Low, Medium, Decreasing, and High.  Blood 
pressure at admission and depressive symptom course were found to be significantly 
related, Pearson χ2 (4, N = 474) = 11.99, p = .017, with a large effect size, Cramér’s V = 
.16. Figure 4.7 displays the number of participants in each depression course by blood 
pressure category at admission. 
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Figure 4.7. Blood Pressure (BP) at admission by depression course cluster. 
 
As can be seen in Figure 4.7, for all the depression course clusters more participants 
met the blood pressure target than had high blood pressure at admission.  The proportions 
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of Very Low, Low, Medium, Decreasing, and High course patients who had high blood 
pressure at admission were .28, .38, .31, .15 and .25, respectively. 
Follow-up pairwise comparisons were conducted to evaluate the difference among 
these proportions.  The Holm’s sequential Bonferroni method was used to control for Type 
I error at the .05 level across all ten comparisons.  The results are displayed in Table 4.13. 
 
Table 4.13. 
Pairwise Comparisons of Blood Pressure at Admission between Depression 
Course Group  
Comparison Pearson χ2 p (alpha) Cramer’s V 
Low vs Decreasing 11.11 .001 (.005) * .24 
Medium vs Decreasing 5.77 .016 (.006) .18 
Very Low vs Decreasing 4.52 .03 (.006) .17 
Low vs High 3.43 .06 (.007) .13 
Decreasing vs High 2.37 .12 (.008) .13 
Very Low vs Low 1.89 .17 (.01) .09 
Low vs Medium 1.29 .26 (.013) .07 
Medium vs High .70 .40 (.017) .06 
Very Low vs High .32 .57 (.025) .04 
Very Low vs Medium .08 .78 (.05) .02 
* p value ≤ alpha 
 
As can be seen in Table 4.13, only one of the pairwise comparisons attained 
statistical significance, that between the Low depressive course and the Decreasing 
depressive course.  The probability of a participant having high blood pressure at 
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admission was about two and a half times more likely (.38/.15) when they had a Low 
depressive course than when they had a Decreasing depressive course.   
In order to assess whether course of depressive symptoms was related to blood 
pressure at discharge, a 2 x 5 contingency table analysis was conducted, with the variable 
blood pressure having two categories; low and high, and the variable depressive symptom 
course having five categories; Very Low, Low, Medium, Decreasing, and High.  Blood 
pressure at discharge and depressive symptom course were not significantly related, 
Pearson χ2 (4, N = 468) = 9.22, p = .06.  
In order to assess whether course of depressive symptoms was related to blood 
pressure change between admission and discharge, a 4 x 5 contingency table analysis was 
conducted, with the variable blood pressure change having four categories; low, high, 
improving, and worsening, and the variable depressive symptom course having five 
categories; Very Low, Low, Medium, Decreasing, and High.  Blood pressure change and 
depressive symptom course were not significantly related, Pearson χ2 (12, N = 468) = 
21.04, p = .050.  
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Summary of Findings 
Overall 64.1% (N = 1042) of cardiac patients who enrolled in the cardiac 
rehabilitation program went on to complete 85% or more of the sessions and attend their 
discharge assessment.  The results supported the hypothesis that cardiac rehabilitation 
patients with higher levels of depressive symptomatology would be less likely to complete 
their cardiac rehabilitation program than those with lower levels of depressive symptoms. 
However, whilst CDS score at admission was a significant predictor of program 
completion, its predictive power was weak, with only 52.7% classified as to adherence 
correctly.  Random allocation would yield a correct classification rate of 50%.   
Of the patient characteristics assessed for relationship with program completion, only 
age and cardiac condition were statistically significantly, with no significant relationship 
for sex, BMI, or baseline exercise levels. The findings indicated that patients who 
completed the cardiac rehabilitation program were older.  Furthermore, patients 
undergoing CABG had relatively high levels of program completion and those with heart 
failure had relatively low levels, with heart failure patients being the only diagnostic group 
to be more likely to drop-out of the program (51.0%) than complete it (49.0%). This 
difference in program completion between diagnostic groups translated into a statistically 
significant difference between cardiac condition acuity, with those with acute cardiac 
conditions (AMI, AMI/Stent, CABG, Stent) being more likely to complete the program 
(65.6%) than those with chronic cardiac conditions (Angina, Heart failure, Risk Factors: 
55.8%).  
When these patient characteristics; age, sex, exercise levels, and cardiac condition 
acuity, were accounted for using step-wise logistic regression, depression score at 
admission was not a significant predictor of program completion. Thus, whilst simple 
analysis supported the hypothesis that those who complete the cardiac rehabilitation 
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program have lower levels of depressive symptoms, the small effect size and the lack of 
predictive significance of depression score when other patient characteristics are accounted 
for indicates that the relationship between depression and adherence is not as strong or 
straightforward as reported by other researchers.  
The second hypothesis that patients with higher levels of depressive symptoms 
would be less likely to improve on measures of physical health received little support from 
these findings.  Whilst participants who completed the cardiac rehabilitation program 
showed statistically significant reductions in BMI and blood pressure, and significant 
increases in exercise capacity and weekly exercise, neither CDS score at admission nor 
course of depressive symptoms was related to change between admission and discharge on 
most of these measures.  The only measure for which analysis indicated a statistically 
significant result was for the relationship between change in weekly exercise amount and 
CDS at admission.  In this case those who did not meet the target of 150 minutes exercise 
or more per week at admission but exceeded this target at discharge (increasing exercisers) 
had a lower mean CDS at admission than those who remained below the exercise target at 
discharge (low exercisers).   
Whilst the hypothesis that higher levels of depressive symptoms would be associated 
with less improvement in physical health measures over the course of the cardiac 
rehabilitation program received little support, there was a significant relationship between 
poorer physical health at admission and depression.  For those in the overweight or obese 
range of BMI at admission, those with higher levels of depressive symptoms at admission 
had significantly greater BMI scores.  Higher depressive symptom levels at admission 
were also associated with lower exercise capacity on the bike assessment and number of 
laps walked, but not time spent walking. Those who were exercising less than 150 minutes 
per week at admission also had significantly higher levels of depressive symptoms than 
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those who were exercising above this benchmark. The only exception was the relationship 
between depressive symptom level and blood pressure with those who met the target blood 
pressure at admission reporting a significantly higher mean CDS score at admission than 
those who had high blood pressure.  However, for all of these relationships, the effect sizes 
were small, indicating that these results have limited clinical significance.   
In addition to assessing the relationship between depression score at admission with 
measures of physical health, the longitudinal information about CDS score over time was 
used to assess differences between participants based on their depressive symptom courses.  
Whilst depression course was not significantly related to change in any of the physical 
health measures between admission and discharge, there were relationships between 
depression course and admission scores on some of the physical health measures.  On the 
exercise capacity measure of bike level, participants in the Very Low group had 
significantly higher exercise capacity scores than those in the Medium and the High 
groups, but not significantly higher than those in the Decreasing group.  Similarly on the 
exercise capacity test of number of laps walked at admission, the Very Low group walked 
a significantly greater distance than those in the High group, but again there was no 
significant difference between the Very Low group and the Decreasing group.   
There was also a significant difference in blood pressure at admission between the 
Low and the Decreasing depressive symptom course groups, with those in the Low group 
being two and a half more times likely to have high blood pressure at admission.  
One further finding of interest was identified.  When investigating the relationship 
between depression course and BMI, a significant main effect for time was identified.  
Further investigation indicated that, on average, participants in the overweight or obese 
BMI ranges at admission experienced a significant decrease in BMI between admission 
and discharge, but that there was a subsequent increase in BMI over the following twelve 
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month period such that there was no significant difference between BMI at admission and 
12 month follow-up.  This is important, as it indicates that gains made in obesity levels 
during the cardiac rehabilitation program were not maintained at twelve months for the 
cohort for whom long term follow-up data was available.    
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Chapter 5 
Depressive Symptoms, Morbidity, and Mortality in Cardiac Rehabilitation Patients 
 
Depressed mood has long been recognised as a common feature of patient’s mental 
state following AMI (Bruhn et al., 1969; Kaufmann et al., 1985).  Traditionally it was 
viewed as a ‘normal’ transitory response (Lesperance & Frasure-Smith, 2000), which 
would resolve as the patient adjusted to their condition (Burg & Abrams, 2001; Ladwig et 
al., 1992).  However, research has indicated that depression in those with established 
cardiac conditions is related to poorer prognosis (Blumenthal et al., 2003; Bruhn et al., 
1974; Frasure-Smith & Lesperance, 1999; Irvine et al., 1999; Scheidt, 2000; Thornton, 
2001; Ziegelstein, 2001; Ziegelstein, 2003).  Depression has been associated with an 
increased risk of mortality (Barth et al., 2004; Bush et al., 2001; Frasure-Smith et al., 1995; 
Nicholson et al., 2006; Van Melle et al., 2004), with most studies reporting a dose-
response relationship with greater symptom severity predicting greater mortality risk 
(Jiang et al., 2007; Lesperance et al., 1996; Murberg & Furze, 2004).  
Depression following AMI has also been associated with increases in measures of 
morbidity; both in number of hospital readmissions and outpatient contacts (Frasure-Smith 
et al., 2000; Mayou et al., 2000; Strik et al., 2003) and more frequent need for surgical 
intervention (Lauzon et al., 2003; Sullivan, et al., 2003).   Depression is also associated 
with poorer physical recovery from coronary heart disease and revascularisation 
procedures (de Jonge et al., 2006; Doering et al., 2005; Ruo et al., 2003; Sullivan et al., 
1997).  Furthermore, depression has been found to predict cardiovascular events in patients 
with AMI (Shiotani et al., 2002), unstable angina (Lesperance et al., 2000), heart failure 
(Rutledge et al., 2006), and in those who have undergone CABG (Rafanelli et al., 2006).  
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Whilst participation in cardiac rehabilitation programs has been associated with 
improved morbidity and mortality outcomes for cardiac patients (Belardinelli et al., 1999; 
Clark, Hartling et al., 2005; Hedback et al., 1993; Jolliffe et al., 2001; O'Connor et al., 
1989; Ornish et al., 1990; Sundararajan et al., 2004; Taylor et al., 2004; Wallner et al., 
1999), and with a reduction in symptoms of depression (Barr Taylor, et al., 1986; Denollet 
& Brutsaert, 1995; Lavie et al., 1999; Lavie & Milani, 1996 & 2004; Milani et al., 1996; 
Oldridge et al., 1995), little research has investigated the relationship between cardiac 
rehabilitation participation, depression and long term morbidity and mortality outcomes.   
Milani and Lavie (2007) compared mortality outcomes of patients who completed 
cardiac rehabilitation to a non-randomised sample of cardiac patients who attended less 
than five sessions of cardiac rehabilitation.  They reported that for both groups depression 
at admission to the cardiac rehabilitation program was associated with increased mortality 
during follow-up.  However, depressed patients who completed cardiac rehabilitation had a 
significantly lower mortality rate than depressed patients who dropped out of rehabilitation 
(73% reduction: Milani & Lavie, 2007).  
It was proposed that a large-scale assessment of the relationship between depressive 
symptoms and long term morbidity and mortality outcomes of cardiac patients enrolled in 
an Australian cardiac rehabilitation program should be conducted.  It was hypothesised that 
higher levels of depressive symptoms would be associated with poorer morbidity 
outcomes, in terms of more days spent in hospital during follow-up, and poorer mortality 
outcomes.  Furthermore, it was proposed that the effect of program completion on this 
relationship should also be assessed.  It was hypothesised that patients with high levels of 
depressive symptoms that do not complete the cardiac rehabilitation program would have 
poorer long-term outcomes than those who do complete the program.   
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Method 
Participants. 
The 1625 cases enrolled in the CGMC cardiac rehabilitation program over the study 
period included some patients admitted to the program on more than one occasion.  In all, 
1493 separate patients were enrolled, and of these 1402 (93.9%) were identified in the 
DHS data set, the source of information for morbidity and mortality outcome data.  For 
those who had more than one episode of care with the program their first episode was used 
in analysis in this chapter.  This allowed for the maximum follow-up period and minimises 
the potential skew that repeat attenders may cause if each of their episodes of care was 
included.  This group ranged in age between 20 and 88 years (M = 59.4 yrs, SD = 12.9) and 
included 335 females (23.9%).   Follow-up data was available until date of death, if 
applicable, or June 30, 2005. Patients spent a mean period of 1355 days (approx 3.7 years) 
in the study, with time in study ranging between 29 and 2484 days.  
  
Materials and Procedure. 
The materials and procedure described in Chapter 2 were used. 
 
 138 
Results 
5.1.   Participant characteristics of patients for whom morbidity and mortality outcomes 
were available. 
Of the 1493 patients enrolled in the cardiac rehabilitation program, 1402 (93.9%) 
were identified in the DHS data set.  In order to assess whether patient characteristics 
differed between this subset and the larger set of 1,625 cases comparisons between the two 
groups were conducted.  Independent t-tests indicated that the subset did not differ 
significantly in age, t (3023) = .94, p = .35, or CDS score at admission, t (3025) = .12, p = 
.91, discharge t (1942) = .46, p = .65, 3 month follow-up, t (944) = .17, p = .86, or 12 
month follow-up, t (944) = .03, p = .98.  Two-way contingency table analysis indicated 
there was also no significant difference between the two groups on sex, Pearson χ2 (1, N = 
3027) = .04, p = .85, depression category, Pearson χ2 (3, N = 3027) = .21, p = .98, or 
program completion, Pearson χ2 (1, N = 3027) = .02, p = .90.   Therefore it was considered 
that the subset of participants for whom outcome data for morbidity and mortality were 
available was representative of the original set of cases.   
 
5.2.   Morbidity. 
5.2.1.   Morbidity measures. 
In order to assess the relationship between depressive symptoms and morbidity two 
measures of morbidity were used.  The number of days spent in hospital, hospital bed days, 
and the number of days spent in hospital for cardiac conditions, cardiac bed days.  Each 
patient was tracked from his or her admission date to the cardiac rehabilitation program 
until his or her date of death if applicable (N = 121) or to June 30, 2005.  Table 5.1 
(overleaf) displays the descriptive statistics for both morbidity measures.  
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Table 5.1. 
Descriptive Statistics for Morbidity Measures 
 N M SD Median Minimum Maximum 
Hospital Bed Days 1402 4.32 14.1 .00 0 234 
Cardiac Bed Days 1402 1.53 6.6 .00 0 100 
  
Table 5.1 indicates that the median number of bed days was zero, reflecting that the 
majority of participants had no further recorded hospital admissions, zero hospital bed days 
(N = 809), zero cardiac bed days (N = 1155).  This means both these measures are strongly 
skewed.  However, traditional methods for identifying outliers for exclusion result in most 
of the hospitalised cases being excluded, thus it was decided to retain all cases and use 
appropriate statistical methods to manage any subsequent violations of assumptions 
underlying statistical analyses. 
 
5.2.2.   CDS at admission and morbidity outcomes. 
Correlation coefficients were calculated between CDS score at admission and the 
two morbidity measures.  The Bonferroni approach was used to control for Type I error 
across the two correlations, requiring a p value of less than .025 (.05/2 = .025) for 
significance.   CDS at admission was significantly correlated with both hospital bed days, r 
= .11, p < .001, r2 = .01, and with cardiac bed days, r = .09, p = .001, r2 = .01, though the 
effect sizes were small.  The positive correlation indicates that higher levels of depressive 
symptoms were associated with more days spent in hospital during follow-up. 
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        5.2.3.   CDS at admission, patient characteristics, and morbidity. 
In order to identify potential confounding variables, the relationship between sex, 
cardiac diagnosis, and the two morbidity measures were assessed.  Independent samples t-
tests were conducted with sex as the grouping variable and morbidity measures as the 
dependent variables. The Bonferroni method was used to control for Type I error across 
multiple comparisons, thus requiring a p value of .025 (.05/2= .025) for significance. Sex 
was not significantly related to either hospital bed days, t (1400) = .27, p = .79, or cardiac 
bed days, t (1400) = 1.05, p = .29. 
A one-way multivariate analysis of variance (MANOVA) was conducted with 
cardiac diagnosis as the grouping variable and hospital bed days and cardiac bed days as 
the dependent variables.  Significant differences were found between the seven diagnostic 
categories on the dependent measures, Wilks’s Λ = .96, F (12, 2450) = 4.27, p < .001, 
partial η2 = .02.  Table 5.2 (overleaf) displays the means and standard deviations on the 
dependent measures for the cardiac diagnostic groups. 
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Table 5.2. 
Means and Standard Deviations of Morbidity Measures by Cardiac Condition 
Cardiac Condition N Hospital Bed Days Cardiac Bed Days 
  M SD M SD 
AMI 168 5.62 21.4 1.64 4.5 
AMI/Stent 350 2.09 5.4 0.86 3.5 
Angina 47 3.43 6.6 1.79 4.9 
CABGS 198 4.00 12.53 0.97 4.7 
Heart Failure 206 9.14 22.3 4.33 14.1 
Risk Factors 51 3.57 7.8 1.00 3.2 
Stent 213 3.12 8.1 1.14 3.7 
 
As can be seen in Table 5.2 Heart Failure patients had the highest mean number of 
days in hospital for all causes (M = 9.14) and cardiac causes (M = 4.33), whereas 
AMI/Stent patients had the lowest mean days in hospital (All cause M = 2.09, cardiac M = 
0.86).   
 Analyses of variance (ANOVA) on each dependent variable were conducted as 
follow-up tests to the MANOVA.  Using the Bonferroni method to control for Type I error 
each ANOVA was tested at the .025 level.  The ANOVA for hospital bed days was 
significant, F (6, 1226) = 6.05, p < .001, partial η2 = .03, as was the ANOVA for cardiac 
bed days, F (6, 1226) = 6.64, p < .001, partial η2 = .03. 
Post hoc analyses were conducted to find which diagnostic category or categories 
differed significantly on the measures of morbidity.  Given the Levene statistic was 
significant for both hospital bed days, F (6,1226) = 17.75, p < .001, and cardiac bed days, 
F (6,1226) = 24.87, p < .001, the Games-Howell post hoc statistic was used.  Patients with 
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Heart Failure spent a significantly higher number of days in hospital than those patients in 
the AMI/Stent (p < .001), Angina (p = .04) and Stent (p = .007) diagnostic categories.  
Patients with Heart Failure also spent a significantly higher number of days in hospital for 
cardiac causes than patients with AMI/Stent (p = .01), CABG’s (p = .02), stent (p = .03) or 
Risk Factors (p = .03). There were no other significant differences between cardiac 
condition diagnostic groups.   
In order to assess whether this difference between cardiac condition categories 
translated into a significant difference between chronic and acute cardiac conditions 
independent samples t-tests were conducted with cardiac condition acuity as the grouping 
variable and hospital bed days and cardiac bed days as the dependent variables.  The 
Bonferroni method was used to control for Type I error across multiple comparisons, thus 
requiring a p value of .025 (.05/2= .025) for significance. Both tests were significant with 
large effect sizes; hospital bed days, t (381.7) = 3.35, p = .001, d = .22,  cardiac bed days, t 
(326.2) = 3.29, p = .001, d = .22.  Patients with chronic conditions spent a significantly 
greater number of days in hospital for all causes (M = 7.32) and cardiac causes (M = 3.38) 
than did those with acute conditions (M = 3.37 and M = 1.09 respectively).   
 
5.2.4.   CDS at admission, time in study and morbidity. 
Given that participants in this study were recruited over a seven-year period and 
morbidity data was collected at a single time point, the time in study varied between 
participants.  Those patients who were alive at the end of the follow-up period (N = 1281) 
had a mean time in study of 1395.9 days, with a minimum of 199 days and a maximum of 
2484 days.  For those patients who died in the follow up period (N = 121) the mean time in 
study was 922.4 days, with a minimum of 29 days and a maximum of 2295 days.  Patients 
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who died during the follow-up period spent significantly less time in the study, t (1400) = 
7.98, p < .001, d = .76.   
Correlation coefficients were calculated between time in study (days) and the two 
morbidity measures.  The Bonferroni approach was used to control for Type I error across 
the two correlations, requiring a p value of less than .025 (.05/2 = .025) for significance.  
Time in study was significantly correlated with hospital bed days, r = -.09, p < .001, but 
not with cardiac bed days, r = -.06, p = .03.  The negative correlation with days spent in 
hospital indicates that those who spent less time in the study spent a greater number of 
days in hospital for any cause, but not when only admission for cardiac conditions were 
assessed.  When the same correlation coefficients were calculated excluding those patients 
who died during the study period (N = 1281), time in study was not significantly correlated 
with cardiac bed days, r = .05, p = .1, or hospital bed days, r = .02, p = .4.  However, for 
those patients who died during the study period (N = 121) time in study was significantly 
negatively correlated with hospital bed days, r = -.26, p = .004, but again not with cardiac 
bed days, r = -.17, p = .06.  
 
5.2.5.   Depression category and morbidity. 
In order to assess whether morbidity measures differed significantly between 
participants in each of the four depression categories; Minimal, Mild, Moderate, and 
Severe depressive symptoms, a one-way multivariate analysis of covariance (MANCOVA) 
was conducted.  Depression category was entered as the grouping variable, days in study 
was entered as a covariate and hospital bed days and cardiac bed days entered as the 
dependent variables.  A preliminary analysis evaluating the homogeneity of slopes 
assumption indicated that the relationship between the covariate and the dependent 
variable did not differ significantly as a function of the independent variable for either 
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cardiac bed days, F (3,1394) = .91, p = .43, partial η2 = .002, or hospital bed days, F 
(3,1394) = 1.42, p = .24, partial η2 = .003.  The Box’s test indicated that the assumption 
that the population variances and covariances among the dependent variables were the 
same across all levels of the factors was violated (p < .001), therefore Pillai’s Trace 
criterion was used.  Significant differences were found between the four depressive 
symptom categories on the dependent measures, Pillai’s Trace V = .01, F (6, 2794) = 3.34, 
p = .003, partial η2 = .01.  Table 5.3 displays the means and standard deviations on the 
dependent measures for each depression category. 
 
Table 5.3. 
Means and Standard Deviations of Morbidity Measures by Depression Category 
Depression Category N Hospital Bed Days Cardiac Bed Days 
  M SD M SD 
Minimal 658 2.62 7.7 1.02 4.9 
Mild 183 5.80 16.5 1.49 4.8 
Moderate 206 5.50 15.4 1.87 6.8 
Severe 355 6.01 19.8 2.32 9.4 
 
As can be seen in Table 5.3, the mean number of days spent in hospital for all causes 
and cardiac causes increased by depression category.  Figure 5.1 (overleaf) displays the 
adjusted mean number of hospital bed days for each depression category, adjusted for the 
covariate time in study. 
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Figure 5.1. Adjusted mean number of days spent in hospital by depression category. 
 
As can be seen in Figure 5.1, the mean number of days spent in hospital adjusted for 
the time spent in the study varied between depressive symptom categories, with the 
Minimal group having the lowest adjusted mean (M = 2.66) and the Severe group having 
the highest adjusted mean (M = 6.00).  Follow- up tests were conducted to assess pairwise 
differences among these adjusted means.  The Holm’s sequential Bonferroni procedure 
was used to control for Type I error across the six pairwise comparisons.  Table 5.4 
(overleaf) displays the results of these comparisons. 
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Table 5.4. 
Pairwise Comparison Results Between Depression Categories for Hospital Bed Days 
Comparison p value (alpha) 
Minimal vs Severe  .000 (.008) * 
Minimal vs Mild .009 (.01) * 
Minimal vs Moderate  .012 (.013) * 
Moderate vs Severe .66 (.016) 
Mild vs Severe .82 (.025) 
Mild vs Moderate .86 (.05) 
* p value ≤ alpha 
 
As can be seen in Table 5.4, there were significant differences in the adjusted means 
between the Minimal group and all three other depression categories; Mild p = .009 (α = 
.01), Moderate p = .012 (α = .013), and Severe p < .001 (α = .008).  None of the 
comparisons between the Mild, Moderate and Severe categories were significant.   
Figure 5.2 (overleaf) displays the adjusted mean number of cardiac bed days for each 
depression category, adjusted for the covariate, time in study.  
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Figure 5.2. Adjusted mean number of days spent in hospital for cardiac illness by 
depression category. 
 
As can be seen in Figure 5.2, the mean number of days spent in hospital for cardiac 
conditions adjusted for the time spent in the study increased with level of depressive 
symptomatology, with the Minimal group having the lowest adjusted mean (M = 1.03) and 
the Severe group having the highest adjusted mean (M = 2.31).  Follow-up tests were 
conducted to assess pairwise differences among these adjusted means.  The Holm’s 
sequential Bonferroni procedure was used to control for Type I error across the six 
pairwise comparisons. Table 5.5 (overleaf) displays the results of these comparisons. 
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Table 5.5. 
Pairwise Comparison Results Between Depression Categories for Cardiac Bed Days 
Comparison p value (alpha) 
Minimal vs Severe  .003 (.008) * 
Minimal vs Moderate .11 (.01) 
Mild vs Severe .16 (.013) 
Minimal vs Mild .43 (.016) 
Moderate vs Severe .44 (.025) 
Mild vs Moderate .55 (.05) 
* p value ≤ alpha 
As can be seen in Table 5.5 only one comparison yielded a statistically significant 
difference, that between the Minimal group and the Severe group, p = .003 (α = .008).  
 
5.2.6.   Depression category, cardiac condition and morbidity. 
Given that cardiac condition was significantly related to morbidity the MANCOVA 
was re-run with cardiac condition type, acute or chronic, as an additional grouping 
variable.  Diagnostic category was not used as this left too few participants in some factor 
groups (n ≤ 8 in four groups). The Box’s test again indicated that the assumption that the 
population variances and covariances among the dependent variables were the same across 
all levels of the factors was violated (p < .001), therefore Pillai’s Trace criterion was used.  
Significant differences were found between the four depression categories on the 
dependent measures, Pillai’s Trace V = .01, F (6, 2448) = 2.86, p = .009, partial η2 = .01.  
Significant differences were also found between chronic and acute conditions on the 
dependent measures, Pillai’s Trace V = .01, F (2, 1223) = 7.31, p = .001, partial η2 = .01.  
However the interaction effect between depression category and condition acuity was not 
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significant, Pillai’s Trace V = .01, F (6, 2448) = 1.74, p = .11.   Table 5.6 displays the 
means and standard error on the dependent measures for each depression category by 
condition acuity, adjusted for the covariate time in study. 
 
Table 5.6. 
Means and Standard Error for Morbidity Measures by Depression Course and Cardiac 
Condition Acuity 
   Hospital Bed Days Cardiac Bed Days 
  N M SE M SE 
Minimal Acute 479 2.38 0.6 0.76 0.3 
 Chronic 94 4.03 1.5 2.72 0.7 
Mild Acute 116 4.90 1.3 1.74 0.6 
 Chronic 45 6.78 2.1 1.44 1.0 
Moderate Acute 131 4.21 1.2 1.42 0.6 
 Chronic 49 10.44 2.0 3.48 1.0 
Severe Acute 203 4.47 1.0 1.35 0.5 
 Chronic 116 8.60 1.3 4.55 0.6 
 
As can be seen in Table 5.6, the mean number of days spent in hospital adjusted for 
the time spent in the study varied between depression categories and between cardiac 
condition acuity, with the Minimal/Acute group having the lowest adjusted mean (adj. M = 
2.38) and the Moderate/Chronic group having the highest adjusted mean (adj. M = 10.44).  
Follow-up tests of the main effects were conducted to assess pairwise differences between 
these adjusted means.  The Holm’s sequential Bonferroni procedure was used to control 
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for Type I error across the pairwise comparisons. Table 5.7 displays the results of these 
comparisons for hospital bed days. 
 
Table 5.7.  
Pairwise Comparison Results Between Depression Categories for Hospital Bed Days 
Adjusted for Time in Study and Cardiac Condition Acuity 
Comparison p value (alpha) 
Minimal vs Severe  .004 (.008) * 
Minimal vs Moderate  .004 (.01) * 
Minimal vs Mild  .07 (.013) 
Mild vs Moderate .38 (.016) 
Moderate vs Severe .58 (.025) 
Mild vs Severe .63 (.05) 
* p value ≤ alpha 
 
As with the previous MANCOVA those with Minimal depressive symptoms spent a 
significantly lower adjusted mean number of days in hospital than those with Moderate p = 
.004 (α = .008), and Severe p = .004 (α = .01), depressive symptoms.  However, when 
cardiac condition acuity was included the difference between the Minimal and the Mild 
group was no longer significant.  Again none of the comparisons between the Mild, 
Moderate and Severe groups were significant. Table 5.8 (overleaf) displays the results for 
the comparisons for cardiac bed days.   
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Table 5.8.  
Pairwise Comparison Results Between Depression Categories for Cardiac Bed Days 
Adjusted for Time in Study and Cardiac Condition Acuity 
Comparison p value (alpha) 
Minimal vs Severe  .029 (.008) 
Mild vs Severe  .06 (.01) 
Mild vs Moderate  .30 (.013) 
Minimal vs Moderate  .31 (.016) 
Moderate vs Severe .47 (.025) 
Minimal vs Mild .84 (.05) 
* p value ≤ alpha 
 
As Table 5.8 shows pairwise comparisons between depressive symptoms categories 
for cardiac bed days yielded no significant differences when cardiac condition acuity was 
included as a factor in the model, Minimal vs Severe p = .029 n/s (α = .008).   
Pairwise comparisons were also conducted to follow-up the main effect for cardiac 
condition acuity.  For both hospital bed days, p = .001 (α = .05), and cardiac bed days, p = 
.001 (α = .05), those with acute conditions spent a significantly lower adjusted mean 
number of days in hospital than those with chronic conditions.  Figure 5.3 (overleaf) 
displays the adjusted mean number of days spent in hospital for each depressive symptom 
category by acuity of cardiac condition. 
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Figure 5.3. Adjusted mean number of days spent in hospital by depression category and 
cardiac condition acuity. 
 
As can be seen in Figure 5.3, the adjusted mean number of days spent in hospital was 
lower for those with acute conditions than those with chronic conditions for all four 
depression categories.  Figure 5.4 (overleaf) displays the adjusted mean number of days 
spent in hospital for cardiac causes for each depression category group by acuity of cardiac 
condition. 
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Figure 5.4. Adjusted mean number of days spent in hospital for cardiac causes by 
depression category and cardiac condition acuity. 
 
As can be seen in Figure 5.4, those with chronic cardiac conditions in the Minimal, 
Moderate and Severe depressive symptom categories spent a greater average number of 
days in hospital for cardiac illness in the follow up period.  However, those in the Mild 
depressive symptoms category did not replicate this difference. 
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5.3.   Mortality. 
5.3.1.   CDS at admission and mortality. 
Of the 1402 patients who were identified in the DHS data set 121 (8.6%) were 
identified in the death registry dataset prior to the end of the follow-up period. Of those 
who died, 9 died within 90 days of admission to the cardiac rehabilitation program.   
An independent sample t-test was conducted with survival as the grouping variable, 
alive or dead, and CDS at admission as the dependent variable.  The test was significant, t 
(1400) = -2.58, p = .01, with a small effect size d = .25.  Mean CDS score at admission was 
higher for those patients who died during follow-up (M = 87.9) than those who were alive 
at the end of the study period (M = 81.8).  This test was repeated excluding the nine 
patients who died within 90 days of admission into the cardiac rehabilitation program.  The 
test remained significant, t (1391) = -2.19, p = .03, d = .22, with the mean CDS score at 
admission significantly higher for those who died (M = 87.1) than those who remained 
alive (M = 81.8).   
The proportion of participants who died during follow-up was calculated for each 
depressive symptom category.  The odds ratio of mortality for those in the Severe 
depressive symptom category (10.7% mortality) compared to those in the Minimal 
category (7.1% mortality) was determined, OR = 1.56 (CI 95% = 1.00, 2.44).  Whilst the 
OR indicates those in the Severe depressive symptom category at admission (CDS score 
100 or greater) have a higher risk of death during follow-up than those in the Minimal 
category (CDS below 80 at admission), the lower bound confidence interval falls at one 
indicating that this difference is just statistically significant.   
The odds ratio of mortality for those in the Severe and Moderate depressive 
symptom categories combined (9.8% mortality) compared to those in the Minimal 
category (7.1% mortality) was determined, OR = 1.41 (CI 95% = 0.94, 2.12), the lower 
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bound confidence interval fell below one indicating that this ratio is not statistically 
significant. 
 
5.3.2.   Mortality and patient characteristics. 
The relationship between patient characteristics; sex and cardiac condition, and 
mortality was investigated.  A two-way contingency analysis was conducted to evaluate 
whether patient sex was related to survival.  The two variables were survival with two 
levels; alive or dead, and sex with two levels; male or female.  Patient sex and survival 
were not significantly related, Pearson χ2 (1, N = 1402) = 2.38, p = .12. 
A two-way contingency analysis was conducted to evaluate whether cardiac 
condition was related to survival.  The two variables were survival with two levels; alive or 
dead, and cardiac condition with seven levels; AMI, AMI/Stent, Angina, CABGSs, Heart 
Failure, Risk Factors, Stent.  Cardiac condition and survival were found to be significantly 
related, Pearson χ2 (6, N = 1233) = 31.97, p < .001, with a large effect size Cramers V = 
.16.  However two cells (14.6%) had expected cell frequencies less than five, with the 
smallest expected frequency being 4.12.  Due to the large number of comparisons and the 
number of cells effected being less than twenty per cent (as recommended by Green & 
Salkind, 2003) it was decided that the result was still valid. The proportions of patients 
with each cardiac condition who died during the follow-up period were as follows; AMI 
.11, AMI/Stent .04, Angina .09, CABGSs .11, Heart Failure .16, Risk Factors .14, Stent 
.05.   
Follow-up pairwise comparisons were conducted to evaluate the difference among 
these proportions.  Table 5.9 (overleaf) shows the results of these analyses.  The Holm’s 
sequential Bonferroni method was used to control for Type I error at the .05 level across all 
twenty-one comparisons.  
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Table 5.9. 
Results for the Pairwise Comparisons Between Cardiac Conditions for Survival 
Comparison Pearson χ2 p  (alpha) Cramer’s V 
AMI/Stent vs Heart Failure 25.87 .000 (.002)* .22 
Heart Failure vs Stent 13.13 .000 (.003)* .18 
AMI vs. AMI/stent 11.30 .001 (.003)* .15 
AMI/Stent vs CABG’s 10.32 .001 (.003)* .14 
AMI/Stent vs Risk Factors ** 9.42 .002 (.003)* .15 
AMI vs Stent 4.89 .027 (.003) .11 
Risk Factors vs Stent ** 4.75 .029 (.003) .13 
CABG’s vs Stent 4.23 .04 (.004) .10 
CABG’s vs Heart Failure 2.56 .11 (.004) .08 
AMI/Stent vs Angina ** 2.33 .18 (.004) .08 
Angina vs Heart Failure 1.73 .19 (.005) .08 
AMI vs Heart Failure 1.72 .19 (.005) .07 
Angina vs Stent ** 0.79 .37 (.006) .06 
AMI/Stent vs Stent 0.68 .41 (.006) .04 
Angina vs Risk Factors 0.67 .41 (.007) .08 
CABG’s vs Risk Factors 0.40 .53 (.008) .04 
AMI vs Risk Factors 0.22 .64 (.013) .03 
AMI vs Angina 0.30 .58 (.01) .04 
Angina vs CABG’s ** 0.18 .67 (.017) .03 
Heart Failure vs Risk Factors 0.16 .67 (.025) .03 
AMI vs CABG’s .05 .83 (.05) .01 
* p value ≤ alpha      ** one or more cells have expected cell frequencies < 5 
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As can be seen in Table 5.9, five of the pairwise comparisons were significant.  
However, one of these, AMI/Stent vs risk factors, had fewer than five expected cases (2.5) 
in one cell so was at risk of violating the assumption that the test statistic is approximately 
distributed as a chi-square, and was deemed invalid.  The remaining four significant 
pairwise comparisons indicated that dying during the follow period was approximately 
3.04 times (.11/.04) more likely for those with AMI, 2.86 times (.11/.04) for CABGs and 
4.31 times (.16/.04) for those with Heart Failure than for those patients with AMI/Stent.  
Furthermore, those with Heart Failure were 3.10 times more likely (.16/.05) than those 
with Stent to die during the study period.  
Figure 5.5 (overleaf) displays a comparison of number of patients who were alive or 
dead at the end of the follow-up period by cardiac condition.  
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Figure 5.5. Survival rates by cardiac condition. 
 
In order to assess whether these significant differences translated into a difference in 
survival between acute and chronic cardiac conditions a two-way contingency table 
analysis was conducted with the two variables survival; alive, dead, and cardiac condition 
acuity; acute, chronic.  Survival and acuity were found to be significantly related, Pearson 
χ2 (1, N  = 1233) = 16.49, p < .001, with a moderately large effect size Cramers V = .12.  
Those with chronic conditions; Angina, Heart Failure, Risk Factors, were twice as likely 
(.14/.07) to die during the follow-up period than those with acute conditions; AMI, 
AMI/Stent, CABGs or Stent.   
 159 
        5.3.3.   CDS at admission, cardiac condition and mortality. 
In order to assess whether the relationship between CDS score at admission and 
survival remains when cardiac condition is accounted for a 2 x 2 ANOVA was conducted.  
The variable cardiac condition acuity with two levels; acute and chronic, was used rather 
than the seven level factor cardiac condition as there were too few cases in some 
contingencies for the test to be valid.  The ANOVA indicated no significant interaction 
between condition acuity and survival, F (1,1229) = .07, p = .79, partial η2 = .00, but there 
were significant main effects for survival F (1,1229) = 4.88, p = .03, though the effect size 
was minimal, partial η2 = .004, and for condition acuity F (1,1229) = 24.09, p < .001, 
partial η2 = .02.   
The main effect for survival indicated that those who died during the study period 
had higher mean CDS scores at admission (adj. M = 90.8) than those who survived (adj. M 
= 85.2), though the difference between mean CDS at admission was smaller when adjusted 
for condition acuity (5.6 points compared to 6.1 points).  The main effect for cardiac 
condition acuity indicated that those who had a chronic cardiac condition had a higher 
CDS at admission (adj. M = 94.2) than those with an acute condition (adj. M = 81.7).  
Figure 5.6 (overleaf) displays a comparison of mean CDS score at admission by survival 
and cardiac condition acuity.  
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Figure 5.6. Adjusted mean CDS score at admission by survival and cardiac condition 
acuity. 
 
As can be seen in Figure 5.6 those with acute conditions overall had lower mean 
CDS score at admission than those with chronic conditions, however within these groups 
those who were alive at the end of the follow-up period had lower mean CDS score at 
admission than those who died. 
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5.4.   Cardiac rehabilitation program completion and outcomes. 
5.4.1.   Program completion and morbidity. 
In order to assess whether completing the cardiac rehabilitation program was related 
to long-term patient outcomes independent t-tests were conducted with program 
completion as the grouping variable and morbidity measures of hospital bed days and 
cardiac bed days as the dependent variables. The Bonferroni method was used to control 
for Type I error across multiple comparisons, thus requiring a p value of .025 (.05/2 = 
.025) for significance. Both tests were significant with large effect sizes; hospital bed days, 
t (637.9) = 3.69, p < .001, d = .21, cardiac bed days, t (595.6) = 3.71, p < .001, d = .21. The 
test was repeated excluding those who died within 90 days of admission to the program, 
and the significant relationship remained; hospital bed days t (624.1) = 3.59, p < .001, d = 
.20, cardiac bed days, t (586.0) = 3.44, p < .001, d = .19.  Patients who completed the 
program spent fewer days on average in hospital than those who did not complete the 
program for all causes, M = 3.09 vs M = 6.53 (all cases), M = 3.07 vs M = 6.47 (excluding 
those who died within 90 days), and for cardiac conditions, M = 0.94 vs M = 2.60 (all 
cases), M = 0.94 vs M = 2.49 (excluding those who died within 90 days).   
 
5.4.2.   Depression category, program completion and morbidity. 
In order to assess whether program completion and CDS at admission were related to 
morbidity outcomes, a two-way multivariate analysis of covariance (MANCOVA) was 
conducted with depressive symptom category (Minimal, Mild, Moderate, Severe) and 
program completion (completers, non-completers) as grouping variables, hospital bed days 
and cardiac bed days as dependent variables and time in study entered as a covariate.  
Patients who died within 90 days of admission to the program were excluded.  The Box’s 
test indicated that the assumption that the population variances and covariances among the 
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dependent variables were the same across all levels of the factors was violated (p < .001), 
therefore Pillai’s Trace criterion was used.  A significant interaction effect was found 
between depression category and program completion, Pillai’s Trace V = .01, F (6, 2768) = 
2.78, p = .01, partial η2 = .01.  Significant main effects were also found for program 
completion, Pillai’s Trace V = .01, F (2, 1383) = 7.78, p < .001, partial η2 = .01, and 
depression category, Pillai’s Trace V = .02, F (6, 2768) = 4.29, p < .001, partial η2 = .01.    
Analyses of Variance (ANOVA) on each dependent variable were conducted as 
follow-up tests to the significant interaction effect on the MANCOVA.  Because the 
interaction was significant it was decided to ignore the main effects for depression 
category and program completion and examine the simple main effect for depression 
category separately across the two levels of program completion.  Using the Bonferroni 
method each ANOVA was tested at the .025 level. There were no significant differences in 
hospital bed days between depressive symptom categories for those who completed the 
cardiac rehabilitation program, F (3, 1384) = 1.82, p = .14, partial η2 = .004, but there were 
significant differences for those who did not complete the cardiac rehabilitation program, F 
(3, 1384) = 8.51, p = .000, partial η2 = .02.  Similarly there were no significant differences 
in cardiac bed days between depressive symptom categories when the cardiac 
rehabilitation program was completed, F (3, 1384) = 0.45, p = .71, partial η2 = .001, but 
there were for those who did not complete the program, F (3, 1384) = 5.22, p = .001, 
partial η2 = .01.   
Figure 5.7 (overleaf) displays a comparison of the mean number of hospital bed days 
for participants who completed the cardiac rehabilitation program to those who did not 
complete the program by depressive symptom category. 
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Figure 5.7. Adjusted mean number of days spent in hospital by depression category and 
program completion. 
 
As can be seen in Figure 5.7, the adjusted mean number of days spent in hospital is 
similar for participants who completed the cardiac rehabilitation program regardless of 
depressive symptom category, however for those who did not complete the program the 
mean number of hospital bed days increases with increasing level of depressive symptoms.  
Follow-up tests were conducted to evaluate the six pairwise differences between 
depression categories for those who did not complete the program, with alpha set at .004 
(.025/6 = .004) to control for Type I error.  Table 5.10 (overleaf) displays the results of 
these comparisons for hospital bed days. 
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Table 5.10.  
Pairwise Comparison Results Between Depression Categories for Hospital Bed Days for 
Participants who did not complete the Cardiac Rehabilitation Program. 
Comparison p value  
Minimal vs Severe .000 * 
Minimal vs Moderate  .011 
Mild vs Severe .012 
Moderate vs Severe .16 
Minimal vs Mild .22 
Mild vs Moderate .32 
* alpha < .004 
 
As can be seen in Table 5.10, for those who did not complete the program those in 
the Severe depressive symptoms category spent significantly higher mean days in hospital 
during follow-up than those in the Minimal depressive symptoms category (p = .000).  No 
other comparisons were significant.  
Figure 5.8 (overleaf) displays a comparison of the mean number of cardiac bed days 
for patients who completed the cardiac rehabilitation program to those who did not 
complete the program by depression category. 
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Figure 5.8. Adjusted mean number of days spent in hospital for cardiac causes by 
depression category and program completion. 
 
As can be seen in Figure 5.8, the adjusted mean number of days spent in hospital is 
similar for participants who completed the cardiac rehabilitation program regardless of 
depressive symptom category.  However, for those who did not complete the program the 
mean number of cardiac bed days increases for those in the Moderate depressive symptoms 
category and further increases for those in the Severe depressive symptoms category.  
Follow-up tests were conducted to evaluate the six pairwise differences between 
depression categories for those who did not complete the program, with alpha set at .004 
(.025/6 = .004) to control for Type I error.  Table 5.11 (overleaf) displays the results of 
these comparisons for cardiac bed days. 
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Table 5.11.  
Pairwise Comparison Results Between Depression Categories for Cardiac Bed Days for 
Participants who did not complete the Cardiac Rehabilitation Program. 
Comparison p value  
Minimal vs Severe .000 * 
Mild vs Severe  .002 * 
Moderate vs Severe .06 
Mild vs Moderate .27 
Minimal vs Moderate .31 
Minimal vs Mild .74 
* alpha < .004 
 
As can be seen in Table 5.11, for those who did not complete the program those in 
the Severe depressive symptoms category spent significantly higher mean days in hospital 
than those in the Minimal depressive symptoms category (p = .000) and those in the Mild 
depressive symptoms category (p = .002).  No other comparisons were significant.  
 
5.4.3.   Depression category, program completion, cardiac condition and morbidity. 
Given the significant relationship between cardiac condition and morbidity outcomes 
separate MANCOVA’s were conducted for acute cardiac patients (N = 927) and chronic 
cardiac patients (N = 298).  Each MANCOVA had depressive symptom category and 
cardiac program completion entered as factors, cardiac bed days and hospital bed days 
entered as dependent variables, and time in study entered as a covariate.  Participants who 
died within three months of the study were excluded.   
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5.4.3.1.   Participants with acute cardiac conditions. 
The Box’s test indicated that the assumption that the population variances and 
covariances among the dependent variables were the same across all levels of the factors 
was violated (p < .001), therefore Pillai’s Trace criterion was used. A significant 
interaction effect was found between depressive symptom category and program 
completion, Pillai’s Trace V = .02, F (6, 1836) = 2.51, p = .02, partial η2 = .01.  A 
significant main effect was found for depressive symptom category, Pillai’s Trace V = .02, 
F (6, 1836) = 2.24, p = .04, partial η2 = .01, but not for program completion, Pillai’s Trace 
V = .004, F (2, 917) = 1.93, p = .15, partial η2 = .004.   
Analyses of Variance (ANOVA) on each dependent variable were conducted as 
follow-up tests to the significant interaction effect on the MANCOVA.  Because the 
interaction was significant it was decided to ignore the main effect for depressive symptom 
category and examine the simple main effect for depression category separately across the 
two levels of program completion.  Using the Bonferroni method each ANOVA was tested 
at the .025 level. There were no significant differences in hospital bed days between 
depressive symptom categories for those who completed the cardiac rehabilitation 
program, F (3, 918) = 1.82, p = .14, partial η2 = .006, but there were significant differences 
for those who did not complete the cardiac rehabilitation program, F (3, 918) = 5.45, p = 
.001, partial η2 = .02.  There were no significant differences in cardiac bed days between 
depressive symptom categories whether the cardiac rehabilitation program was completed, 
F (3, 918) = 2.15, p = .09, partial η2 = .007, or not completed, F (3, 918) = 2.27, p = .09, 
partial η2 = .007.   
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Figure 5.9 displays a comparison of the mean number of hospital bed days for 
patients with acute conditions who completed the cardiac rehabilitation program to those 
who did not complete the program by depression category. 
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Figure 5.9. Adjusted mean number of days spent in hospital by depression category and 
program completion for participants with acute conditions. 
 
As can be seen in Figure 5.9, the adjusted mean number of days spent in hospital is 
similar for acute cardiac patients in the Minimal, Mild and Moderate depressive symptom 
categories regardless of program completion.  However, those in the Severe depressive 
symptoms category spent a greater mean number of days in hospital if they did not 
complete the cardiac rehabilitation program.  
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Follow-up tests were conducted to evaluate the six pairwise differences between 
depressive symptom categories for those who did not complete the program, with alpha set 
at .004 (.025/6 = .004) to control for Type I error.  Table 5.12 (overleaf) displays the 
results of these comparisons for hospital bed days. 
 
Table 5.12.  
Pairwise Comparison Results Between Depression Categories for Hospital Bed Days for 
Participants with Acute Conditions who did not complete the Cardiac Rehabilitation 
Program. 
Comparison p value  
Minimal vs Severe .000 * 
Moderate vs Severe .03 
Mild vs Severe .05 
Minimal vs Mild .26 
Minimal vs Moderate .35 
Mild vs Moderate .86 
* alpha < .004 
 
As can be seen in Table 5.12, for those who did not complete the program those in 
the Severe depressive symptoms category spent a significantly higher mean number of 
days in hospital than those in the Minimal depressive symptoms category (p = .000).  No 
other comparisons were significant.  
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5.4.3.2.   Participants with chronic cardiac conditions. 
The Box’s test indicated that the assumption that the population variances and 
covariances among the dependent variables were the same across all levels of the factors 
was violated (p < .001), therefore Pillai’s Trace criterion was used. The interaction effect 
between depressive symptom category and program completion was not significant, 
Pillai’s Trace V = .02, F (6, 578) = 1.01, p = .42, partial η2 = .01.  However, both the main 
effect for depressive symptom category, Pillai’s Trace V = .05, F (6, 578) = 2.29, p = .03, 
partial η2 = .02, and program completion, Pillai’s Trace V = .02, F (2, 288) = 3.45, p = .03, 
partial η2 = .02, were significant.   
Analyses of Variance (ANOVA) were conducted on each dependent variable as 
follow-up tests to the MANOVA.  Using the Bonferroni method each ANOVA was tested 
at the .0125 (.05/2 = .0125) level.  For the dependent variable, hospital bed days, the 
ANOVA for depressive symptom category was not significant, F (3, 289) = 1.86, p = .14, 
partial η2 = .02, but the ANOVA for program completion was significant, F (1, 289) = 
5.88, p = .016, partial η2 = .02, with those who completed the program spending fewer 
days in hospital during follow-up (Adj. M = 4.88 days) than those who did not complete 
the program (Adj. M = 10.88).  Figure 5.10 (overleaf) displays the adjusted mean number 
of days spent in hospital for all causes by participants with chronic conditions for each 
depressive symptom category by program completion.   
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Figure 5.10. Adjusted mean number of days spent in hospital by depression category and 
program completion for participants with chronic conditions. 
 
As can be seen in Figure 5.10, the adjusted mean number of days spent in hospital is 
similar for chronic cardiac patients who complete the cardiac rehabilitation program 
regardless of depressive symptom category.  However, those in the Moderate depressive 
symptoms category, and to a lesser extent those in the Severe depressive symptoms 
category, spent a greater mean number of days in hospital if they did not complete the 
cardiac rehabilitation program.  
For the dependent variable, cardiac bed days, the ANOVA for depressive symptom 
category was also not significant, F (3, 289) = 1.66, p = .18, partial η2 = .02, but the 
ANOVA for program completion was again significant, F (1, 289) = 6.12, p = .014, partial 
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η2 = .02, with those who completed the program spending fewer days in hospital for 
cardiac causes during follow-up (Adj. M = 1.21 days) than those who did not complete the 
program (Adj. M = 4.95).  Figure 5.11 displays the adjusted mean number of days spent in 
hospital for cardiac causes by participants with chronic conditions for each depression 
category by program completion.   
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Figure 5.11. Adjusted mean number of days spent in hospital for cardiac causes by 
depression category and program completion for participants with chronic conditions. 
 
As can be seen in Figure 5.11, the adjusted mean number of days spent in hospital 
for cardiac causes was lower for those who completed the cardiac rehabilitation program 
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than those who did not complete the program for all depressive symptom categories except 
the at-risk category.   
 
5.5.   Depression course and outcomes. 
It was also deemed important to assess whether depressive symptom course was 
related to morbidity and mortality outcomes.  Of the 474 participants that were allocated 
into a depression course group, morbidity and mortality data was available for 411.   The 
sample size in each group ranged from 58 (Decreasing group) up to 100 (Low group).   
 
5.5.1.   Depression course and morbidity. 
A one-way multivariate analysis of covariance (MANCOVA) was conducted with 
depression course as the grouping variable and hospital bed days and cardiac bed days as 
the dependent variables, time in study was entered as a covariate.  No significant 
differences were found between the five depression course group on the dependent 
measures, Wilks’s Λ = .97, F (8, 808) = 1.64, p = .11. 
Given that previous research investigating depression course and morbidity have 
only looked at patients with AMI the test was re-run only including the 164 patients with a 
diagnosis of AMI or AMI/Stent.  The test remained non-significant, Wilks’s Λ = .95, F (8, 
314) = .96, p = .47.   
 
5.5.2.   Depression course and mortality. 
A two-way contingency analysis was conducted to evaluate whether depressive 
symptom course was related to survival.  The two variables were survival with two levels; 
alive or dead, and depression course with five categories; Very Low, Low, Medium, 
Decreasing, and High.  Depression course and survival were found to be significantly 
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related, Pearson χ2 (4, N = 411) = 11.26, p = .024, with a large effect size Cramers V = .17.  
The proportion of participants in each depression course group who died during the follow-
up period were as follows; Very Low .02, Low .09, Medium .03, Decreasing .05, and High 
.13.   
However, two cells (20.0%) had expected cell frequencies less than five, with the 
smallest expected frequency being 3.7.  Given that the frequency of expected cell values 
less than five equated to the suggested cut-off point of 20% for indication of invalid results 
(as recommended by Green & Salkind, 2003) it was decided to conservatively interpret 
this test statistic.  Rather than conduct follow-up pairwise comparisions using the Pearson 
chi-square statistic it was decided to use the more conservative Fisher’s exact test (2-
sided).  Table 5.13 (overleaf) shows the results of these analyses.  The Holm’s sequential 
Bonferroni method was used to control for Type I error at the .05 level across all ten 
comparisons.  
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Table 5.13. 
Results for the Pairwise Comparisons Between Depression Course for Survival 
Comparison Fischer’s Exact Test (2-sided)  
p value (alpha) 
Very Low vs High ** .010 (.005) 
Medium vs High ** .016 (.006) 
Very low vs Low  .063 (.006) 
Low vs Medium  .134 (.007) 
Decreasing vs High .139 (.008) 
Very Low vs Decreasing ** .383 (.01) 
Low vs High .447 (.013) 
Low vs Decreasing ** .537 (.016) 
Medium vs Decreasing ** .672 (.025) 
Very Low vs Medium ** 1.00 (.05) 
* p value ≤ alpha 
** one or more cells have expected cell frequencies less than 5 
 
As can be seen in Table 5.13, none of the pairwise comparisons were significant 
when Fischer’s Exact test statistic was used.  Thus it was concluded that depression course 
was not differentially related to mortality outcome.  It would have been desirable to also 
include the covariate of cardiac condition acuity, however the sample sizes were too small 
when this variable was included in the contingency analysis, with 55% of cells having an 
expected cell count less than 5.    
The proportion of participants who died during follow-up was determined for each of 
the depression courses.  The odds ratio of mortality for those in the High category 
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compared to those in the Very Low category was determined, OR = 6.75 (CI 95% = 1.41, 
32.37), indicating that those in the High depression course category have a significantly 
higher risk of death during follow-up than those in the Very Low course category. The 
odds ratio of mortality for those in the Decreasing category compared to those in the Very 
Low category was also determined, OR = 2.37 (CI 95% = 0.38, 14.65).  As the lower 
bound confidence interval fell below one this ratio was not significant indicating that there 
was no significant difference in mortality rates for those in the Decreasing depressive 
symptom course group compared to the Very Low Group.  Finally, the odds ratio of 
mortality for those in the High category compared to those in the Decreasing category was 
determined, OR = 2.84 (CI 95% = 0.73, 11.06), indicating that the risk of mortality during 
follow-up was not different for those in the decreasing and the High depression course 
clusters. 
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Summary of Findings 
The hypothesis that higher levels of depressive symptoms would be associated with 
poorer morbidity and mortality outcomes was supported.  CDS score at admission was 
significantly correlated with both of the measures of morbidity, total number of days spent 
in hospital during follow-up and number of days spent in hospital for cardiac related 
illness, though the effect size was small.  When the four depression categories; Minimal, 
Medium, Moderate, and Severe depressive symptoms were compared, those in the 
Minimal depression category spent significantly fewer days in hospital for all causes than 
those in the other three depression categories, and significantly fewer days in hospital for 
cardiac causes than the Severe depression group.      
In relation to mortality outcomes, mean CDS score at admission was significantly 
higher for those who died during the follow-up period than those who survived.  Mortality 
rates were significantly higher for those in the Severe depressive symptoms category 
compared than those in the Minimal depressive symptoms category (OR= 1.56).  However, 
rates for the Moderate and Severe depressive symptom categories combined were not 
significantly higher than those in the Minimal depressive symptoms category.        
Given previous findings in this study regarding relationships between patient 
characteristics and depressive symptom levels, analysis of the relationship between these 
characteristics and patient outcomes were assessed.  Sex was not significantly related to 
morbidity or mortality.  However cardiac condition was significantly related to morbidity, 
with heart failure patients having significantly more days in hospital, both for all causes 
and for cardiac causes, than those in the AMI/Stent condition category. There were also 
significant differences between cardiac condition groups for mortality outcomes, with 
those in the AMI, CABG’s, and Heart Failure having significantly higher mortality rates 
during follow up than those in the AMI/Stent group, and the Heart Failure patients having 
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a significantly higher rate of mortality than those in the Stent group.  Furthermore, cardiac 
condition acuity was significantly related to morbidity, with those with chronic conditions 
spending a significantly greater number of days in hospital both for all causes and cardiac 
causes than those with acute conditions, and mortality, again with those with chronic 
conditions being a significantly greater risk of death than those with acute conditions 
during the follow-up period.   
The relationship between depressive symptom levels and morbidity and mortality 
outcomes was re-assessed controlling for cardiac condition acuity.  Time in study was also 
controlled for in assessment of morbidity outcomes.   When cardiac condition acuity was 
controlled for those in the Moderate and Severe risk depression groups still spent 
significantly greater number of days in hospital for all causes than those in the Minimal 
group, however there was no significant differences between depression category groups 
for the number of days in hospital for cardiac causes.  There was no significant interaction 
effect between cardiac condition acuity and depression category for morbidity outcomes.  
The relationship between survival and level of depressive symptoms remained when 
cardiac condition acuity was accounted for, with those who died during follow-up having 
significantly higher CDS at admission than those who remained alive at the end of the 
follow-up period.   
The second hypothesis that patients with higher levels of depressive symptoms that 
did not complete the cardiac rehabilitation program would have poorer long-term outcomes 
than those who did complete the program was also supported.  Program completion was 
related to morbidity independently, with patients who completed the program spending 
significantly less time in hospital for all causes and cardiac causes during the follow-up 
period than those who did not complete the program.  This effect remained when patients 
that died within ninety days of admission were excluded from the analysis.  There was also 
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a significant interaction effect between program completion and depression category such 
that those in the Severe depressive symptoms category spent significantly more days in 
hospital, both for all causes and cardiac causes, than those in the Minimal depressive 
symptoms category if they did not complete the cardiac rehabilitation program, but not if 
they did complete the program.  When this test was repeated separately for the two cardiac 
acuity categories the interaction effect remained for those with acute cardiac conditions but 
not for those with chronic cardiac conditions.  Those patients with acute cardiac conditions 
in the Severe depressive symptoms category spent significantly longer in hospital during 
follow-up if they did not complete the cardiac rehabilitation program.  Patients with 
chronic cardiac conditions spent significantly longer in hospital, both for all causes and 
cardiac causes, if they did not complete the cardiac rehabilitation program, regardless of 
depressive symptom category.   
Depression course was not significantly related to either measure of morbidity, 
hospital bed days or cardiac bed days.  Given previous research has focussed on depression 
course in patients with AMI the test was repeated with only participants with a recorded 
diagnosis of AMI or AMI/Stent.  The results remained non-significant.    Contingency 
analysis of the relationship between depression course and mortality was hampered by 
relatively small numbers of patients in some cells, however comparison of mortality rates 
between course clusters indicated that those in the High depression course category had 
significantly greater mortality rates than those in the Very Low course (OR = 6.75).  
Interestingly, the mortality rate for those in the Decreasing course was not significantly 
different from those in either the Very Low depressive symptom course or those in the 
High depressive symptom course.   
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Chapter 6 
Discussion 
 
This investigation was designed to explore the relationship between depression, 
participant characteristics, and health outcomes in cardiac rehabilitation patients.  Each of 
the six research aims will be discussed in terms of the results of this study and the 
implications of these findings.  Given the large number of research aims and associated 
findings a summary is provided in Table 6.1, prior to a detailed exploration of each of 
these findings.  This will be followed by discussion of additional findings from this 
project, a review of limitations of the current study, and suggestions for further research 
in this area.   
 
Table 6.1. 
Summary of Research Aims and Main Findings 
1. To investigate the prevalence of elevated depressive symptoms in patients attending a 
cardiac rehabilitation program. 
• 25.1% of the participants reported Severe levels of depressive symptoms,  
• 39.9% of participants reported elevated levels of depressive symptomatology 
(moderate and severe levels combined) 
2. To investigate whether the level of depressive symptoms in cardiac rehabilitation 
patients varies according to age, gender, or cardiac condition. 
• Females were statistically more likely to report higher levels of symptoms than 
males, but the difference was small indicating no clinically meaningful difference 
Table 6.1 cont’d overleaf 
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Table 6.1 cont’d 
• No significant relationship between age and depression was found in this study 
• Those with chronic cardiac conditions; risk factors, angina and heart failure 
reported significantly higher levels of depressive symptoms than those with acute 
conditions; AMI, AMI/Stent, Stent and CABGs 
3. To investigate the course of depressive symptoms in cardiac rehabilitation patients over 
time. 
• On average patients experienced a significant reduction in depressive symptoms 
between admission and discharge, and this reduction was maintained at three and 
twelve month follow-up 
4. To investigate whether level of depressive symptoms predicts completion of a cardiac 
rehabilitation program. 
• Patients with higher levels of depressive symptoms were less likely to complete 
their cardiac rehabilitation program than those with lower levels.  
• However, whilst CDS score at admission was a significant predictor of program 
completion, its predictive power was weak, with only 52.7% classified as to 
adherence correctly. 
5. To investigate the relationship between level of depressive symptoms and physical 
outcomes following participation in a cardiac rehabilitation program.  
• Whilst participants who completed the cardiac rehabilitation program showed 
statistically significant reductions in BMI and blood pressure, and significant 
increases in exercise capacity and weekly exercise, these changes were not 
statistically related to depression symptom levels. 
Table 6.1 cont’d overleaf 
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Table 6.1 cont’d 
• The only excepetion was weekly exercise with those who did not meet the target of 
150 minutes exercise or more per week at admission but exceeded this target at 
discharge (increasing exercisers) having a lower mean CDS at admission than those 
who remained below the exercise target at discharge (low exercisers). 
6. To investigate the impact of depressive symptoms and cardiac program completion on 
morbidity and mortality. 
• CDS score at admission was significantly correlated with both of the measures of 
morbidity, total number of days spent in hospital during follow-up and number of 
days spent in hospital for cardiac related illness, though the effect size was small 
• In relation to mortality outcomes, mean CDS score at admission was significantly 
higher for those who died during the follow-up period than those who survived 
 
 
Prevalence of Clinically Significant Depressive Symptoms 
The first research aim was to investigate the prevalence of elevated depressive 
symptoms in patients attending a cardiac rehabilitation program. A sizeable proportion of 
cardiac rehabilitation patients reported elevated levels of depressive symptoms with one 
quarter (25.1%) of the participants reporting Severe levels of depressive symptoms, and a 
further 14.8 percent reporting Moderate levels of depressive symptoms.  In total, almost 
forty percent (39.9%) of participants reported clinically significant levels of depressive 
symptomatology.   
This figure is relatively high when compared to the range of prevalence figures 
reported in published studies [i.e. from 10% (Saur et al., 2001; Sorenson et al., 2005) to 
65% (McCrone et al., 2001)].  In a review of published rates, a mean rate of 19.8% of 
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patients were identified as being depressed using clinical interview, and between 15.5 % 
and 31.1% when using self-report questionnaire depending on the assessment tool used 
(Thoombs et al., 2006).  Studies focussing on cardiac rehabilitation patients have reported 
a narrower range of prevalence figures: 11.4% (Rafanelli et al., 2003) to 31% (Sanderson 
& Bittner, 2005).  Whilst the prevalence rate of 39.9% found in this study is larger than the 
upper end of this range, it is comparable to the figure of 46.3% obtained in the only other 
large scale assessment of Australian patients with a range of cardiac conditions (Choek et 
al., 2003).    
In a validation study of the Cardiac Depression Scale (CDS) a score greater than 80 
was equivalent to the cut-off for mild depression on the widely used Beck Depression 
Inventory (Di Benedetto et al., 2005).  Use of this cut-off classifies over half of the cardiac 
rehabilitation patients in this study as experiencing clinically significant levels of 
depressive symptoms (53.5%).  This rate was somewhat larger than the proportion 
identified by Di Bennedetto et al. (2005) who classified 43% of their sample, acute 
coronary syndrome patients two weeks post hospitalisation, as depressed using this criteria.   
It is somewhat surprising that the prevalence rate in the present study should be 
larger than that in the study by Di Benedetto and colleagues, and in the upper end of the 
range of prevalence rates reported by other researchers. It is unexpected as previous 
research has found that cardiac patients with depression are less likely to attend cardiac 
rehabilitation than their non-depressed peers (Lane et al., 2001b; Turner et al., 2002), 
therefore lower rates of depression would be expected in a cardiac rehabilitation sample 
than in a hospital sample.  However, several reasons may account for this finding.   
Firstly, the timing of assessment may influence the prevalence rate. Whilst it has 
been suggested that depression rates may be higher in the hospitalisation period, reflecting 
a sharp increase in depressive symptoms that resolves for many patients upon discharge 
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(Poston et al., 2003), studies that have attempted to identify a course of depression in 
cardiac patients by assessing depressive symptoms at multiple time points have reported no 
consistent pattern. Martin, Lewin, and Thompson (2003) reported a decline in depression 
rates in AMI patients from 15.2% during hospitalisation to 12.5% at six week follow-up.  
Similarly Schliefer and colleagues (1989) reported a decline from 45% 8-10 days post 
AMI to 33% 3- 4 months later.  However, Luutonen and colleagues (2002) reported that 
the prevalence of depression in 85 patients following AMI rose from 21.2% during 
hospitalisation to 30% six months later.   
Whilst it is possible that assessment during hospitalisation captures those 
experiencing a transient reactive depressed mood that resolves upon discharge, it is equally 
possible that depression does not develop until later for some cardiac patients.   
Experiencing AMI has been conceptualised by some researchers as experiencing a 
medically traumatic event (Ginzburg, 2006; Spindler & Pedersen, 2005).  Thus, during 
hospitalisation, patients’ affective response may be more like the symptoms of acute stress 
disorder, characterised by emotional numbing or withdrawal, hyperarousal, and intrusive 
thoughts/memories of the event (Spindler & Pedersen, 2005; Tedstone & Tarrier, 2003).  
In the initial phase of hospitalisation for a cardiac event, the acute stress response, in 
particular emotional numbing, may preclude the presence of depressive symptoms as 
emotional numbing is an absence of feeling, including an absence of feelings of depression 
and sadness (Feeny, Zoellner, Fitzgibbons, & Foa, 2000).  As the acute stress response 
resolves, depressive symptoms may then appear or intensify.  This hypothesis is supported 
by the finding that initial stress reactions post AMI have been found to predict depression 
at seven month follow-up (Ginzburg, 2006).  However, further research evaluating the 
course of depressive symptoms, and the relationship with initial symptoms of stress, in 
cardiac patients is required to explore this hypothesis further.   
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The second reason the prevalence rate in this study may be relatively high is the 
assessment measure used.  The Cardiac Depression Scale (CDS) was designed to detect 
degrees of depressive symptoms, rather than distinguishing between cases and non-cases 
of major depression (Hare & Davis, 1996).  As such, it is designed to be more sensitive to 
other depressive disorders, such as dysthymia and adjustment disorders.  Whilst this may 
lead to higher prevalence figures, it is considered a strength given that even mild levels of 
depressive symptoms are associated with poorer outcomes for cardiac patients (Bush et al., 
2001; Rafanelli et al., 2003; Sullivan et al., 1999).  Indeed, validation studies of other 
depression assessment tools in cardiac patients have often recommended adopting lower 
cut-off points to increase sensitivity (Bambauer et al., 2005; Stafford, Berk, & Jackson, 
2007; Strik et al., 2001).  Adoption of lower cut-off scores would presumably have 
increased the prevalence rate reported in most previous studies.   
The third potential reason that this study’s prevalence rate was relatively high was 
the inclusion of a broader range of cardiac conditions.  The majority of studies reporting 
prevalence rates have assessed patients with AMI or CABG (refer to Appendix A).  The 
present study also included patients with chronic conditions such as heart failure and 
angina.  Previous studies that have assessed depression in cardiac patients with chronic 
conditions have reported higher prevalence rates than those studies assessing patients with 
acute conditions.  For example, using the BDI-I as an assessment tool, rates between 
33.3% (Schweitzer et al., 2007) and 51% (Freedland et al., 2003) have been reported for 
heart failure patients, compared to a range of 14.3% (Bush et al., 2001) to 35% (Lauzon et 
al., 2003) in AMI patients.  Whilst this comparison suggests that heart failure patients 
experience greater rates of depression, differences in experimental design mean that direct 
comparison between studies are inconclusive. Whilst some studies have included patients 
with a range of cardiac diagnoses (Cheok et al., 2003; Milani, et al., 1996), none have 
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reported comparative prevalence rates for different diagnostic groups.  In this study such a 
comparison was made, with a greater proportion of patients with chronic conditions; heart 
failure, angina and risk factors, being classified in the Moderate and Severe depression 
categories than those with acute conditions; AMI, AMI/Stent, CABG, and Stent.  This will 
be discussed further in relation to the second research aim, however given the inclusion of 
a large proportion of patients with such chronic conditions (26.4%), it is not surprising that 
the overall prevalence rate for elevated depressive symptoms was at the higher end of the 
range reported in published studies.    
Finally, though well validated against others measures of depression, the CDS does 
not have well established cut-off scores.  The CDS was not originally published with cut-
off scores (Martin & Thompson, 2006), however the authors recommend a statistically 
driven cut-off score of 100 (approximately 1 SD above the mean) for detection of severe 
depressive symptoms (Martin & Thompson, 2006; Wise et al., 2006).  Validation against 
the Geriatric Depression Scale recommended a cut-off score of 90 for mild/moderate 
depression (Wise et al., 2006) and validation against the BDI suggested a cut-off of 80 for 
mild depressive symptoms (Di Benedetto et al., 2006).  Whilst the study by Wise and 
colleagues (2006) assessed 627 cardiac rehabilitation patients, Di Benedetto’s (2006) 
validation study had a relatively small sample (N = 81), and as such replication of their 
results should occur before confirming 80 as the equivalent cut-off point for comparison 
with BDI assessment. A need for further analysis to determine ideal cut-off scores has been 
identified (Martin & Thompson, 2006).  
Regardless of the cut-off score used, a clinically significant proportion of cardiac 
rehabilitation patients report elevated levels of depressive symptoms.  Whilst the 
ramifications that this has for recovery will be addressed later, it is worth noting that this 
indicates a significant proportion of patients are reporting psychosocial distress and are 
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likely to be experiencing associated impacts on their quality of life (Bekelman et al., 2007; 
de Jonge et al., 2006; Lane et al., 2001a).  Apart from the potential impact depression has 
on morbidity and mortality in cardiac patients, this rate of depressive symptoms indicates 
an area of need for treatment for cardiac patients.  This study lend support to calls for 
assessment and treatment of depression in all cardiac patients, regardless of potential 
benefits on longer term morbidity and mortality outcomes, even if purely to improve these 
patients quality of life (Glassman, Shapiro et al., 2003).   
 
Relationship between Patient Characteristics and Depressive Symptoms 
The second research aim was to investigate whether the level of depressive 
symptoms in cardiac rehabilitation patients varied according to patient characteristics, 
specifically sex, age, or cardiac condition.   
In this study female patients reported a higher mean CDS score than male patients.  
This is consistent with previous findings that females report higher levels of depressive 
symptoms both in cardiac populations (Blumenthal et al., 2003; Forrester et al., 1992; 
Frasure-Smith, Lesperance, Juneau et al., 1999) and in the general population (Korten & 
Henderson, 2000; Wilhelm et al., 2003).  However, whilst this difference was statistically 
significant, the effect size was small, indicating the clinical significance of this difference 
is limited.  Furthermore, the odds ratio indicated that being female was not a significant 
risk factor for having a CDS score in the Moderate or Severe depressive symptom 
categories, either overall or when calculated separately for those with acute conditions and 
chronic conditions.   
This finding contrasts with research in the general population, where being female is 
significantly associated with increased rates of depression (OR = 1.63, Wilhelm, Mitchell, 
Slade, Brownhill, & Andrews, 2003) and, in the cardiac population, where being female 
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conferred a doubled risk for depression as rated on the BDI for AMI patients (OR = 2.00, 
Frasure-Smith, Lesperance, Juneau et al., 1999).  It is possible that such findings were not 
replicated in this study because of the timing of assessment, as the cardiac studies all 
assessed patients during hospitalisation following AMI or CABG, and this study assessed 
patients at a later point in their recovery.  Previous reference has already been made to the 
possible difference in depression rates between hospitalisation and follow-up.   
Furthermore, the sex difference in depression rates had been shown to decrease with 
age, such that males and females over 60 yrs are reported to have equivalent rates of 
depression (OR=1.00: Gutierrez-Lobos, Scherer, Anderer, & Katschnig, 2002).  Given that 
just over half of this study’s cases (N = 815, 50.2%) were aged 60 years or above, the sex 
difference in depression would be expected to be reduced.   
Alternatively, the assessment tool used in this study is designed to capture a broader 
range of depressive disorders than the BDI (Frasure-Smith, Lesperance, Juneau et al., 
1999), CES-D (Blumenthal et al., 2003) and SCID (Forrester et al., 1992), and there may 
be less of a sex difference when such an approach is taken.  Assessment of depressive 
symptoms in those with diagnosed depressive disorders has indictaed that females tend to 
report more severe levels of symptomatology (Barnow, Linden, Lucht, & Freyberger, 
2002; Kornstein et al., 2000), thus when cut-off scores are reduced, the proportion of males 
identified may increase.  Though several studies using the CDS have included both male 
and female participants (Birks et al., 2004; Di Benedetto et al., 2006; Hare & Davis, 1996) 
only one has reported a comparison of depressive symptoms between males and females.  
Astin, Jones, and Thompson (2005) reported that females reported significantly higher 
mean CDS scores than males prior to undergoing the PTCA cardiac procedure, but not at 
6-8 week follow-up or 6 month follow-up.   Replication is required to assess whether this 
finding is robust.   
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It is also possible that the sex difference may be less robust in the cardiac population.  
Grace and colleagues (2005) reported an absence of significant difference in depression 
prevalence between male and female acute coronary syndrome patients.  Similarly, no sex 
difference in depression prevalence was found in a study of patients with heart failure 
(Havranek, Spertus, Masoudi, Jones, & Rumsfeld, 2004). In a study of young adults, 
chronic illness was associated with increased depressive symptoms for males but not 
females when compared to healthy controls (Kiviruusu, Huurre, & Aro, 2007). 
Furthermore, a study of chronic illness in older adults (55-93 years) found no significant 
relationship between sex and depression (Mills, 2001).  Thus, whilst the effect of sex 
should be controlled for statistically in research evaluating depression in cardiac patients, 
in practice both male and female patients should be equally evaluated for the presence of 
depressive symptoms. 
No significant relationship between age and CDS score was found in this study.  
Whilst most previous published research has similarly reported no significant relationship 
between patient age and depression (Ladwig et al., 1992; Rieckmann et al., 2006; 
Romanelli et al., 2002; Schleifer et al., 1989; Schulz et al., 2000; Shiotani et al., 2002; 
Sorensen et al., 2005; Spijkerman et al., 2005), some studies have reported increased 
depressive symptoms with age (Timberlake et al., 1997; Valkamo et al., 2001) and others 
have reported an inverse relationship (Ruo et al., 2003; Sherwood et al., 2005; Strik et al., 
2004; Watkins et al., 2003).  Research in the general population indicates that depression 
rates decline in those aged above 54 years (Korten & Henderson, 2000; Wilhelm et al., 
2003). 
Whilst most of these studies had considerably smaller participant pools (200 or less), 
or a restricted variance in the age range of participants (Valkamo et al., 2001) than the 
present study, these methodological limitations cannot be levelled at the study by Ruo and 
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colleagues (2003).  In this, the Heart and Soul Study, 1,024 cardiac outpatients were 
assessed and the mean age of depressed patients was found to be six years younger than 
the non-depressed patients (Ruo et al., 2003).  This difference in finding from the current 
study may be due to cultural differences between the two study populations (the Heart and 
Soul study was conducted in the United States of America) or due to differences in 
assessment. In the Heart and Soul study the Patient Health Questionnaire was used to 
assess depressive symptoms.  This tool has more recently been validated for use in cardiac 
populations, however a much lower cut-off score was recommended to improve specificity 
(Stafford et al., 2007).  It is possible that the significant age difference may not have been 
maintained in the Heart and Soul population if this more rigorous cut-off score was used.   
The inclusion in the present study of cardiac patients with a variety of cardiac 
conditions allowed comparisons to be made between diagnostic groups, with cardiac 
condition being found to relate significantly to CDS score at admission.  Analysis 
indicated that those with chronic cardiac conditions; Risk Factors, Angina, and Heart 
Failure reported significantly higher levels of depressive symptoms than those with acute 
conditions; AMI, AMI/Stent, Stent, and CABGs.  Both these findings were maintained 
when the influence of sex was controlled statistically.  The difference between chronic and 
acute condition cardiac patients was illustrated with chronic patients having twice the risk 
of experiencing elevated levels of depressive symptoms (Moderate or Severe categories) 
than those with acute conditions.  Comparison of these findings with previous research is 
limited as most published studies investigate patients of a single diagnostic group and 
those studies that have included patients with a range of cardiac conditions (e.g., Cheok et 
al., 2003; Milani et al., 1996), have not reported comparisons.  
Research investigating psychosocial adjustment to chronic illness, however, suggests 
possible theoretical reasons for the difference identified in this study.  Chronic illness is 
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associated with increased levels of depressive symptoms (Petrie & Revenson, 2005).  In a 
longitudinal study of chronic illness, persistent illness, rather than illness with a fluctuating 
course, was predictive of greater levels of depression (Huurre & Aro, 2002). Research has 
also indicated that the presence of a chronic illness per se is not necessarily predictive of 
depression, but rather the extent to which illness places limitations on daily functioning 
(Huurre & Aro, 2002; Schroder et al., 2007).  In this study, the cardiac illnesses classified 
as chronic all have more persistent courses than those classified as acute conditions.  
Furthermore, there is some evidence that they have greater impacts on daily functioning.  
Previous comparative research has indicated that functional disability is greater in those 
with chronic heart failure than those who experience AMI, and that decline in function 
following diagnosis is also greater for those with heart failure than those with AMI 
(Kempen, Sanderman, Miedema, Meyboom-de Jong, & Ormel, 2000; van Jaarsveld, 
Sanderman, Miedema, Ranchor, & Kempen, 2001).  Therefore, the findings of the current 
study are consistent with the broader literature on the relationship between chronic illness 
and depression.   
Research evaluating the relationship between illness and depression has evaluated 
the importance of psychological processes in determining psychosocial adjustment to 
illness.  In particular, perceptions of control over illness course and symptoms have been 
associated with lower levels of depression (Affleck, Tennen, Pfeiffer, & Fifield, 1987; 
Helgeson, 1992; Newsom, Knapp, & Schulz, 1996; Vilhjalmsson, 1998).  Though not 
assessed in the current study, it is possible that those with acute conditions experienced 
greater levels of perceived control over outcome than those with chronic conditions.  
Further research evaluating perceived control and depressive symptoms in cardiac patients 
is required to assess this hypothesis.   
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The degree of perceived control may also be influenced by the treatment received by 
the cardiac patient.  For example, cardiac rehabilitation programs may increase patient’s 
perceived control by educating them about their illness, and training them in ways to 
improve their health through diet, exercise and medication adherence.  Indeed increased 
self-efficacy, the belief in one’s capacity to achieve goals, was strongly related to 
improvements in physical health and functioning in a cohort of cardiac rehabilitation 
patients (Burns & Evon, 2007; Evon & Burns, 2004).  It is feasible that increased 
perceived control may have beneficial effects on levels of depressive symptoms, as it may 
reduce the feelings of hopelessness and helplessness that are characteristic of depression 
(Beck, Riskind, Brown, & Steer, 1988; Clark, Beck, & Brown, 1989; Miller & Seligman, 
1975). Indeed optimism, the expectation of favourable outcomes (Scheier & Carver, 1985) 
has been found to be associated with lower levels of depression in cardiac patients (Shnek, 
Irvine, Stewart, & Abbey, 2001).  Further investigation of the role such psychological 
processes play in the relationship between cardiac illness acuity, treatment, and depressive 
symptom levels is warranted.   
 
Course of Depressive Symptoms 
The third aim of this investigation was to explore the course of depressive symptoms 
over time in cardiac rehabilitation patients.  The CDS was administered at admission to the 
cardiac rehabilitation program, discharge, and at three month and twelve month follow up.  
Overall, participants showed a significant reduction in depressive symptoms between 
admission and discharge, and this reduction was maintained at three and twelve month 
follow-up.  This same pattern was displayed when participants were grouped according to 
sex and cardiac condition acuity.  This finding is consistent with previous studies that 
report a decline in depressive symptoms over the time patients are involved in a cardiac 
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rehabilitation program (Barr Taylor et al., 1986; Denollet & Brutsaert, 1995; Lavie & 
Milani, 2004; Milani et al., 1996; Milani & Lavie, 2007; Oldridge et al., 1995).   
The current study extended upon previous research by assessing patients over a 
twelve-month follow-up period.  Assessment at three and twelve months post discharge 
from the cardiac rehabilitation program showed that this decrease in symptoms was 
maintained over time.  It is important to note that symptoms did not increase once 
involvement with the cardiac rehabilitation program ceased.  Thus, if cardiac rehabilitation 
program participation is related to the reduction in depressive symptoms, it produces a 
lasting rather than temporary reduction in symptoms.  Unfortunately follow-up CDS scores 
were not available for those participants who dropped out of the cardiac rehabilitation to 
confirm whether this symptom reduction occurred for all patients regardless of cardiac 
rehabilitation participation and is therefore a naturally occurring reduction over time, or 
whether it could be a potential beneficial result of participation in the program. 
Previous research has indicated that a substantial proportion of initially depressed 
cardiac patients experience improvement in depressive symptoms with no specific 
intervention.  For example, in the ENRICHD study, depression treatment was found to be 
effective in improving depression rates however the relative improvement compared to 
usual care was less than expected as the control group also demonstrated significant 
improvement in depressive symptoms over the six month intervention period (ENRICHD, 
2003).  Whilst a randomised controlled trial of cardiac rehabilitation and depression may 
be ethically infeasible (due to the established efficacy of cardiac rehabilitation in 
improving morbidity and mortality), a comparison of depression outcomes for attenders 
and non-attenders of cardiac rehabilitation is needed to further assess the efficacy of 
cardiac rehabilitation as an intervention for depression. 
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Previous research has suggested that there is not a single course for depressive 
symptoms for cardiac patients (Kaptein, et al., 2006; Murphy et al., 2008), and this 
proposal was supported by this study. Cluster analysis was used to differentiate 
participants into five groups and the patterns of depressive symptoms over time in these 
groups were similar to the five groups identified in the study by Kaptein and colleagues 
(2006).  Four of these groups had stable mean CDS scores over time, with two groups 
remaining in the Minimal range, one in the Mild range, and the fourth group in the 
Moderate/Severe depressive symptom range at all four assessment points.  The final group 
showed a decreasing symptom course with an initial mean CDS in the Moderate range, but 
subsequent mean CDS in the Minimal range.   
It is of interest that this pattern of depression course was replicated in this study.  It 
prompts further questions about the reasons why some patients have a sustained high level 
of depression and some experience an apparent resolution of these symptoms.  Whilst the 
possible differences in outcomes for these two groups of patients were explored in this 
study, and are described in a later section, it is also important to consider the implications 
this has for detection and treatment.  Intervention studies have commonly targeted all 
cardiac patients defined as depressed, eg ENRICHD, SADHART, and the lack of relative 
improvement in intervention groups has commonly been explained by the relatively high 
remission rate in control groups (ENRICHD, 2003).  The recognition of these two differing 
courses allows for the possibility of determining which patient characteristics may indicate 
whether their depression is likely to be sustained or remit, and allow for more targeted 
interventions for those whose depression is unlikely to resolve without intervention.  This 
could allow for a more cost-effective use of limited resources and ensure patients do not 
undertake an unnecessary course of treatment.  Whilst analysis of possible differences is 
beyond the scope of this study given its design, further examination could look at factors 
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associated with resolution of depression, such as social support (Barefoot, Burg et al., 
2003), locus of control (Affleck et al., 1987) or illness perceptions (Grace, Krepostman et 
al., 2005).   
Research has indicated that course of depression rather than initial level of 
depressive symptoms may be more important in determining subsequent health outcomes 
such as morbidity and mortality (Murphy et al., 2008).  Persistent depression symptoms 
have been found to predict poorer health at 12 months post hospitalisation in patients with 
acute coronary syndrome (Thombs et al., 2008).  Additionally, AMI patients with 
persistent or increasing symptoms of depression have been found to be at greater risk of 
new cardiac events in the follow-up period (Kaptein et al., 2006).  Identification in this 
study of these differing courses of depression allows investigation of the relationship 
between both depression course and initial depressive symptom level with health 
outcomes.    
 
Depressive Symptoms and Cardiac Rehabilitation Program Completion 
The fourth research aim was to investigate the relationship between level of 
depressive symptoms and completion of the cardiac rehabilitation program. Overall 64.1% 
(N = 1042) of cardiac patients who enrolled in the cardiac rehabilitation program were 
classified as program completers.  This figure is comparable with a study of 39 Queensland 
cardiac rehabilitation programs that cited an adherence rate of 71% for all patients who 
enrolled in their program (Scott et al., 2003). 
The findings support the hypothesis that cardiac rehabilitation patients with higher 
levels of depressive symptomatology would be less likely to complete their cardiac 
rehabilitation program than those with lower levels of depressive symptoms. This finding 
is consistent with previous research (Glazer et al., 2002; Turner et al., 2002; Grace et al., 
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2005).  However, whilst CDS score at admission was a significant predictor of program 
completion, its predictive power was weak, with only 52.7% classified correctly, random 
allocation would yield 50% classified correctly.  This relative lack of clinical significance 
may explain why not all researchers have found a significant relationship between 
depressive symptoms and attendance or adherence (Cooper et al., 2002; Farley et al., 2003; 
Grace, Abbey, Pinto et al., 2002). 
Of the patient characteristics assessed for relationship with program completion, only 
age and cardiac condition were statistically significantly, with no significant relationship 
for sex, BMI or baseline exercise levels.  This was contrary to published reviews that have 
identified female sex and older age as being significantly related to poor attendance and 
adherence to cardiac rehabilitation programs (Beswick et al., 2005; Daly et al., 2002).  
Furthermore, it was distinct from the studies that have linked obesity (Farley et al., 2003; 
Sanderson et al., 2005) and lower levels of exercise prior to cardiac event (Lane et al., 
2001b; Farley et al., 2003) with program attendance and adherence.   
In this study, patients who completed the cardiac rehabilitation program were 
significantly older.  This may be due to the wide age range of participants accepted into 
this cardiac rehabilitation program (age range 20-88 years).  Though the above mentioned 
studies did not report age ranges of participants, only one study had a lower mean age for 
participants (Glazer et al., 2002), and all reported smaller standard deviation scores 
indicating that the current study included a larger proportion of younger participants.  This 
may affect the relationship between age and adherence identified in this study, as returning 
to work is recognised as a common reason for non-adherence to a cardiac rehabilitation 
program (Lane et al., 2001b; Scott et al., 2003), a barrier to adherence that 
disproportionately affects those in the younger age bracket.  Additionally, an evaluation of 
non-attenders beliefs about cardiac rehabilitation attendees described them as being older 
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and needier, a perception that may encourage non-attendance in younger patients (Clark et 
al., 2004).  
In addition to age, cardiac diagnosis was significantly related to program adherence.  
Patients undergoing CABG had relatively high levels of program completion and those 
with Heart Failure had relatively low levels, with Heart Failure patients being the only 
diagnostic group to be more likely to drop-out of the program (51.0%) than complete it 
(49.0%). This difference in program completion between diagnostic groups translated into 
a statistically significant difference between cardiac condition acuity, with those with acute 
cardiac conditions (AMI, AMI/Stent, CABG, Stent) being more likely to complete the 
program (65.6%) than those with chronic cardiac conditions (Angina, Heart Failure, Risk 
Factors: 55.8%).   This finding was similar to that of Glazer and colleagues (2002) who 
reported that patients with angina had significantly poorer adherence rates than patients 
with AMI or CABG.   
In order to further assess the possible clinical significance of depression as a 
predictor of adherence, a stepwise regression was used to account for patient 
characteristics; age, sex, exercise levels and cardiac condition acuity. Using this procedure 
depression score at admission was not a significant predictor of program completion. This 
is similar to the findings of Grace and colleagues who reported that depression did not 
predict participation in a cardiac rehabilitation program when sociodemographic variables 
were accounted for (Grace et al., 2002). Thus, whilst simple analysis supported the 
hypothesis that those who complete the cardiac rehabilitation program have lower levels of 
depressive symptoms, the small effect size and the lack of predictive significance of 
depression score when other patient characteristics are accounted for, indicates that the 
relationship between depression and adherence is not as strong or uncomplicated as 
commonly reported. 
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Depressive Symptoms and Physical Health Outcomes 
The hypothesis that patients with higher levels of depressive symptoms would be less 
likely to improve on measures of physical health during the course of the cardiac 
rehabilitation program received little support from these findings.  Whilst participants who 
completed the cardiac rehabilitation program showed statistically significant reductions in 
BMI and blood pressure, and significant increases in exercise capacity and weekly 
exercise, neither CDS score at admission nor course of depressive symptoms was related to 
change between admission and discharge on most of these measures.  The only measure 
for which analysis indicated a statistically significant result was for the relationship 
between change in weekly exercise amount and CDS at admission.   
This relative lack of relationship between depressive symptoms and change in 
physical health measures is important as it helps evaluate the behavioural hypothesis 
regarding the relationship between depressive symptoms and poorer long-term morbidity 
and mortality.  In this hypothesis it is proposed that depressed patients adhere less well to 
lifestyle changes recommended for cardiac health, such as increased exercise and 
improved diet, and thus have poorer morbidity and mortality outcomes (Carney et al., 
2002; Grace et al., 2002; Ziegelstein et al., 2000).   
The results provide partial support for this hypothesis.  Participants who increased 
their amount of weekly exercise had lower mean CDS scores at admission than those who 
remained below the exercise target at discharge.  Previous research has similarly reported a 
relationship between depression levels and adherence to exercise recommendations in 
cardiac patients (Kronish et al., 2006; Ziegelstein et al., 1998).  However, there was no 
relationship between depression score and change in the other indicators; blood pressure, 
BMI or exercise capacity, which would be influenced by improved exercise or diet.  It is 
possible that differences were not found on these indicators because they are affected more 
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strongly by other factors, for example medication in the case of blood pressure, or that the 
time between admission and discharge, usually six weeks, is not sufficient to see clear 
differences between depressed and non-depressed patients in the change on these 
measures.   
Whilst the hypothesis that higher levels of depressive symptoms would be associated 
with less improvement in physical health measures over the course of the cardiac 
rehabilitation program received little support, there was a significant relationship between 
poorer physical health at admission and depression.  For those in the overweight or obese 
range of BMI at admission, higher levels of depressive symptoms were associated with 
significantly greater BMI scores.  There is some evidence in the general population that 
obesity is related to development of depressive symptoms (Atlantis & Baker, 2008), and 
conversely that the presence of depression is associated with weight accumulation (Miller 
et al., 2003).  Previous research in cardiac patients has reported similar findings to the 
present study.  Both the INTERHEART and ENRICHD studies of CAD patients reported 
that depressive symptom levels increased significantly with increased BMI for those in the 
overweight to morbidly obese weight ranges (Lahiri, Rettig-Ewen, Bohm, & Laufs, 2007; 
Lopez-Jimenez et al., 2008).   
Cardiac rehabilitation programs have been associated with significant improvements 
in both BMI and depression for obese patients (Lavie & Milani, 1997).  In this study, 
participants in the overweight or obese BMI ranges at admission, on average, experienced 
a significant decrease in BMI between admission and discharge.  However, there was a 
subsequent increase in BMI over the following twelve month period such that there was no 
significant difference between BMI at admission and 12 month follow-up, indicating that 
improvements made in obesity reduction during the cardiac rehabilitation program were 
not maintained. 
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Whilst other evaluations of cardiac rehabilitation programs have reported 
improvements in weight/BMI reduction between admission and discharge from cardiac 
rehabilitation programs (Aoun & Rosenberg, 2004; Artham, Lavie, & Milani, 2008; 
Savage, Lee, Harvey-Berino, Brochu, & Ades, 2002), some have reported no change 
(Evans, Turner, & Bethell, 2004; Salamonson, Everett, Davidson, & Andrew, 2007).  For 
those who have assessed long-term outcomes, no difference between weight/BMI at 
admission to cardiac rehabilitation and 12 month follow-up has been found, regardless of 
change at discharge (Arrigo, Brunner-LaRocca, Lefkovits, Pfisterer, & Hoffmann, 2008; 
Evans et al., 2004).   
Lack of change in BMI does not necessarily indicate that cardiac rehabilitation is 
ineffective in addressing weight management in cardiac patients.  A comparison of usual 
care patients to those who received weight management advice indicated that intervention 
lead to maintenance of BMI, but controls experienced significant increases in BMI over 12 
month follow-up (Hankey, Leslie, Curral, Matthews, & Lean, 2002).  It has been suggested 
that, without specific intervention, cardiac patient’s weight may increase due to reduced 
physical functioning post-cardiac event (Savage & Ades, 2006), and thus weight 
maintenance, though not ideal, is a preferential outcome to weight gain.  In some cases 
weight gain may be a preferential or even desired outcome.  Detry and colleagues reported 
a significant increase in weight for cardiac rehabilitation patients and control patients over 
12 months follow-up due to CABG patients regaining weight lost prior to, and during, 
hospitalisation and weight gain by those who ceased smoking (Detry, Vierendeel, 
Vanbutsele, & Robert, 2001).  Whilst this issue was partly addressed in this study by 
excluding those with BMI in the normal or underweight classifications from analysis, 
information about other factors, such as smoking cessation, which may have effected 
weight change were not available.  Furthermore, a comparison group was not available to 
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assess the possibility that without intervention the cardiac patients BMI may have 
increased over time.   
The relative importance of BMI as an indicator of health has also been questioned.  
A number of studies have reported a paradoxical relationship between weight and 
morbidity and mortality outcomes (Romero-Corral et al., 2007).  With weight loss after MI 
being associated with worse outcomes in the ENRICHD study (Lopez-Jimenez et al., 
2008), and an inverse relationship between BMI and cardiac death in another study (Sierra-
Johnson, Wright, Lopez-Jimenez, & Allison, 2005).  Furthermore, BMI has been shown to 
be a poor marker of obesity in coronary artery disease patients, as it does not distinguish 
between weight due to excess body fat and weight due to increased lean muscle mass 
(Romero-Corral et al., 2007).  Whilst alternative anthropometrical measures, such as waist 
circumference or waist/hip ratio have shown greater predictive value for cardiac mortality 
and morbidity (Welborn, Dhaliwal, & Bennett, 2003), alternative measures of 
cardiovascular health, such as exercise capacity, have also been shown to have stronger 
predictive powers than BMI in terms of cardiac morbidity and mortality (Yu et al., 2000).   
The relationship between depressive symptoms and measures of exercise capacity 
was also explored in this study.  Statistically significant relationships between level of 
depressive symptoms and three of the four measures of exercise capacity were found.  
Higher depressive symptom levels at admission were significantly related to lower exercise 
capacity on the bike assessment and number of laps walked, but not time spent walking. 
Those who were exercising less than 150 minutes per week at admission also had 
significantly higher levels of depressive symptoms than those who were exercising above 
this benchmark.   
Previous research has similarly found that higher levels of depressive symptoms are 
associated with less time spent exercising in both the general population (Merrill, Taylor, 
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& Aldana, 2008) and the cardiac patient population (Grace et al., 2005).  Furthermore, 
depressive symptoms have been negatively correlated with measures of exercise capacity 
(Hughes et al., 2006; Hughes et al., 2008; Spijkerman et al., 2005), even when influence of 
illness severity is controlled statistically (Ruo et al., 2004).   
However, not all studies have reported a significant relationship, with Scholz and 
colleagues (2006) finding no relationship between depressive symptoms and weekly 
exercise at entry into cardiac rehabilitation, and Milani et al. (2007) reporting no 
significant difference in exercise capacity between depressed and non-depressed cardiac 
rehabilitation participants at entry.  It should be noted that both these studies used 
screening tools designed for the general population to assess depressive symptoms, rather 
than assessments validated in medical populations as the previous researchers had.  As 
discussed previously, such tools may not be the most appropriate measures for use in a 
cardiac rehabilitation population, and this may confound subsequent research findings.   
The relationship between exercise capacity and depressive symptom level may be 
related to the finding that exercise is an effective treatment for mild to moderate depressive 
symptoms (Barbour & Blumenthal, 2005; Dunn et al., 2005).  It is therefore possible that 
cardiac patients who are already engaging in exercise prior to attending cardiac 
rehabilitation are either less likely to become depressed, or if depressed following their 
cardiac event have already, in a sense, self-treated through exercise.  However, without 
knowledge of their experience of depressive symptoms prior to admission firm conclusions 
regarding this cannot be drawn.     
Spjikerman and colleagues (2005) reported that for AMI patients discharged without 
significant levels of depressive symptoms, poor performance on exercise testing prior to 
discharge, but not measures of illness severity, predicted the onset of clinically significant 
depressive symptoms at three, six, or twelve month follow-up. In the current study, 
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improvement in weekly exercise between admission and discharge was significantly 
related to CDS score at admission.  Of the participants who did not meet the weekly 
exercise target at admission, those who improved their weekly exercise to meet the target 
at discharge reported fewer depressive symptoms at admission than those who continued to 
exercise less than the exercise target at discharge.  These two findings indicate a possible 
bi-directional relationship between exercise and depressive symptoms in cardiac patients.  
Further comprehensive longitudinal assessment of exercise capacity, exercise performance, 
and depressive symptoms in cardiac patients is warranted to elucidate the nature of this 
relationship.   
In addition to assessing the relationship between depression score at admission with 
measures of physical health, the longitudinal information about CDS score over time was 
used to assess differences between participants with similar depression courses. Whilst 
depression course was not significantly related to change in any of the physical health 
measures between admission and discharge there were relationships between depression 
course and admission scores on some of the physical health measures.  On two of the 
exercise capacity measures, participants in the Very Low group had significantly higher 
exercise capacity scores than the High group, but not than those in the Decreasing group.  
This finding indicates that exercise capacity may be a useful measure for discriminating 
whom among those with initially high levels of depressive symptoms are likely to 
experience a reduction in symptoms and those whose symptoms are likely to persist.   
Few previous researchers have assessed depression course in cardiac patients, and to 
this writer’s knowledge, none have assessed the relationship with measures of exercise 
capacity.  Replication of these results is required to assess the value of exercise capacity as 
a predictor of depression course in cardiac patients.    
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Only one of the physical health indicators, blood pressure, had an inverse 
relationship with depressive symptoms.  In this study, those who met the target blood 
pressure at admission reported a significantly higher mean CDS score at admission than 
those who had high blood pressure.  This finding differs to previous research.  In the 
general population depression has not been related to blood pressure (Konttinen, Haukkala, 
& Uutela, 2008; Miller et al., 2003; Yan et al., 2003), and previous research in cardiac 
populations has similarly found no significant relationship (Stein et al., 2000), though 
depression has been found to be related to blood pressure reactivity during episodes of 
stress (Thornton & Hallas, 1999).  No record was taken in this study of blood pressure 
medication, which would need to be assessed to further explore this relationship.  
Furthermore, when the variable of cardiac condition acuity was included, this relationship 
was no longer significant, indicating that the significant relationship may have been an 
artefact of the uneven distribution of cardiac condition types across the blood pressure 
groupings.   
 
Depressive Symptoms, Cardiac Program Completion, and Morbidity and Mortality 
The final research aim of this investigation involved exploring the relationship 
between level of depressive symptoms, cardiac rehabilitation program completion and long 
term outcomes of mortality and morbidity.  The hypothesis that higher levels of depressive 
symptoms would be associated with poorer morbidity outcomes was supported.  CDS 
score at admission was significantly correlated with both of the measures of morbidity, 
total number of days spent in hospital during follow-up and number of days spent in 
hospital for cardiac related illness, though the effect size was small.  When the four 
depression categories; Minimal, Mild, Moderate, and Severe depressive symptoms, were 
compared, those in the Minimal depression category spent significantly fewer days in 
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hospital for all causes than those in the other three depression categories, and significantly 
fewer days in hospital for cardiac causes than those in the Severe depressive symptoms 
group.   
These findings are consistent with previous research investigating the relationship 
between depressive symptoms and morbidity in cardiac patients.  Depression following 
AMI has been associated with increases in health care costs through hospital readmissions, 
increased length of stay and increased outpatient contacts (Frasure-Smith et al., 2000; 
Mayou et al., 2000; Sayers et al., 2007; Strik et al., 2003) and more frequent need of 
surgical intervention (Lauzon et al., 2003; Sullivan et al., 2003).   Depression is also 
associated with increased medical comorbidity (Thombs et al., 2008) and poorer physical 
recovery from coronary heart disease and revascularisation procedures (de Jonge et al., 
2006; Doering et al., 2005; Ruo et al., 2003; Sullivan et al., 1997; Thombs et al., 2008).  
Depression has been found to predict cardiovascular events, both fatal and non fatal, in 
patients with AMI (Jaffe et al., 2006; Shiotani et al., 2002), unstable angina (Lesperance et 
al., 2000), heart failure (Rutledge et al., 2006), coronary artery disease (Frasure-Smith & 
Lesperance, 2008), and in those who have undergone CABG (Burg et al., 2003; Oxlad et 
al., 2006; Rafanelli et al., 2006; Tully et al., 2008). 
Not all studies have found a significant relationship between depressive symptoms 
and morbidity.  In a study by Lane and colleagues (2000) depression did not predict 
cardiac events, fatal and non-fatal, in the twelve months following AMI.  In a large study 
of elderly patients with heart failure, depression was not predictive of re-hospitalisation, 
though it was predictive of vascular events and mortality (Macchia et al., 2008).  In one 
study of AMI patients, Strik and colleagues reported that depression predicted cardiac 
events but not health care costs (Strik et al., 2003), but the reverse finding was reported in 
another study of patients with first ever AMI (Strik et al., 2004).  
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It has been suggested that the relationship between depression and poorer outcomes 
is due to researchers’ failure to account for the possible confounding effect of disease 
severity (Lane et al., 2000).  However several studies have reported the significant 
relationship remains once the influence of disease severity is controlled statistically (Burg 
et al., 2003; de Jonge et al., 2006; Frasure-Smith & Lesperance, 2008; Lesperance et al., 
2000; Oxlad et al., 2006; Shiotani et al., 2002; Tully et al., 2008).   
In this study, no specific measures of disease severity were included, however 
investigation of the impact of cardiac conditions was possible.  Cardiac condition was 
significantly related to morbidity, with Heart Failure patients having significantly more 
days in hospital, both for all causes and for cardiac causes, than those in the AMI/Stent 
condition category. Furthermore, cardiac condition acuity was significantly related to 
morbidity, with those with chronic conditions spending a significantly greater number of 
days in hospital both for all causes and cardiac causes than those with acute conditions. 
The relationship between depressive symptom levels and morbidity and mortality 
outcomes was re-assessed controlling for cardiac condition acuity. When the impact of 
cardiac condition acuity was controlled, those in the Moderate and Severe depressive 
symptom groups still spent significantly greater number of days in hospital for all causes 
than those in the Minimal group, however there were no significant differences for the 
number of days in hospital for cardiac causes.  Whilst this is a crude measure of cardiac 
condition severity, it does emphasise the importance of controlling for the impact of illness 
severity when assessing the relationship between depression and morbidity outcomes.     
More recently researchers have suggested that the presence of depressive symptoms 
may not be specific enough to determine risk of poorer outcomes.  Spijkerman and 
colleagues (2005) reported that depression is more related to AMI severity in patients 
experiencing their first depressive episode following the cardiac event, whereas depression 
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in AMI patients with a history of recurrent depressive episodes is more related to 
personality traits.  They suggested that these subtypes might have differential impacts on 
prognosis (Spijkerman et al., 2005), with a later study finding that only incident episodes 
of depression, that is, those with onset after AMI rather than those pre-existing the AMI, 
predicted new cardiovascular events in the year following AMI (Peter de Jonge, van den 
Brink, Spijkerman, & Ormel, 2006).   
Thombs and colleagues (2008) also found a trend for new onset depressive 
symptoms to predict poorer health at 12 months post acute coronary syndrome.  However, 
they reported that persistence of depressive symptoms post cardiac event was a more 
important predictor of prognosis.  Findings indicated that patients with persistent 
depressive symptoms, but not those with transient depressive symptoms, had significantly 
poorer health at 12 months post cardiac event than those without depressive symptoms 
(Thombs et al., 2008).  This echoes earlier findings that course of depressive symptoms 
over the twelve months following AMI predicts prognosis, with patients with sustained 
elevated or increasing depressive symptoms experiencing significantly higher risk of new 
cardiovascular events over a mean follow-up period of 2.5 years (Kaptein et al., 2006).   
In this study, no relationship was found between depression course and morbidity 
outcomes.  The failure to replicate these previous findings may be due to several reasons.  
Firstly, the present sample comprised cardiac patients with a range of diagnoses, compared 
to the previous studies focussing solely on patients following AMI.  When the same 
analysis was conducted with just those patients with a diagnosis of AMI or AMI/Stent, the 
relationship remained non-significant, however this reduced the participant pool (N = 164), 
a figure substantially lower than that of the two previous studies (N = 425 and 475) which 
may have resulted in insufficient power for this analysis.  Secondly, the initial assessment 
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of depressive symptoms occurred at entry to cardiac rehabilitation compared to during 
hospitalisation in the cited studies.   
Whilst no single course of depressive symptoms has been defined following cardiac 
event (Grace, Abbey, Pinto et al., 2005; Luutonen et al., 2002; McCrone et al., 2001; 
Schrader et al., 2004; Timberlake et al., 1997; Trelawny-Ross & Russell, 1987), it is 
possible that persistence of depressive symptoms from illness onset (hospitalisation) is the 
important factor, and this information was not available for this study’s set of participants.  
Additionally, the sub group of patients included in the analysis of depressive symptom 
course comprised those patients for whom CDS scores were available at all four time 
points.  This excluded all patients who dropped out of cardiac rehabilitation or dropped out 
during follow-up.  The patients who did not complete cardiac rehabilitation had 
significantly poorer morbidity outcomes than those who completed the program.  Had it 
been possible to include them in this analysis of depressive symptom course the results 
may have replicated those of previous studies.  Furthermore, it is possible that the impact 
of completing cardiac rehabilitation may influence the relationship between depressive 
symptom course and morbidity outcomes.  Further analysis of this relationship is 
warranted.   
The hypothesis that higher levels of depressive symptoms would be associated with 
poorer mortality outcomes was also supported. The average CDS score at admission was 
significantly higher for those who died during the follow-up period than those who 
survived, however the effect size was small.  Those in the Severe depressive symptoms 
category at admission had higher odds of death than those in the Minimal group (OR= 
1.56). There were significant differences between cardiac condition groups for mortality 
outcomes, with those in the AMI and CABG’s groups having significantly higher mortality 
rates during follow up than those in the AMI/Stent group, and those in the Heart Failure 
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group having a significantly higher rate of mortality than those in both the AMI/Stent and 
the Stent group.  The relationship between mortality and higher levels of depressive 
symptoms remained when cardiac condition acuity was accounted for. 
These results are consistent with previous research findings that depression is 
associated with an increased risk of mortality in patients with cardiac conditions (Barth et 
al., 2004; Nicholson et al., 2006; Rutledge et al., 2006; Van Melle et al., 2004), with most 
studies reporting a positive relationship with greater symptom severity predicting greater 
mortality risk (Jiang et al., 2007; Lesperance et al., 1996; Murberg & Furze, 2004).  The 
relationship between depression and mortality has been demonstrated in cardiac patients 
following AMI (Bush et al., 2001; Carney et al., 2003; Frasure-Smith et al., 1995), 
coronary artery bypass graft or other cardiac valve surgery (Baker, Andrew, Schrader, & 
Knight, 2001; Blumenthal et al., 2003; Burg, Benedetto, & Soufer, 2003; Ho et al., 2005), 
and in those with unstable angina (Lesperance, Frasure-Smith et al., 2000), coronary artery 
disease (Barefoot et al., 2000), and heart failure (Jiang et al., 2007; Johansson, Dahlstrom, 
& Alehagen, 2007; Murberg & Furze, 2004).   
Not all researchers have found a relationship between depressive symptoms and 
mortality.  Two studies have reported that depression post AMI was not significantly 
related to mortality at 12 months follow-up (Lane et al., 2001a; Mayou et al., 2000), 
however this is a relatively short follow-up period which may have been insufficient to 
detect long term differences in outcome.  Depressive symptoms prior to CABG surgery 
were not related to mortality at two to five years follow-up (Saur et al., 2001; Tully, Baker, 
& Knight, 2008).  However, timing of assessment is important with post-event depressive 
symptoms, assessed during hospitalisation, being the best predictor of mortality when 
compared to history of depression (Dickens et al., 2008; Grace, Abbey, Kapral et al., 2005) 
or depression at later time points (Lesperance, Frasure-Smith, Talajic, & Bourassa, 2002).  
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Stewart and colleagues (2003) reported no relationship between depression in coronary 
artery disease patients and mortality over an 8.1 year follow-up, however patients in that 
study were enrolled in a treatment trial, and thus depression was assessed at various time 
points post cardiac event or onset of cardiac condition.  Unfortunately in this trial no 
assessment of depressive symptoms during hospitalisation was available, precluding 
comparison of the timing of assessment.    
Whilst data on depressive symptom levels during hospitalisation were unavailable 
for the cohort included in this study, depression scores over time enabled categorisation of 
patients into different depressive symptom courses.  Comparison of mortality rates for 
those in the High course, the Decreasing course, and those in the Very Low course 
indicated that those in the High course had significantly higher odds of death during 
follow-up (OR= 6.75) than those in the Very Low course.  There was no significant 
difference in ratio for the Decreasing and Very Low group, or for the Decreasing and High 
group.  This indicates that persistently elevated depressive symptoms are associated with 
poorer mortality outcomes, but that those with decreasing symptoms do not have the same 
elevated level of risk.  This finding is contrary to that of Lesperance and colleagues (2002) 
who evaluated the relationship between depression during hospitalisation, at 12 months 
follow-up, and mortality over five year follow-up.  They reported that depression scores at 
baseline had greater prognostic importance than those at 1 year, and that change in scores 
was unrelated to long term prognosis for those with low and those with severe levels of 
depressive symptoms at baseline (Lesperance et al., 2002).  It is possible that this 
difference in findings is related to the timing of assessment as the study by Lesperance et 
al. (2002) included assessment during hospitalisation as a comparison point, additionally 
the current study findings may be effected by the intervention of cardiac rehabilitation.  In 
the ENRICHD study it was reported that those patients who remained depressed following 
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treatment had significantly higher risk of mortality than those who responded to treatment 
(Carney et al., 2004).  This provides additional support for the suggestion that persistence 
of depression, not just presence of elevated depressive symptoms at a single time point, is 
related to ongoing prognosis.   
The final hypothesis that patients with higher levels of depressive symptoms that did 
not complete the cardiac rehabilitation program would have poorer long-term outcomes 
than those who did complete the program was also supported.  Program completion was 
related to morbidity independently, with patients who completed the program spending 
significantly less time in hospital for all causes and cardiac causes during the follow-up 
period than those who did not complete the program.  This effect remained when patients 
that died within ninety days of admission were excluded from the analysis.   
There was also a significant interaction effect between program completion and 
depression category.  Participants in the Severe depressive symptom category spent 
significantly more days in hospital, both for all causes and cardiac causes, than those in the 
Minimal depressive symptom category if they did not complete the cardiac rehabilitation 
program, but not if they did complete the program.  When participants were assessed 
according to their cardiac condition acuity, this interaction effect remained for those with 
acute cardiac conditions but not for those with chronic conditions.  For participants with 
chronic conditions, program completion was significantly related to morbidity independent 
of level of depressive symptoms.   
The interaction effect between depression category and program completion is of 
particular interest.  Whilst, overall, patients who did not complete the cardiac rehabilitation 
program replicated previous results that higher levels of depressive symptoms are 
associated with poorer morbidity outcomes (Frasure-Smith et al., 2000; Mayou et al., 
2000; Sayers et al. 2007; Strik et al., 2003), the participants who did complete the cardiac 
 212 
rehabilitation program showed similar morbidity outcomes across all of the depressive 
symptom categories.  This indicates that it is possible that participation in cardiac 
rehabilitation may have a therapeutic effect on the relationship between depression and 
outcomes.  Cardiac rehabilitation may be an effective intervention for reducing the risk of 
subsequent morbidity in those cardiac patients with elevated levels of depressive 
symptomatology.  This is consistent with recent findings that participation in cardiac 
rehabilitation was associated with both reductions in depressive symptoms and mortality 
(Milani & Lavie, 2007).   
Whilst cardiac rehabilitation has demonstrated beneficial effects on depression (Ades 
& Coello, 2000; Artham et al., 2008; Denollet & Brutsaert, 1995; Lavie et al., 1999; Milani 
et al., 1996) and long term outcomes of morbidity and mortality (Belardinelli et al., 1999; 
Clark et al., 2005; Giada et al., 2008; O'Connor et al., 1989; Taylor et al., 2004), only 
recently has research begun to investigate the potential impact of cardiac rehabilitation on 
the relationship between depression and poorer outcomes for cardiac patients.   
It is possible that the potential therapeutic effect of cardiac rehabilitation is due its’ 
structured exercise component.  Exercise as a treatment for depression in the general 
population has received much attention (Lawlor & Hopker, 2001).  Whilst several studies 
have reported that exercise is associated with a decrease in depressive symptoms for those 
with mild or moderate depression in the general population (Barbour & Blumenthal, 2005; 
Brenes et al., 2007; Dunn et al., 2005) and the cardiac population (Blumenthal et al., 2005; 
Yu, Lee, Woo, & Hui, 2007), poor research design has precluded definitive evaluation of 
its efficacy as a treatment (Lawlor & Hopker, 2001; Lett, Davidson, & Blumenthal, 2005).  
In the cardiac population its potential effectiveness is two-fold, firstly as a treatment of 
depression leading to a reduction in symptoms (Blumenthal et al., 2007; Lett et al., 2005) 
and secondly for its known direct beneficial effects on cardiac health (Giada et al., 2008).  
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Thus, through both direct and indirect pathways, exercise may improve long-term 
outcomes of morbidity and mortality for cardiac patients with depression. 
The ENRICHD study, reported that depression treatment did not improve long term 
mortality outcomes of patients, however those patients who exercised regularly had half 
the mortality rate of those who did not exercise (Blumenthal et al., 2004). The relationship 
between exercise and improved mortality outcomes remained when baseline levels of 
depressive symptoms and change in symptoms over the course of treatment were 
controlled for (Blumenthal et al., 2004).   
In the recent evaluation of cardiac rehabilitation by Lavie and Milani (2007) patients’ 
improvements in exercise capacity were related to reductions in depressive symptoms and 
subsequent improvement in mortality rates.  It is observations such as these that have 
prompted recommendations for further trials of exercise as a treatment for depression in 
cardiac patients and evaluation of its impact on long term outcomes (Blumenthal, 2008; 
Lett et al., 2005).  This is particularly important given the lack of success of the gold 
standard treatment for depression (pharmacotherapy and evidence-based psychotherapy) in 
averting poorer long term outcomes for depressed cardiac patients in large scale trials 
(Berkman et al., 2003; Joynt & O'Connor, 2005; Sheps, Freedland, Golden, & McMahon, 
2003). The UPBEAT study, currently in progress, aims to further the understanding of this 
relationship through a randomised controlled trial comparing the efficacy of exercise with 
pharmacological intervention (sertraline) in CAD patients (Blumenthal et al., 2007).  
Should the efficacy of exercise be confirmed, cardiac rehabilitation programs are ideally 
structured to implement this treatment on a wide scale.   
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Conclusion 
Whilst this study has helped further knowledge about depression in cardiac 
rehabilitation patients and its relationship with outcomes, the interpretation of these 
findings are restricted by several limitations of the study.   This study was a naturalistic 
follow-up of a cohort of cardiac patients enrolled in a cardiac rehabilitation program over a 
period of seven years.  The study design prevented inclusion of a randomised control 
group.  The comparison groups of completers versus non-completers were self-selected, 
not the product of random allocation, thus it is possible that identified differences between 
the two groups were not due to the effect of cardiac rehabilitation but due to some other 
factor which precipitated both drop-out and outcome differences.   
Furthermore, the study group comprised only cardiac patients who presented for 
initial assessment at cardiac rehabilitation.  This may be unrepresentative of cardiac 
patients as a whole, thus interpretations of these findings can only be applied to cardiac 
rehabilitation patients, not the wider population of all cardiac patients.   However, the 
participant pool included in this study comprised cardiac patients representative of a board 
range of patient demographics, in terms of age, sex, ethnicity, and cardiac diagnoses, and, 
as such, is more representative of the range of cardiac patients than the majority of studies 
which have focussed on specific age groups (e.g., Milani & Lavie, 1998; Shiotani et al., 
2002), sex (e.g., Frasure-Smith et al., 2007; Lavie et al., 1999) or cardiac conditions (e.g., 
Blumenthal et al., 2003; Strik et al., 2003). 
This study was innovative in that it utilised existing databases of patient information 
and used identifying information to link patients across databases to determine long term 
outcomes.  Whilst this demonstrates a useful method for using existing records for large 
scale, long term research, it inhibits a priori decision making about inclusion of relevant 
variables.  In this study, information about patient history of depression and treatment, 
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current depression treatment, depression score on CDS during hospitalisation, and disease 
severity was not available in the databases and thus not able to be included in the analysis.  
There was also no comparable follow-up data for those who did not complete cardiac 
rehabilitation on physical health measures or long term course of CDS depression scores.   
Inclusion of this information would enable stronger inferences to be made from the results 
of this study.   
Despite these limitations, this study achieved its stated aim of conducting a 
comprehensive, large scale investigation into depression and subsequent outcomes in 
cardiac rehabilitation patients.  A clinically significant proportion of cardiac rehabilitation 
patients reported elevated levels of depressive symptoms, and this level was greater for 
those with chronic cardiac conditions than those with acute conditions.  Depression was a 
weak predictor of cardiac rehabilitation completion and did not predict completion once 
sociodemographic variables were controlled for.  For those who completed cardiac 
rehabilitation, a significant reduction in symptoms was experienced between admission 
and discharge, a reduction that was maintained at three and twelve month follow-up.   
Whilst depression was related to poorer physical health at admission, it was not 
related to changes in physical health measures between program admission and discharge. 
Of particular interest was the inverse relationship between depressive symptoms and 
exercise capacity at admission, and the finding that those not achieving exercise targets at 
admission were less likely to achieve these targets at discharge if they had higher levels of 
depressive symptoms.  Furthermore, those with a High depressive course, but not those 
with a remitting symptom course, had poorer exercise capacity than those with a Very Low 
course of depressive symptoms. 
Depression at admission but not depression course was significantly related to long 
term outcomes of morbidity, in terms of number of days spent in hospital for all causes and 
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cardiac causes.  However, the relationship with cardiac bed days became non-significant 
when the effect of cardiac condition acuity was controlled.  Depression at admission was 
related to mortality, as was depression course, with those in the High course having a 
substantially increased rate of mortality compared to those in the Very Low course 
(OR=6.75).  The relationship between depressive symptoms and morbidity outcomes 
differed between those who completed the cardiac rehabilitation program and those who 
did not.  Cardiac patients with higher levels of depressive symptoms spent more days in 
hospital during follow-up than their peers with lower levels of depressive symptoms if they 
failed to complete to complete the cardiac program.  However, there was no significant 
difference in days spent in hospital during follow-up between those with higher and lower 
levels of depressive symptoms for patients who completed the cardiac rehabilitation 
program.   
Overall, these findings indicate that the relationship between exercise, depression, 
and outcomes for cardiac patients warrants further investigation.  If exercise receives 
further support as an effective treatment for depression in cardiac patients and influences 
the associated morbidity and mortality, such as through the study by Blumenthal and 
colleagues (2007), cardiac rehabilitation has the potential to deliver this treatment on a 
wide scale with little alteration to its current format.  Further evaluation of the capacity of 
cardiac rehabilitation to address depression as a secondary risk factor is required.  Whilst 
support has been identified in this study for cardiac rehabilitation as a therapeutic 
intervention for depression, the aspects of cardiac rehabilitation involved in this need to be 
examined.  The exercise component has received support here and in other research, 
however other aspects may be equally important.  For example, the social support provided 
through group based programs or the promotion of self-efficacy through increased 
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knowledge about self-management strategies for cardiac conditions may exert beneficial 
influences on depression.   
The potential for improvement of cardiac rehabilitation as a comprehensive 
intervention for depression should also be addressed.  The role of cardiac rehabilitation 
programs in addressing depression in cardiac patients could be strengthened through 
inclusion of routine assessment of depressive symptoms, provision of treament within the 
program, or referral for treatment externally. Whilst a randomised controlled trial of the 
relationships between cardiac rehabilitation, depression and outcomes would be unethical 
(Milani & Lavie, 2007), a matched subjects design with comprehensive follow-up data for 
non-attenders or non-completers is recommended.   
Depression is a significant clinical issue for cardiac patients. Depression is associated 
with poorer quality of life, and poorer morbidity and mortality outcomes.  Cardiac 
rehabilitation shows potential as an effective intervention with completers showing 
significant improvements in depressive symptom levels and long-term outcomes.  
Replication of these findings, and further, more rigorously controlled, evaluations of the 
processes by which these outcomes are achieved are recommended.   
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Appendix A 
Published Depression Prevalence Rates in Cardiac Patients 
 
 
Country & Study Participants  Condition  Recruitment   Time since     Measure           Incidence 
                    event 
 261 
Australia     
 
Baker, Andrew, Schrader  158 (25%) 65.4 yrs CABG   Inpatient 1 day pre DASS  15.2% 
& Knight (2001) 
 
Choek, Schrader, Banham, 1455 (32%) 62.2 yrs AMI / unstable angina / Inpatient Inpatient CES-D / HADS 46.3 % 
Marker & Hordacre (2003)    arrhythmia / CHF /               (CES-D only = 44.6%) 
CABG / angioplasty       (HADS only=24%) 
        
 
Farley, Wade & Birchmore  85 (35%) 64.8yrs  ACS   Inpatient post-discharge CES-D  24 % 
(2003)                        (6%mild, 19%mod/sev) 
 
Di Benedetto, Lindner,   81 (19%) 57 yrs  AMI / unstable angina /  Inpatient 2 weeks  CIDI  11% 
Hare & Kent (2006)     ACS       BDI  32% 
 
Parker, Heruc et al (2006) 489 (29.6%) 65.8yrs ACS   Inpatient Inhospital CIDI  10.6% 
(major) 
                
Schweitzer, Head & Dwyer  115 (29.4%) 63 yrs Heart Failure  Inpatient & Outpatient n/r BDI  33.3% 
(2007) 
 
Australia & New Zealand    
 
Stewart, North et al (2003) 1130 (19%) n/r  AMI / unstable angina Inpatient >5months GHQ  22% 
 
Country & Study Participants  Condition  Recruitment   Time since     Measure           Incidence 
                    event 
 262 
Japan 
 
Shiotani, Sato et al (2002) 1042 (19%) 63 yrs AMI   Inpatient 10 days - 3 months Zung SDS 42% 
 
Hata, Yagi et al (2006)  452 (35.2%) 65 yrs Open heart  Inpatient In hopsital CES-D  21.5 % 
       surgery 
 
Taiwan     
 
Chiou, Potempa &   40 (12.5%) 63 yrs AMI   Inpatient 3-5 days  HADS  30% 
Buschmann (1997)                        (15% mild, 15% severe) 
 
Lahore 
 
Akhtar, Malik & Ahmed (2004) 100 (20%) 50.9yrs AMI   Inpatient 5-7 days  HADS  14% 
 
Canada     
 
Frasure-Smith, Lesperance,  896 (32%) 59.4 yrs AMI   Inpatient In hospital BDI  33% 
Juneau, Talajic & Bourasssa (1999)                 (47% females, 26% males) 
 
Lesperance, Frasure-Smith,  430 (29%) 62 yrs  CAD / unstable angina Inpatient In hospital DIS  15.1 %  
Juneau & Theroux (2000)           BDI  41.4% 
 
Lauzon, Beck et al. (2003) 550 (21%) 60 yrs  AMI   Inpatients 2-3 days  BDI  35 % 
 
Country & Study Participants  Condition  Recruitment   Time since     Measure           Incidence 
                    event 
 263 
Grace, Krepostman et al  661 (23.8 %) 61.2 yrs AMI / unstable angina  Inpatients In hospital HADS  14.7% 
(2005)       CHF / PCI / CABG  
 
Grace, Abbey et al (2005) 750 (35.2%) 61.6 yrs AMI / unstable angina    Inpatients In hospital BDI  31.3% 
 
Mitchell, Robertson et al (2005) 137 (47%) 63.3 yrs CABG   Inpatients Pre-admisison BDI / MINI 28.2 %  
            6-12 weeks   16.4 %  
 
Kronish, Rieckmann et al 492 (41%) 60 yrs  ACS   Inpatients <7 days  BDI  44.7%   
(2006)            3 months   25.2% 
 
Morgan, Masoudi et al (2006) 522 (235) 61 yrs  Heart Failure  Outpatients n/r  MOS-D  29% 
 
 
USA  
    
Barr-Taylor, Houston-Miller,  210(0%) 52yrs  AMI   Inpatient 3 weeks  Ham-D  13% 
Ahn, Haskell & DeBusk (1986)      
 
Carney, Rich et al. (1988) 52 (27%) 55 yrs  CAD   Inpatient 1 day prior DIS  17% 
 
Schleifer, Macari-Hinson  283 (36%) 64 yrs  AMI   Inpatients 8-10 days SADS / DIS 45% 
et al. (1989)           3-4 months   33%  
 
Forrester, Lipsey, Teitelbaum,  129 (26%) 58 yrs  CAD   Inpatients <10days  PSE   21% 
DePaulo & Andrzejewski (1992)             (19%dep, 2%dysthymia) 
 
Country & Study Participants  Condition  Recruitment   Time since     Measure           Incidence 
                    event 
 264 
Hance, Carney, Freedland  200 (n/r) n/r  CAD   Inpatients On day of DIS  34% 
& Skala (1996)           procedure       (17%major, 17%minor) 
 
Milani, Lavie & Cassidy (1996) 338 (22%) 63 yrs  AMI / CABG /   Cardiac rehabilitation Entry Kellner SQ 20 % 
       Angioplasty 
 
McKhann, Borowicz,  124 (21%) 63 yrs  CABG   Inpatient Pre-surgery CES-D  27 %  
 Goldsborough, Enger & Selnes (1997)         1 month    24.2 % 
 
Brummett, Babyak et al (1998) 506 (32%) 63 yrs  Angiography  Inpatient In hospital CES-D  42%  
          Community 1 month    38%  
 
Con, Linden, Thompson  90 (33%) 65.5 yrs  CABG   Inpatient > 3days  BDI  41% 
& Ignaszewsksi (1999)                                   (54% female, 35% male) 
 
Pirraglia, Peterson,   218 (19%) 65.3 yrs CABG   Inpatient < 7 days pre CES-D  43%  
Williams-Russo,  Gorkin & Charlson (1999)       6 months post   23.4% 
 
Barefoot, Brummet et al. (2000) 1250 (18%) 52 yrs CAD / Angiography Inpatient In hospital ZUNG-SDS 11% 
 
Bush, Ziegelstein et al. (2001) 285 (42%) 64.8 yrs AMI   Inpatient 2-5 days  BDI  14.3 % 
 
Connerney, Shapiro,   309 (33%) 63.1 yrs post CABG  Inpatient 4-10 days DIS / BDI 20% 
McLaughlin, Bagiella & Sloan (2001)  
 
Country & Study Participants  Condition  Recruitment   Time since     Measure           Incidence 
                    event 
 265 
Jiang, Alexander et al (2001) 357 (36%) 63 yrs  CHF   Inpatient In hospital BDI  35.3% 
              DIS  13.9% 
 
McCrone, Lenz, Tarzian  31 (35%) 70yrs  CABG   Inpatient Pre-surgery CES-D  26% 
& Perkins (2001)          2-3 days    65% 
            8 weeks    29% 
            12 weeks   26% 
 
Saur, Granger et al. (2001) 416 (28%) 63.5 yrs pre CABG  Inpatients Pre-surgery SF-36 MHS 10-11% 
 
Blumenthal, Lett et al. (2003) 817 (23%) 61 yrs  CABG   Inpatient 1 day prior CES-D  38% 
                         
(12%major, 26%minor) 
 
Burg, Benedetto, Rosenberg  89 (0%) 66 yrs  CABG   Inpatient <1 week prior BDI  28%  
& Soufer (2003) 
 
Freedland, Rich et al (2003) 682 (52%) 66 yrs  CHF   Inpatient n/r  DIS  36% 
                       (20% major, 16% minor) 
              BDI  51% 
 
Ruo, Rumsfeld et al (2003) 1024 (18%) 66 yrs Stable CHD  Outpatient n/r  PHQ  20% 
 
Sullivan, LaCroix, Spertus,  198 (17%) 62 yrs  CAD / Angiography Inpatient In hospital DIS / Ham-D 31% 
Hecht & Russo (2003)                     (12% major, 19%minor) 
 
Zeigelstein (2003)  204 (43%) 64.3 yrs AMI   n/t  n/r  BDI  17.2 % 
 
Gottlieb, Khatta et al (2004) 155 (21%) 64 yrs  Heart Failure  Outpatient n/r  BDI  48% 
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Gehi, Mangano, Pipkin,   873 (18%) 67 yrs  Stable CHD  Outpatients n/r  CDIS-IV 22.3% 
Browner & Whooley (2005)  
 
Ho, Masoudi, Spertus,   648 (2%) 65 yrs  Valve surgery  Inpatients n/r  MHI-5  29.2%  
Peterson, Shroyer, McCarthy et al (2005) 
 
Sanderson & Bittner (2005) 228 (100%) 62 yrs CHD    Cardiac Rehabilitation Intake BDI-II  31 % 
 
Sherwood, Hinderliter, Watkins,  143 (30.8%) 63 yrs CHD   n/r  n/r  BDI  32.8 % 
Waugh & Blumenthal (2005) 
 
Ziegelstein, Kim et al (2005) 60 (40%) 66 yrs  AMI   Inpatient 2-5 days  BDI  30% 
  
Doering, Magsarili, Howitt 75 (100%) 62 yrs  CABG   Inpatient In hospital DISH  36% 
 & Cowan (2006)                   (9.3% major, 26.3% minor)
  
Huffman, Smith et al (2006) 74 (22%) 63.1 yrs AMI   Inpatient < 3 days  SCID  12% 
              BDI-II  28% 
 
Rieckmann, Gerin et al (2006) 172 (45%) 59 yrs  ACS   Inpatients < 1 week BDI  45.9% 
                                   (28.5%mild,17.4%mod/sev) 
 
Urizar & Sears (2006)  120 (29%) 66yrs CHD   Outpatients  n/r  CES-D  25.8% 
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Brazil     
 
Fraguas, Ramadan, Pereira  50 (14%) 54.4 yrs CABG   Inpatient 1-3 days pre Ham-D  22 %  
& Wajngarten (2000)          1-3 days prior to discharge 21%  
    
UK     
 
Trelawny-Ross & Russell 31(0%) n/r  AMI   Inpatient In hospital Goldbergs -CIS 26 % 
 (1987)           10 days    20% 
            2 months   26% 
            6 months   26% 
 
Timberlake, Klinger et al (1997) 121 (9.9%) 56 yrs CABG   Inpatients Pre-surgery BDI  37%  
            8 days    50 % 
            8 weeks    24%  
            12 months   23 %  
  
O’Rourke & Hampson (1999) 60 (30%) 58 yrs  AMI   Inpatient 3-5 days  HADS  20% 
 
Martin & Thompson (2000) 194 (27%) 63 yrs  AMI   Inpatient <1 day  HADS  25% 
 
Mayou, Gill, Thompson, Hicks,  344 (27%) 63.2 yrs AMI   Inpatient av <48 hrs HADS  17.5% 
Volmik & Neil (2000) 
 
Lane, Carroll, Ring,  Beevers  288 (25%) 63 yrs  AMI   Inpatient 2-15 days BDI  30.9 % 
& Lip (2000, 2002) 
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Turner, Bethell, Evans,   1443 (20%) 60 yrs AMI / CABG / Angina / Cardiac Rehabilitation Intake HADS  12.6% 
Goddard & Mullee (2002)    Angioplasty / Valve surgery / other 
 
Fitchett, Doherty et al (2003) 16 (12%) 58 yrs  ICD   Inpatient n/r  HADS  44% 
 
Martin, Lewin & Thompson  335 (33%) 67 yrs  AMI   Inpatient < 1 week HADS  15.2%  
(2003)            6 weeks    12.5%  
            6 months   10.4%  
 
Steeds, Bickerton, Smith  131 (n/r) n/r  AMI   Inpatient 2-7 days  BDI-II  47% 
& Muthuamy (2003) 
 
Dickens, McGowan et al  589 (30%) 60 yrs  AMI   Inpatient 3-4 days  HADS  23.8% 
(2004) 
 
Harrison (2005)  130 (n/r) n/r  AMI / cardiac surgery Cardiac Rehabiltation  1-6 months  HADS  13.1% 
 
Bane, Hughes & McElnay  122 (41.2%) 54 yrs IHD / CHF  Outpatients n/r  CES-D  41.7% 
(2006) 
 
Denmark 
 
Sorenson, Brandes et al (2005) 899 (24.8%) 59.2 yrs ACS   Inpatients av. 7 days MDI  10.0% 
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Finland     
 
Lehto, Koukkunen et al (2000) 414 (31.4%) 61.7 yrs CHD   Inpatient > 6 months DEPS  14-19% 
 
Valkamo, Hintikka et al (2001) 144 (26%) 59.4 yrs CHD / angiography Inpatient 1 day prior BDI  24% 
     
Luutonen, Holm, Salminen,  85 (24%) 60.7 yrs AMI   Inpatient In hospital BDI  21.2%  
Risla & Salokangas (2002)         6 months   30.0% 
            18 months   33.9% 
 
Salminen, Isoaho, Vahlberg,  222 (52.3%) 74 yrs CHD   General  n/r  ZUNG- SDS 26.6 % 
Ojanlatva & Kivela (2005) 
 
Netherlands 
 
Strik, Honig, Lousberg &  206 (24%) 59 yrs  AMI   Inpatient 1 month  SCID / HAM-D 18.7% 
Denollett (2001)                    (11% major, 7.7% minor) 
 
Strik, Denollet, Lousberg 318 (0%) 58yrs  AMI   Inpatient 1 month  SCL-90  47.1% 
& Honig (2003) 
 
Pederson, van Domburg   221 (19%) 62 yrs  ICD   Inpatient n/r  HADS  28% 
et al (2004) 
 
Spijkerman, van den Brink,  502 (19%) 61 yrs  AMI   Inpatient n/r  BDI  23.5% 
Jansen, Crijns & Ormel (2005) 
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de Jonge, Spijkerman,  421 (20%) 61 yrs  AMI    Inpatient 3 months CIDI  25.2%  
van den Brink & Ormel (2006)         & 1 year   (during 12 months) 
 
Norway 
 
Havik & Maeland (1990) 383 (n/r) 59.3 yrs  AMI   Inpatient av. 9 days SED-Q / Clinician rating  19% 
 
Sweden 
 
Edell-Gustafsson & Hetta 38 (0%) 61 yrs  CABG   Inpatient < 3 days prior Zung SDS 16% 
(1999)            1 month    26% 
            6 months   13% 
Germany 
 
Ladwig, Lehmacher et al.  552 (0%) 54 yr  AMI   Inpatient 17-21 days n/r  14 % 
(1992)  
 
Rothenhausler, Grieser   34 (35%) 68.2 yrs CABG   Inpatient 1-3 days pre SCID  20.5% 
et al (2005)                  (11.8% minor, 2.9%, major, 5.9% dysthmia) 
 
Italy 
 
Rafanelli, Roncuzzi et al. (2003) 61 (15%) 60.7 yrs AMI   Cardiac rehabilitation Intake DIS  11.4% 
            <1 month post AMI     (major1.6%, minor 9.8%) 
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Rafanelli, Roncuzzi &   47 (23%) 66 yrs CABG   Cardiac rehabilitation Intake SCID  23.4% 
Milaneschi (2006)         <1 month post CABG    (major 10.6%, minor 12.8%) 
 
 
 
 
Note. Participants are reported as total number (% female), and mean age.  Prevalence rates are the percentage of participants who exhibited a level of 
depressive symptoms warranting clinical diagnosis. n/r indicates not reported. 
a. AMI = acute myocardial infarction; CAD = coronary artery disease; CABG  = coronary artery bypass graft; ICD = implantable cardiovascular 
defibrillator. 
b.  
self report questionnnaires 
CES-D - Center for Epidemiological Studies Depression Scale;  
HADS - Hospital Anxiety and Depression Scale;  
BDI - Beck Depression Inventory;  
BDI-II - Beck Depression Inventory  second edition 
Ham-D - Hamilton Depression Rating Scale;  
GHQ - General Health Questionnaire;  
Kellner SQ - Kellner Symptom Questionnaire;  
Zung SDS - Zung Self-rating Depression Scale;  
SF-36 MHS - Medical outcomes study Short Form health survey - Mental Health Scale;  
SED-Q - n/r,  
DASS - Depression Anxiety & Stress Scales 
MOS-D - n/r 
PHQ- Patient Health Questionnaire 
MHI-5 - n/r 
DEPS - Depression Scale 
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MDI - Major Depression Inventory 
SCL-90 - Symptom Check List - 90 
 
 
Interview Schedules 
DIS - Diagnostic Interview Schedule;  
PSE - Present State Examination;  
SADS - Schedule for Affective Disorders and Schizophrenia;  
MINI - Mini International Neuropsychiatric Interview 
CIDI - Composite International Diagnostic Interview 
DISH - Diagnostic Interview and Structured Hamilton 
Goldbergs - CIS - Goldbergs Clinical Interview Schedule 
 
  
 
